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This work investigates the application of Subsensory Electrical Noise Stimulation 
(SENS) to improve symptoms of HIV-related peripheral sensory neuropathy (HIV-
PN). HIV-PN occurs in roughly half of the 5 million people in South Africa with HIV. 
The disease has been shown to reduce quality of life and increase the risk of secondary 
ailments. Currently there is no treatment available. 
Previously, SENS has shown promise to improve tactile sensitivity in healthy 
populations and elderly individuals with peripheral neuropathic desensitisation. This 
work first establishes if SENS can improve the peripheral sensitivity of patients with 
HIV-PN, and secondly addresses practical aspects of using SENS in a therapeutic 
context. 
The vibrotactile sensitivity deficits of participants with HIV-PN and a matched control 
cohort is documented and analysed. It is found that HIV-PN participants have reduced 
sensitivity at all tested vibration frequencies (25 Hz, 50 Hz and 128 Hz), but especially 
at low frequencies. The interaction with vibration frequency indicates that HIV-PN may 
interact differently with different types of peripheral mechanoreceptors. 
SENS is then applied at four different amplitudes in an attempt to improve perception 
thresholds of the three vibration frequencies. SENS was shown to generally have a 
beneficial effect on 50 Hz vibration sensitivity for low SENS amplitudes. It had no 
effect, or a detrimental effect, at high SENS amplitudes, and also for 25 Hz and 128 Hz 
vibration frequencies. This work is also the first to document measures of pain with 
interventions of this type. No clear effects of SENS on sensations of pain were 
observed, which is a vital outcome if the therapy is to be developed further, since 
neuropathic pain is a frequent symptom of HIV-PN. 
The application of SENS as a practical therapy requires the accurate measurement of 
the participant’s electrical perception threshold, and a wearable device to apply the 
electrical signal on an ongoing basis. Research into the stability of electrical perception 
thresholds specifically aimed at subthreshold signals that would improve tactile 
sensitivity is presented. It was found that these thresholds vary wildly and correlated 
very little with possible explanatory variables, which introduces a new challenge for 
the development of SENS in future research. 
Currently there are no devices available to apply SENS in non-laboratory settings or 
for continuous use. The electronic design of a stimulator for using SENS as a wearable 
intervention is presented and characterised. The circuit is an efficient, low-power 
voltage to current converter that generates high voltages (120 V peak to peak) from a 
small, low-voltage rechargeable battery. The design and testing of control and 
instrumentation circuitry, as well as the addition of various safety and interface features 
is also documented. The battery life of the circuit is tested to operate for up to 33 hours 
and the circuit is tested to operate as expected in vivo. 
The results of this work demonstrate the potential viability of SENS as a therapy for 
HIV-PN, reveals the variability of electrical perception thresholds, explores the 
measures of pain for SENS interventions, and provides a complete and thoroughly 
tested design and implementation of an unparalleled electronic stimulator for non-
laboratory environments. The conclusions of this work form both a strong theoretical 
and practical basis for future SENS intervention research.  
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GLOSSARY AND ABBREVIATIONS 
AC Alternating Current (an electrical signal that changes in amplitude 
with time, usually with a periodic component). (see DC) 
ADC Analogue to Digital Converter. 
ART Antiretroviral Therapy. 
Axon Long slender nerve fibre that carries spike information/action 
potentials. (see Spike or action potential) 
Boost A voltage converter that increases the input voltage to a higher level. 
BPNS Brief Peripheral Neuropathy Screening tool. 
Buck A voltage converter that reduces the input voltage to a lower level. 
Case-control A scientific study design where results are compared between two 
groups of participants exposed to different conditions. (see Crossover) 
Compliance The amount of voltage a current source can provide in order to 
overcome the load impedance and achieve the desired output current. 
Crossover A scientific study design where results are compared for each subject 
separately between two conditions. (see Case-control) 
DAC Digital to Analogue Converter. 
DC Direct Current (an electrical signal which does not alter amplitude 
over time). (see AC) 
Distal Situated away from the head, centre of the body or point of 
attachment. (see Proximal) 
Duty cycle The ratio of ‘on’ time to ‘off’ time for something that is cycling on 
and off with a set frequency. 
EPT Electrical Perception Threshold. 
Hallux A person’s big toe. 
HIV Human Immunodeficiency Virus. 
HIV-PN HIV-related Peripheral sensory Neuropathy. 
HVCP High Voltage Current Pump. 
HVPSU High Voltage Power Supply. 
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Li-Po Lithium-Polymer battery technology. 
Noise A time varying signal with multiple present frequencies such that a 
pattern cannot be observed and exact future values cannot be predicted 
from past values. 
PCB Printed Circuit Board. 
PN Length dependent poly-neuropathy or Peripheral Neuropathy. 
PND Peripheral Neuropathic Desensitisation. 
Proximal Situated closer to the head, or centre of the body, or point of 
attachment. (see Distal) 
SENS Subsensory Electrical Nerve Stimulation. 
Signs Features of a disease detected through medical examination. (see 
Symptoms) 
Spike or action 
potential 
A spike shaped change in the membrane voltage of a neuron occurring 
when a neuron is stimulated above its threshold. Spikes travel along 
the neuron and convey information to subsequent neurons (over 
simplification). 
RMS Root Mean Square, a measure of the amplitude of a signal over time. 
(see AC) 
SR Stochastic Resonance. 
Symptoms Features of a disease that are apparent to the patient. (see Signs) 
TENS Transcutaneous Electrical Nerve Stimulation (usually applied at 
perceivable amplitudes). 
TF Tuning Fork. 
TNSr Reduced version of the Total Neuropathy Screen. 




The work that follows is the accumulation of projects and sub-projects completed over 
a period of years for the singular goal of ultimately intervening to improve tactile 
sensitivity in patients with HIV-related peripheral sensory neuropathy (HIV-PN). 
This foreword introduces the thesis and describes the way in which the various chapters 
inter-relate. It further acts to highlight the challenges overcome by, and value of the 
work. Finally, any conventions used in writing this thesis are outlined. 
Origins of the work 
This thesis originates from previous work conducted by the primary supervisor, 
Dr Breen from 2012 to 2015, which showed improvements in tactile sensitivity in 
healthy and elderly participants when using benchtop equipment to stimulate 
participants’ peripheral nerves in a particular manner. The intervention uses Subsensory 
Electrical Nerve Stimulation and has been dubbed SENS. Little was known about how 
SENS worked, and consequently which types of peripheral neuropathic desensitisation 
could be affected. Further, SENS was only known to have an effect while being applied, 
but no tool existed that was capable of applying it in everyday life. 
At a similar time, The University of Cape Town (South Africa) was conducting a 
follow-up examination of a cohort of patients with HIV. The study sought to document 
the progression of various physiological parameters prospectively over a period of 
years after enrolment in an anti-retroviral therapy program. It was very evident that the 
prevalence of HIV-PN was extensive. 
The original project goals where thus firstly, to investigate if Dr Breen’s SENS would 
be effective in reducing symptoms of HIV-PN, and secondly, to research and address 
limitations that prevented SENS from being used in non-laboratory conditions. 
To this end, a partnership between the two universities was formed. Work relating to 
the question of how to apply the intervention was the realm of Western Sydney 
University (Australia), and work with the HIV patients was the realm of The University 
of Cape Town (South Africa). 
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Chapter descriptions 
Chapter 1 presents an extensive analytical review of prior work attempting similar 
interventions to improve sensory perception. The meta-analysis contained therein 
examines results from the existing literature in detail, identifying several “holes” in the 
previous research and where scientific rigor could be improved. Chapters 2, 3, 4, 5, and 
6 seek to fill some of those holes, but were not necessarily conducted in sequence, and 
in many instances the work ran in parallel. 
Chapters 2 and 3 document research completed at the University of Cape Town, 
working with HIV patients diagnosed with HIV-PN, and age matched control 
participants. It cannot be overstated how unique and challenging this population is to 
work with, and how fortunate we were to have this opportunity. Both cohorts primarily 
live in shanty towns, have limited access to technology and for the most part, grew up 
in a socio-political and economic context where they were denied various human rights 
including access to education and health care. More than 5 million people in South 
Africa have HIV, the vast majority of which still live with the adverse effects of 
Apartheid in their daily lives. Compare this to Australia where there are only 25 000 
people with HIV. 
We entered into this research with a fair degree of ignorance as to how alien our 
research was and how difficult it would be to communicate the experimental tasks. In 
retrospect, our plan to have a young white man (the researcher) in a closed office, doing 
experiments with black South African women, was a significant oversight considering 
the social relations in post-Apartheid South Africa. Our saving grace was the expertise 
and skill of Noluthando Primrose Mgwayi, our fieldworker who recruited our patients 
and controls, acted as a translator, both in language and culture, and sat in on all the 
patient testing. The research would have failed without her. 
Chapter 2 creates the premise for Chapter 3. In order to intervene to improve tactile 
sensitivity of patients with HIV-PN, first we must document the effects of the disease 
on vibrotactile sensitivity compared to a matched control cohort. This work presents 
the first such documentation with HIV-PN using a double blinded protocol at various 
vibration frequencies, measuring perception levels in mechanical units which can be 
repeated by others. Chapter 2 in part has been published in “Brain and Behaviour”, an 
open access peer-reviewed journal [1]. The target audience for this work is those 
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working in fields linked with neuropathy, as opposed to Chapter 3, which has a target 
audience of those working to develop this particular class of tactile intervention. 
Chapter 3 uses the baseline data collected in Chapter 2 and investigates the effects of 
SENS in this cohort. It should be noted that even the control, non-HIV participants are 
sufficiently different from past research that it is uncertain as to whether they will 
exhibit a response to SENS. This chapter is the first report of the effect of SENS with 
HIV-PN and also the first to report changes in symptoms of pain in response to this 
class of intervention. This addresses an important short-coming of past work and will 
hopefully lead to the inclusion of neuropathic pain assessment in future research 
attempting to enhance tactile sensitivity in neuropathic populations. 
This work has yet to be submitted as a journal publication, but preliminary findings of 
this work were presented in part at the Australasian Neuroscience Society Annual 
Scientific Meeting in 2016 [2]. 
The application of SENS required the measurement of the participant’s electrical 
perception threshold. It was clear during the measurement of the data for Chapter 3 that 
this threshold did not behave in the stable and easy to detect manner described many 
times in the literature. We suspected that, through using simple single blinded 
measurement protocols, along with the strong expectation that this variable was stable, 
past researchers had placed reality into a preformed mould. Since the stability of the 
electrical perception threshold is core to the theory of operation of SENS, this justified 
research into the idea independently of other research questions. 
Chapter 4 presents the only known research into the stability of electrical perception 
thresholds specifically aimed at subthreshold signals that would improve tactile 
sensitivity. We found that these thresholds vary wildly and correlated poorly with 
possible explanatory variables. This matched well with observations made when trying 
to apply these subthreshold signals in Chapter 3, where finding the threshold was like 
chasing a rabbit in the dark. Indeed, even when found with certainty, in the experiments, 
mere minutes later, the previously subthreshold signal could become apparent to the 
participant. 
This research raises a big and important flag in the use of SENS and other subthreshold 
interventions. However, it does not propose a solution beyond recommending further 
research into the topic. 
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This chapter was published in part as a paper and presentation at the 2017 39th Annual 
International Conference of the IEEE Engineering in Medicine and Biology Society 
(EMBC) [3].  
Chapters 5 and 6 present the design of a SENS stimulator for wearable interventions. 
Part of Chapter 4 characterised the impedance of the connection between the stimulator 
and the participant. This data demonstrated that high voltages would be needed to apply 
SENS. The design of a high-voltage stimulator for arbitrary signals, that is also small 
and battery operated is very challenging. An experienced biomedical electronics-
engineer at several points during the design pointed out that aspects of what we were 
attempting were “impossible”. We present the work in the chapter as a clear solution to 
the problems faced in the design. However, in the academic context it is difficult to 
bring across just how challenging it was to develop this circuit. The work took three 
years to develop to completion. 
Chapter 5 documents the design of the base circuitry for voltage to current conversion 
at high voltages from a low voltage battery. The characterisation of the circuit is 
published in “BioMedical Engineering OnLine” [4]. The design is shown to perform 
much better than other designs that may compete in a similar design space. Presenting 
only the voltage to current converter allows other researchers to adapt the design, 
implementing controlling interfaces appropriate for their needs.  
Upon completion of this design block we faced a fork in the road. We could choose to 
delve into computational neuroscience, in an attempt to use finite element modelling 
and complex neuron models to further understanding of how the electrical stimulation 
passes through the skin and tissue to stimulate the sensory axons and enhance the 
transmission of signal. Or, we could choose to complete the electronic design of the 
published stimulator. Considering that 1) the electronics had shown such promise to 
help with future research, extending beyond interventions to improve tactile sensitivity, 
and 2) the modern research environment holds greater value in producing tangible 
outputs with real world impact, it was a clear decision that the design should be 
completed and tested in vivo. 
Chapter 6 documents the design of control and instrumentation circuitry for the voltage 
to current converter as well as the addition of various safety and interface features not 
found in the original design. The battery life of the circuit is tested under various 
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circumstances to prove how appropriate the device is for applications requiring 
continuous daily use. Finally, the circuit is tested to operate as expected in vivo. The 
graph in Chapter 6 demonstrating the circuit accurately driving a multi-frequency 
current signal into 5 participants, together with measured battery life of 18 to 33 hours 
succinctly demonstrates the ultimate output of years of difficult design work. Chapter 6 
in part has been submitted for publication in “IEEE Transactions on Biomedical 
Circuits and Systems” (TBioCAS). The full design has been handed over to an 
industrial design firm for modification to convert into a production ready device. 
While completing the design it became evident that the original power supply needed 
to be changed. However, with a multitude of design variables to be balanced, a trial and 
error process of building circuits would not result in an optimal power supply design. 
The parts being used were not readily available in libraries for modelling software such 
as SPICE. Consequently, to investigate different power supply architectures and 
optimise the design, a novel circuit-modelling framework was created. The simulations 
resulted in a regulated power supply that is over 30% more efficient than commercially 
available solutions. The modelling software developed and the power supply 
architectures investigated are documented in Appendix B. 
Thesis conventions 
The chapters in this thesis are designed to be read independently of each other. 
Consequently, a small amount of repetition occurs, especially in the introductions. 
Further, Chapters 2 and 3 report data from the same parent study and a certain amount 
of repetition occurs in the description of the methods and participant cohort. 
Abbreviations are declared the first time they are used in each chapter regardless of use 
in previous chapters. 
The use of the plural, such as “we”, to refer to the author is used on occasion, especially 
to facilitate the ‘active voice’ in the written language. Be assured that work I cannot 
legitimately claim as my own will be clearly highlighted in the text as such. 
As there are different types of controls in different parts of the thesis, such as control 
participants, and control test conditions, the word “control” could become confusing. 
In most instances the use of the word ‘control’ will be avoided and a replacement term 
defined where needed. 
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I hope you enjoy reading this work. I am very proud of it. 
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ANALYTICAL REVIEW ON THE APPLICATION 
OF SUBSENSORY SIGNALS FOR THE 
IMPROVEMENT OF PERIPHERAL 
SENSITIVITY 
 
Peripheral desensitisation is a common problem that is caused by a multitude of 
prevalent diseases. Currently there are no symptomatic treatments for loss of peripheral 
sensitivity, however a family of intervention studies over the past 20 years, which 
applied subthreshold external signals to the limbs, have shown that it is possible to 
improve sensitivity in some population groups. This review provides meta-analysis of 
this class of research and suggests future research directions for this form of therapy. 
43 studies, and a total of 277 outcome measures met the inclusion criteria and 
collectively demonstrate that subsensory signals can be used to enhance peripheral 
sensation in a multitude of settings. We found that improvements in scientific rigour, 
and scientific reporting are needed. High quality investigations into the mechanisms of 
the improvement in parallel with investigations into non-laboratory long-term 
applications are also needed. Overall the methodology shows promise for being 






Peripheral desensitisation is a common problem that can be caused by diabetes, stroke, 
alcoholism, HIV, aging and many other conditions. It is estimated that 20-30 million 
people worldwide suffer symptomatic diabetic neuropathy [5]; approximately 50-85% 
of stroke survivors have reduced somatosensory performance [6–9]; all people with 
aging have reduced peripheral sensation [10]; in South Africa, as many as 1.8 million 
people suffer HIV-related peripheral neuropathy [11]. 
Length dependent poly-neuropathy, the most common form of peripheral 
neuropathy (PN), causes reduced tactile sensation primarily in the extremities, and 
dramatically impacts quality of life. Foot ulceration [12] is common, but not in 
HIV-related PN, and can result in lower extremity amputation [13]. Plantar sensitivity 
also affects balance [14–18] and increases the risk of falling [19]. Falls account for the 
highest proportion of hospital admissions, hip fractures and accidental death in 
individuals over the age of 65 [16,20,21]. Tactile feedback from the hand is important 
for maintaining motor control [22–24], and impaired hand sensation reduces the ability 
to approximate grip force and manipulate objects [25,26]. Ultimately, reduced hand 
function affects vocation and self-care [27] as well as resulting in reduced use of the 
hand [28]. Specifically, HIV-related sensory neuropathy has an adverse effect on health 
related quality of life [29]. 
Currently there are no treatments for loss of peripheral sensitivity [30]. However, a 
family of intervention studies over the past 20 years, which applied subthreshold 
external signals to the limbs, have shown that it may be possible to improve sensitivity 
in some population groups. These studies sought to improve tactile sensitivity by 
applying either an electrical current or a mechanical signal to the extremities. The signal 
itself is low enough in amplitude that the participant cannot perceive its presence 
(subsensory, subperception, or subthreshold). In each of these exploratory studies the 
intervention is not shown to continue to have an effect once removed. In this sense the 
therapy is not meant to treat the underlying condition, but rather to reduce symptoms 
and enable function while it is in use. Most of these studies prescribe to a common 
scientific method. First, the intervention or treatment, either a mechanical vibration or 
an electric current is applied to the participant at different amplitudes to establish the 
perception threshold of this particular intervention, for this particular participant. The 
intervention signal is then set to a subthreshold value, usually a set percentage of the 
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perceptual threshold. Finally, some other functional measure is made with and without 
the intervention turned on, to establish the interventions influence on the measure. 
Common output measures are touch sensitivity, or balance performance. 
Figure 1 shows a typical application of an electrical intervention for the improvement 
of tactile sensitivity at the Hallux (big toe). The current is applied across the tibial nerve 
that sub-serves the tactile receptors of the plantar aspect of the foot [31]. The biological 
effect of an electrical current injected into a sensory axon is well understood [32–34], 
but the effect of applying a current through the limb and across the axon is a 
substantially more complex problem. The manner in which the current distributes in 
the limb tissue and the effect of simultaneous, and different, currents within the same 
nerve compartment is not understood, and is beyond the scope of this work. Despite 
this, several statements can be made about the effect of subsensory stimulation on the 
biopotentials of the nerve. 
A bidirectional current stimulation will cause both hyperpolarisation and depolarisation 
of the nerve membrane potential in the region of the stimulation. The changing 
membrane potential is likely to have an effect on the passage of action potentials 
through the nerves in this region, modifying their timing and amplitude. Further, the 
stimulation will force the nerve into a different region of its dynamic response, 
potentially allowing for action potential generation under conditions that would 
previously have not produced action potentials, and vice versa. 
Collins et al. in 2003 published a functional summary of various intervention methods 
and outcomes that provides adequate background to the general format of participant 





Figure 1. Typical application of Subthreshold Electrical Stimulation proximal to the site where tactile 
sensitivity is to be tested. 
 
While there is a substantial body of literature, and many different types of interventions 
and outcome measures used, a cohesive picture of this research field, and where it 
should head, has yet to emerge. 
1.1.1 Scope 
This literature review attempts to incorporate all studies investigating interventions 
using subsensory stimuli to improve peripheral sensation or related measures through 
in vivo experiments published in 2015 or earlier. Studies included for analysis were 
required to be published in English peer-reviewed journals or presented as part of a 
published scientific conference proceeding. Studies were searched for using online 
databases, such as PubMed and Google Scholar and extended to cited and citing 
articles. 
This review does not cover methods of enhancing other sensing modalities such as the 
vestibular system [35–37], hearing [38,39], sight [39–42] and blood pressure [43]. This 
review does not cover supra-threshold interventions such as Transcutaneous Electrical 
Nerve Stimulation (TENS) [44] or chemical interventions such as limb deafferentation 
[45,46]. 
In several cases a study is presented in part as a conference preceding and then 
presented again as a full paper. In these cases, only the fullest presentation of the work 
 
 5 
is included for analysis. Additional articles outside of the abovementioned scope are 
included for discussion but not analysis. 
1.1.2 Aims 
This review will evaluate and describe the success of these interventions collectively, 
identify gaps in the literature and discuss the proposed mechanism by which the 
interventions have an effect on peripheral sensitivity. Further, the general scientific 
quality of the literature will be evaluated. 
This review, unlike many systematic reviews, does not aim to establish any form of 
medical treatment best practice, but rather to aid in directing future research. Analyses 
performed are akin to those performed in formal systematic reviews, however are not 
designed to provide specific numerical outcomes, rather simply portray trends in the 
literature to possibly guide future work. While the heterogeneous nature of the various 
study outcomes strictly makes the analysis performed inappropriate, the results can still 
be informative. 
1.2 Origins of subsensory interventions 
The first studies to use subsensory interventions in humans for improvement of 
peripheral sensitivity was Collins et al. in 1996, who showed increased ability to detect 
a mechanical perturbation that was summed with white-noise vibration, and 
Cordo et al. who showed stochastic resonance (SR) in muscle-spindle afferents at the 
same time [21,47–49]. 
Earlier work focusing on characterising tactile sensitivity, and the sensory mechanisms 
through which vibration is perceived in the presence of subthreshold external signals, 
rather than researching a potential intervention, had also been conducted, but is 
generally not recognised as the genesis of subthreshold noise interventions [50–52]. 
The earlier work found that sensitivity was enhanced by signals with the same 
characteristics, such as a single frequency 70 Hz sine wave vibration “pedestal”, aiding 
in the detection of 70 Hz vibration stimuli. The studies did investigate the effect of 
mechanical noise at different near threshold amplitudes but did not find an enhancement 
of tactile thresholds in contradiction to future work. 
Collins showed, in accordance with theory in SR [53,54], that if the intervention noise 
was too small the participant showed no improvement in tactile sensitivity and if the 
noise was too large it drowned the perturbation to be detected. This created a classic 
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inverted “u” shape for the benefit versus intervention amplitude, which held true for 
many experiments that followed. The term “stochastic resonance” has been called into 
question, with the term “stochastic facilitation” being motivated as more 
appropriate [55]. The motivation given is that SR is a specific theoretical model of how 
added noise can improve performance, but most experimental work only shows that the 
added noise creates improvements, not that it occurs through the specific mechanism 
of SR. Despite this, the term “stochastic resonance” is used here to remain consistent 
with those who reported in their research using this term. 
Since then many interventions have been attempted. Table 1 describes each study’s 
intervention, intervention signal’s frequency characteristics, the outcomes measures 
and investigated populations. Before proceeding to Table 1, the following text describes 
how the characteristics of each study were classified for use in the table. 
1.3 Classification of existing literature 
43 studies, and a total of 277 outcome measures were selected for inclusion in this 
review. Table 1 summarises the characteristic of each study according to the following 
criteria. 
1.3.1 Intervention signal classification 
The interventions used can be categorised using two factors. The first is the mode of 
the intervention signal (mechanical or electrical). Mechanical interventions take the 
form of a vibrating element of some description that induces perturbations in the tissue, 
so as to improve peripheral sensitivity. Electrical interventions take the form of an 
electric current applied through the skin for the same purpose. 
The second factor is the location of the applied intervention signal, distal or proximal. 
Distal interventions are applied at the site of sensory enhancement and proximal 
interventions are applied proximal to the site of enhancement. 
An example of an intervention that acts proximal to the site of enhancement would be 
the application of the therapeutic intervention at the forearm, to improve sensitivity at 
the fingertips. Proximal application allows the extremities to be free of devices while 
still receiving the benefit distally where sensitivity is of greater importance. 
The therapeutic signal itself is a time varying waveform and has a particular frequency 
spectrum. This can generally be categorised as single frequency (a sine wave, or in one 
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case a triangular wave), white (noise with a flat frequency spectrum), pink (noise with 
an inverse relationship with frequency) or ‘not given’. Each spectrum can be further 
described by a frequency bound with lower and upper limits in Hz.  
1.3.2 Outcome measure classification 
Each study can have several outcome measures. In this analysis we seek to categorise 
similar output measures in an attempt to reduce the amount of heterogeneity in the 
subsequent analysis. A full description of each outcome measure is beyond the scope 
of this work, but any one measure can be more closely examined by reviewing the 
related article reference in Table 1. Six outcome measure categories were devised. 
Detection Tasks (DT) seek to identify a change in sensory threshold by evaluating the 
participant’s ability to detect certain stimuli. Detection tasks include indentation 
detection, vibration detection, Semmes-Weinstein monofilament detection, two-point 
discrimination and one-point touch test. In each case a form of threshold is established 
above which more correct detections occur, and below which fewer correct detections 
occur. Assessments of variability in the outcome of detection tasks are not detection 
task output measures themselves but are classified as a proxy measures instead (see 
Proxy Measures). 
Balance Measures (BM) are all measures of postural sway during still standing. These 
include centre of pressure motion parameters (area swept, total path length, mean centre 
of pressure (COP) radius, maximum excursion and standard deviation along 
perpendicular axes); as well as more advanced balance parameters: critical mean 
square displacement, effective long-term diffusion coefficient and long-term scaling 
exponent. 
Gait Measures (GAIT) are all measures relating to how a person walks and include 
joint ranges of motion, moments around joints, walking speed, and various stance 
parameters included ground reaction forces. 
Physiological Measures (PHY) are measures that document what is occurring in the 
internal biochemical or bioelectrical physiology of the participant. These measures 
include inter-spike timing of single sensory neurons in response to mechanical stimuli 
(in vivo), timing variability of stimulated sensory neurons (in vivo), and reaction times 




Practical Tasks (PRAC) measure the competency of particular tasks which correlate 
to everyday activities. These include the nine-hole peg test, the box and block test, 
texture discrimination test and the timed up and go test. 
Proxy Measures (PROX) are outputs indirectly affected by peripheral sensitivity. 
These include pinch grip, shear force, active range of motion for a joint (not during 
gait), hand stabilisation time after perturbation, minimal force grasping and variability 
in other measures such as detection tasks. Some categories, such as balance measures, 
are a form of proxy task, but for the sake of this analysis they have been considered 
separately to be more informative to the reader. 
1.3.3 Participant classification 
Many population groups can benefit from improvement of peripheral sensitivity. The 
studies presented here investigate healthy younger (HY) individuals, elderly 
individuals (ELD), post stroke individuals with a peripheral insensitivity 
component (STR), individuals with ankle instability (ANK), individuals with knee 
osteoarthritis (OST), single below knee amputees (AMP), and individuals with diabetic 
neuropathy (DN). One study investigated a subcategory of ELD, elderly fallers, and 
elderly non-fallers. This distinction is made clear where relevant. 
1.3.4 Study design 
All studies, with the exception of three, made use of a crossover design where each 
participant acts as their own control. Hoskins et al. 2015 [56], Ross et al. 2006 [57] and 
Ross et al. 2007 [58], used a case-control design with two groups of participants, one 
group receiving the intervention and one receiving a placebo. This is a weaker scientific 
method for investigating possible interventions. Despite this, these studies have been 
included for analysis. 
1.4 Numerical Analysis 
A wide array of data was extracted from each study. In addition to the variables listed 
in Chapter 1.3, information regarding participant age, gender, the amplitude of the 
treatment signal, the method of determining the sensory threshold for the treatment 
signal, details regarding the blinding used in the study and finally the actual outcome 
measures were captured (see Chapter 1.4.2 for more information regarding the 
extraction of the study outcome measures). The full raw dataset is available in the 
folder, “Literature review data” in the digital appendix. 
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1.4.1 Summary statistics 
Table 1 provides a summary of the primary distinguishing characteristics of the 
included studies. Aside from the works by Collins et al.1 [59–62], most of the studies 
were small with participant numbers ranging from 5 to 18. There were a similar number 
of studies investigating mechanical interventions and electrical interventions, and also 
a similar number investigating distal interventions and proximal interventions (see 
Table 2). When mode and location are examined in combination, electrical 
interventions appear to favour the use of proximal interventions, whereas mechanical 
interventions have a moderate bias toward distal interventions. 
Table 1. Classification of 43 studies using subsensory signals in vivo to improve peripheral sensitivity listed 
by publication year. The total number of each output measure is placed in brackets and a ‘*’ indicates 
statistical significance at at-least p<0.05 was found, suggesting success of the intervention. Participants: 
HY = Healthy Young, ELD = Elderly, DN = Diabetic Neuropathy, STR = Stroke, AMP = Single Leg Amputee, 
OST = Knee Osteoarthritis, ANK = Unstable Ankle and n = number of participants. Output Measures: 
DT = Detection Task, BM = Balance Measure, GAIT = Gait Variable, PHY = Physiological Measure, 
PRAC = Practical Task, PROX = Proxy Measure. 
First Author Year Mode Location 
Spectrum 
[Bandwidth (Hz)] 
Participants(n) Output Measures 
Collins 1997 [48] Mechanical Distal White [0 30] HY(10) DT*(1) 
Richardson 1998 [63] Electrical Distal White [0 30] HY(11) DT*(1) 
Dhruv 2002 [64] Electrical Distal White [0 1000] ELD( 9) DT*(1) 
Gravelle 2002 [15] Electrical Proximal White ELD(13) BM*(7) 
Liu 2002 [65] Mechanical Distal White [0 100] 
DN( 8), ELD(12), 
STR(5) 
DT*(4) 
Priplata 2002 [18] Mechanical Distal White [0 100] ELD(16), HY(14) BM*(16) 
Khaodhiar 2003 [66] Mechanical Distal Noise DN(20) DT*(3) 
Priplata 2003[16] Mechanical Distal White [0 100] ELD(12), HY(15) BM*(16) 
Wells 2005 [67] Mechanical Distal 
White [0.125 25], 
[0.125 50],  
[25 500],  [50 500] 
ELD(6), HY(6) DT*(16) 
Priplata 2006 [17] Mechanical Distal White [0 100] DN(15), STR(15) BM*(16) 




Lee 2007 [68] Electrical Proximal Triangular, 2 Hz AMP(5) BM*(4) 
Ross 2007 [69] Electrical Proximal White ANK(12) BM*(1) 
Ross 2007 [58] Electrical Proximal 
White [not given 
1000] 
ANK(210) BM*(5) 
Hijmans 2008 [70] Mechanical Distal White [25 500] DN(17), HY(15) BM*(24) 
Collins 2009 [71] Electrical Distal White [0 1000] HY(12) PROX(4) 
 
1 Note that the Collins (Amber) in publications from 2009 onward is a different 
Collins to in the influential Collins 1997 (James) publication and subsequent studies 
where he is a co-author. 
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Breen 2011 [30] Electrical Proximal Noise HY(10) DT*(1) 
Collins 2011 [60] Electrical Proximal White [0 1000] OST(52) 
PHY*(3), PROX(1), 
GAIT(6) 
Collins 2011 [61] Electrical Distal White [0 1000] OST(38) PROX(2) 
Collins 2012 [59] Electrical Proximal White [0 1000] OST(52) BM*(7) 
Magalhães 2012 [73] Electrical Proximal White [5 2000] HY(10-11) BM*(5), PROX*(2) 
Kurita 2012 [74] Mechanical Distal White [0 300] HY(11) PRAC*(1) 
Breen 2013 [75] Electrical Proximal Pink HY(6-7) 
DT*(1), PHY*(1), 
PROX(1) 
Enders 2013 [76] Mechanical Proximal White [0 500] STR(10) DT*(2) 
Ross 2013 [77] Mechanical Proximal White [0 100] HY(12), ANK(12) BM*(10) 
Sueda 2013 [78] Mechanical Distal White [0 300] HY(12) DT*(1) 





Mechanical Proximal White [0 100] HY(10) DT*(1) 
Breen 2014 [31] Electrical Proximal Pink HY(10) DT*(1), PROX*(1) 
Collins 2014 [62] Electrical Proximal White [0 1000] OST(35) GAIT*(16) 
Hur 2014 [82] Mechanical Proximal White [0 500] HY(18) PHY*(1), PROX*(1) 




White [0 200] HY(10-12) DT*(23) 
Magalhães 2014 [84] Electrical Proximal White [5 2000] HY(11) BM*(9) 
Seo 2014 [85] Mechanical Proximal White [0 500] STR(8-10) 
DT(1), PRAC(2)*, 
PROX(3)* 
Keshner 2014 [86] Mechanical Distal White [10 55] HY(21) BM*(5) 
Hoskins 2015 [56] Mechanical Proximal White [0 300] HY (42) PRAC*(2) 
Lakshminarayanan 
2015 [87] 
Mechanical Proximal White [0 500] HY(12) DT*(2) 
Lipsitz 2015 [88] Mechanical Distal Not given ELD(12) 
BM*(4), PRAC*(1), 
GAIT*(5) 
Ross 2015 [89] Mechanical Proximal White [0 100] HY(12), ANK(12) PROX*(6) 
Dettmer 2015 [90] Mechanical Distal White [1 500] ELD(9), HY(10) BM*(8) 
Wang 2015 [91] Mechanical Proximal White [10 1000] Not given (5) DT*(1) 
Breen 2016 [92] 
reporting on Breen 
2011[30] and 
Serrador 2012 [93] 





Table 2. Frequency table characterising the location (distal or proximal) and nature (mechanical or electrical) 
of the intervention signal in the included studies. One study is counted twice as being both proximal and distal 
as both interventions were examined. This results in 44 data points for 43 studies. Percentage in brackets. 
 Mechanical Electrical Total 
Distal 15 (35%) 5 (12%) 20 (47%) 
Proximal 9 (21%) 15 (35%) 24 (56%) 
Total 24 (56%) 20 (47%) 44 (102%) 
 
The vast majority of studies used white noise as their intervention signal usually low 
pass filtered to 500, 300 or 100 Hz. Only Breen et al. made use of pink noise (See 
Chapter 3.2.3 for more details on the noise signal use by Breen et al.).  
The studies investigated signal amplitudes ranging from 5% to 90% of detection 
threshold, with a number of studies declaring their amplitude as “subthreshold” with no 
percentage or absolute amplitude given. Studies investigating the effect of different 
subthreshold amplitudes usually found an effect between 60% and 90% of threshold 
but the best level was study dependant, and in several cases allowed to be participant 
dependant (e.g. [69,73,77,92,94]). 
The subsensory nature of the intervention lends itself well to the design of blinded 
studies. However, blinding was not well reported in the manuscripts with only 4 
studies (9%) being definitely double-blinded and a further 8 (19%) possibly being 
double-blinded, but failing to report so. 16 studies (37%) were definitely single-blinded, 
with a further 3 (7%) being probably single-blinded, and 9 (21%) being possibly single-
blinded, but it was not made clear in the text. Only 3 (7%) failed to provide enough 
information to infer anything about the blinding used in the study. 
Studies needed to establish what the sensory threshold for the intervention signal was 
in order to ensure the signal was subsensory and to control for relative amplitude of the 
intervention signal. 9 (21%) of the studies failed to provide a method of threshold 
determination, or none was used. 15 (35%) are recorded to have used a “self-
determined” method, where the participant determines their threshold with no scientific 
method being applied. 5 (12%) used a single direction method of limits or levels, and 
13 (30%) used a method of limits or levels in both ascending and descending modes. 
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Only one study used a forced choice paradigm to produce the sensory threshold for the 
intervention signal. 
1.4.2 Data extraction for meta-analysis of outcome measures 
The Cochrane organisation, known for producing high quality systematic reviews, 
provides a tool for producing analytical literature reviews, Review Manager 
(RevMan) [95]. The program can produce various statistical outputs and automated 
graphics, and requires that for each output measure, that the user provides a signed 
(beneficial or detrimental) effect magnitude, and a standard error (SE) for this effect. 
In the context of this review, we required from each study, the mean percentage change 
from the control (sham) condition, when applying the subthreshold signal, and the SE 
of this percentage change. These two outputs must be for paired analysis and not group 
analysis. 
Studies often presented the data in formats inappropriate for this analysis. The most 
prevalent error was presenting group data instead of paired data, but performing a 
paired analysis. This took the form of providing the mean of the group of participants 
in the sham condition, and the mean of the group of participants in the experimental 
condition for a given output measure, and their associated variabilities, usually standard 
deviation (SD). 
The difference in the means of the groups, is mathematically equivalent to the mean of 
differences in the paired data, thus the mean effect was easily recoverable. However, 
there is no perfect way to recover the variability data (SE) from the two group SDs. In 
these cases standard errors were calculated using the methodology described in [96] 
from the extracted p-values to infer what the variability must have been to get such a 
result.  
In 128 of 277 output measures, data was extracted from graphical representations using 
a custom written Matlab program developed as part of this work (See digital appendix 
folder “Data Extraction Tool”). The program loads a screenshot of a graphic from a 
paper, allows the user to manually identify the axis and limits, and then allows the 
export of individual data points contained within the image. 
Not every output measure from every study was extracted. Studies often swept various 
parameters, essentially measuring the effect of many different versions of the 
intervention. Only the most optimal data of each output measure was extracted (for 
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example, the outcome for an optimal amplitude of intervention signal, rather than all 
levels intervention). Only outputs that represented the effect of the intervention over an 
appropriately matched sham condition were extracted. 
1.4.3 Forrest plot analyses 
Review Manager was used to produce two different types of meta-analyses. Firstly, we 
produced analyses of the mean effect of the intervention on each outcome measure 
category weighted to the level of certainty that each measure affords through its stated 
variability. This is graphically represented as a “forest plot” for each outcome category, 
which shows a single data point for outcome measure, and the associated 95% 
confidence interval. 
Calculated study outputs in the meta-analysis were removed if they were considered 
outliers. This was done to prevent individual studies from dominating the overall 
analysis, and because outlier studies are less likely to represent the true outcome value, 
not more. Items with a percentage change from sham of more than 3.5 SD (odds of 1 
in 2149) away from the mean of that output type were removed. This was also done for 
the SE, although items with a large SE have little weight in the analysis. 4 of 141 
balance measures, 2 of 66 detection tasks, 1 of 36 gait measures, 1 of 22 proxy tasks 
and 1 of 7 practical tasks were removed. In addition, 2 of the remaining 137 balance 
measures, 3 of the remaining 64 detection tasks and 3 of the remaining 35 gait measures 
with small SEs were also removed because their weighting was greater than greater 
than 20%, causing the overall results to have a strong bias towards those specific 
outcomes. 
Figure 2 to Figure 10 are the outputs of the forest plot analysis. Studies appear more 
than once if they have multiple output measures in that category. The overall effect of 
each study type is shown as a black diamond with width proportional to the confidence 
interval of the overall effect at the bottom of the figure2. 
 
2 In some cases, the width of the black diamond is so narrow that the diamond is 
barely visible. The mean and confidence interval are represented in numeric form on the 




Figure 2. First half of the forest plot for the Detection Task outcome measures listed alphabetically by first 





Figure 3. Second half of the forest plot for the Detection Task outcome measures listed alphabetically by first 
author. Outputs are normalised to a fraction of 1 relative to the sham condition. Positive data points represent 
beneficial effects. There was a statistically significant beneficial overall effect of 9-11% related to the 




Figure 4. First third of the forest plot for the Balance Measure outcomes listed alphabetically by first author. 





Figure 5. Second third of the forest plot for the Balance Measure outcomes listed alphabetically by first 





Figure 6. Final third of the forest plot for the Balance Measure outcomes listed alphabetically by first author. 
Outputs are normalised to a fraction of 1 relative to the sham condition. Positive data points represent 
beneficial effects. There was a statistically significant beneficial overall effect of 2-3% related to the 




Figure 7. Forest plot for the Gait outcome measures listed alphabetically by first author. Outputs are 
normalised to a fraction of 1 relative to the sham condition. Positive data points represent beneficial effects. 





Figure 8. Forest plot for the Practical Task outcome measures listed alphabetically by first author. Outputs 
are normalised to a fraction of 1 relative to the sham condition. Positive data points represent beneficial 
effects. There was a statistically significant beneficial overall effect of 2-5% related to the application of the 
intervention. 
 
Figure 9. Forest plot for the Physiological Measures listed alphabetically by first author. Outputs are 
normalised to a fraction of 1 relative to the sham condition. Positive data points represent beneficial effects. 





Figure 10. Forest plot for the Proxy Measures listed alphabetically by first author. Outputs are normalised 
to a fraction of 1 relative to the sham condition. Positive data points represent beneficial effects. There was a 
statistically significant beneficial overall effect of 1-3% related to the application of the intervention. 
The measures of heterogeneity for Gait (I2 = 41%) and Physiological (I2 = 37%) 
Measures indicate that these groups moderately confirm to the notion that they were 
attempting to measure the same effect and are appropriately grouped. The measures of 
heterogeneity for Detection Tasks (I2 = 97%), Balance Measures (I2 = 93%), Practical 
Tasks (I2 = 89%) and Proxy Measures (I2 = 81%) indicate that these study outcomes 
are very heterogeneous in nature. 
The overall measure of effect indicated a mean beneficial difference of 4% of outcomes 
relative to the sham condition with 95% confidence interval of 3-4% (p < 0.00001), and 
a high level of heterogeneity (I2 = 94%). 
1.4.4 Funnel plot analyses 
The second output of the Review Manager analysis was funnel plots for each output 
category. Funnel plots are a graphical tool that allows the observation of outlier results 
and publication bias. If a group of results is measuring the same effect in different 
studies, one would expect that effects with small SEs to cluster together to represent 
 
 22 
the true effect, while effects with large SEs are expected to show more variability in 
outcome. 
Consequently, when plotting effect magnitude on the horizontal axis and SE (inverted, 
with small values on top and larger values below) on the vertical axis, one expects the 
data points to form an upward pointing triangle. The position of the point of the triangle 
represents the true effect of the intervention. Review Manager includes the 95% 
confidence bounds of this triangle and a vertical line for the weighted output effect for 
reference. 
We expect to see that studies are symmetrically distributed to the left and right of the 
true effect. If studies appear predominantly to the beneficial (right) side of the triangle, 
then studies showing a smaller or negative effect have been omitted from the literature 
and this is evidence of publication bias. 
Further, we expect that 95% of the outcomes will lie within the triangle. Studies lying 
outside of the triangle, especially to the right are likely outlier results that have been 
influenced by some form of bias. 
Figure 11 shows the output of this analysis for the 6 different output categories. Each 




Figure 11. Funnel plots of intervention affect (% change from sham) versus the Standard Error of the 
measurement for the 6 outcome measure categories. Data points positioned to the right of zero indicate 
positive intervention outcomes. The dashed line triangle indicates the 95% confidence region for this outcome 
measure with the centre line being the weighted mean effect. 
1.5 Discussion 
1.5.1 Extent of effect of interventions 
The majority of studies found significant effects for their intervention in at least one of 
their key outputs. The meta-analysis indicates beneficial effects of 10% for Detection 
Tasks, 2% for Balance Measures, 1% for Gait Measures, 4% for Practical Tasks, 12% 
for Physiological Measures, 2% for Proxy Measures, and an overall effect of 4% 
improvement when all the outcomes are combined. The reason why the mean effects 
shown here are much lower than those presented in the literature is because most 
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literature focuses on the outcomes that produced the largest benefit, where here we have 
analysed all the measured outcomes from each study. 
The only work that consistently produced null results was that done by Collins et 
al. [59–62] who failed to find meaningful improvement in output measures of applying 
electrical SR to the knee compared to the control condition of using a neoprene sleeve, 
usually in patients with knee osteoarthritis. Interestingly these studies were also the 
largest of those analysed here (35 to 52 participants versus 5 to 18). 
1.5.2 Mechanism of effect 
The majority of studies postulate stochastic resonance (SR) as the mechanism of the 
positive effect observed on peripheral sensitivity outcomes. This is usually meant in the 
sense that SR is experienced by the sensory end receptors themselves, such as tactile 
neurons, muscle spindles and Golgi tendon organs. The alternative explanation is that 
both the sensory signal and the intervention signal are causing some other form of SR 
more centrally in the spine or brain.  
Behaviour of distal interventions does appear to behave in accordance with SR as 
investigated by Collins (James) and colleagues in multiple papers. Distal, as opposed 
to central SR as a governing theory of the effect presents three challenges to researchers. 
Firstly, it predicts that different intervention amplitudes are required to enhance 
performance when detecting sensory signals of different amplitudes. This is evidenced 
by Wells et al. 2005 [67] when investigating a sweep of intervention amplitudes for 
detection of signals at 80% and 90% of detection threshold. Wells et al. found that 
different intervention amplitudes produced optimal results for different sensory signal 
amplitudes. This makes the design of an intervention for dynamic situations difficult. 
This point was taken further by Galica et al. 2009 [97], when applying an intervention 
to the feet during gait. Galica attempted to apply varying intervention amplitudes 
appropriate for each stage of gait. This dynamic intervention amplitude appears to be 
key to developing that technology into a medical device. 
Secondly, the amplitude required relative to the participants threshold may be simple 
to calculate when the output measure and the intervention are tightly related, for 
example when applying mechanical noise to affect perturbation detection. However, 
SR fails to allow for prediction of more complex scenarios. For example, what is the 
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required electrical signal amplitude to aid for balance enhancement? This cannot be 
calculated from theory, and has to be measured experimentally. 
Finally, classical SR fails to provide explanations for when the intervention is applied 
proximally. These interventions appear to show a similar enhancement to their distal 
counterparts. An alternative hypothesis is that despite the added noise not reaching the 
perception threshold of the individual, it is sufficiently strong to activate local sensory 
organs [87,98]. Action potentials generated by the noise and signal source may combine 
more centrally (e.g. in the spinal cord or somatosensory cortex) to provide central 
SR [82,99]. 
The location of the intervention does not seem to have strong effect on the 
outcome [87], going as far as to show that remote vibratory stimulation at the hand has 
a similar influence on balance as a vibratory intervention at the feet [100,101]. Further, 
cross modal SR has been observed where one sensory mode such as audio noise, 
produces SR in the visual system [102,103]. This implies the signals are mixed 
centrally. 
A further alternative hypothesis postulates that the intervention signal affects the 
transmission of the sensory signal as it comes past the intervention site, making it more 
coherent to central perception improving neural synchrony [30,31,76,87,92,98] and 
reducing spike time variance [75]. This can occur through alterations to the 
extracellular field enabling transmitted information to improve synchronicity and thus 
signal amplitude when summed more proximally. 
Of course, it is possible that multiple processes combine to generate the observed 
enhanced response, that is not explained by a single hypothesis. Further work is 
required to unravel the underlying mechanism, and how this may vary depending on 
factors such as noise spectrum and location of intervention application. 
1.5.3 Scientific rigour 
The majority of studies used a crossover study design with at least single-blinding to 
the intervention condition. This inherently leads to higher quality scientific outcomes 
than common “case-control” study designs, with interventions where a convincing 
placebo/sham condition is difficult to generate. However, factors were found that could 
lead to bias and artefact. 
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While at least single-blinding is essential, double-blinding is not difficult to include in 
studies of this nature. Many studies failed to report clearly the nature of their blinding 
which makes it difficult to assess the scientific quality of the work. 
While care was taken to accurately determine the outcome measures of the studies, 
similar care was not taken to determine perceptual threshold of the intervention. Most 
studies made it clear that the percentage of threshold of the intervention was important, 
and that SR, which relies on an accurately determined threshold, was the likely 
mechanism of effect. However, threshold data was only reported in one study, which 
showed that there was large individual variability (20%) in vibratory thresholds over 9 
tests over three days [88]. 
The funnel plots shown in Figure 11 allow for an informal assessment of the 
homogeneous nature of the output measures in each category, the likelihood of 
publication bias and the frequency of occurrence of outlier measurements. The 
clustering shown in the detection tasks funnel plot indicates that either these output 
measures are not comparable, or they were not performed in a consistent fashion. The 
plots for the other measures show a much more even spread indicating a common effect 
magnitude. 
The bulk of the data points in the balance measures funnel plot lie to the right of the 
vertical dotted line (which indicates the likely true mean of the intervention effect). 
This asymmetry to the right is probably the result of publication bias where outputs that 
showed less effect, no effect, or an adverse effect have not made it to the literature. 
Finally, one expects about 5% of the data points to lie outside of the triangle, more than 
this indicates outlier studies containing some form of artefact. Funnel plots are only 
strictly appropriate if the data is sufficiently homogeneous. One must be careful not to 
over interpret the graphs presented here as the analysis indicates a high level of 
heterogeneity. However, it would seem the data calls for higher consistency in 
experimental procedures and outcome measures. 
Finally, in all cases, cross-over study-data must be analysed in a pairwise fashion using 
appropriate statistics. However, in many cases, the data was reported as group means 
and variability for the sham and intervention conditions. This inhibits the ability of the 
reader to analyse the results and include the data for meta-analysis. Crossover trials 
must be reported in a fashion appropriate for paired data. 
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1.5.4 Gaps in the literature 
Signal frequency 
The analysed studies present little evidence to justify the “shape” and frequency 
characteristics of the signal. Most agree that “noise” works best because it is more 
biological and less likely to have learning effects that would reduce its efficacy over 
time. Little has been done to investigate what types of signals offer optimal 
enhancement. Trenado et al. [104] suggest using a spectrum that includes the frequency 
ranges of the receptors the intervention wishes to enhance. This is supported by early 
work that investigated using single frequency stimulation “pedestals” to enhance 
sensitivity to that frequency alone, and that frequencies outside of the range of the 
receptor failed to enhance sensation [50–52]. 
If the effect of the intervention is occurring more centrally, it may be more important 
to consider the frequency response of the whole neural control loop. This is discussed 
in some detail in a different paper also by Trenado et al. [105]. 
Little is known about the actual frequencies of the interventions reaching the 
physiological targets. In most mechanical studies, piezo-electric vibrators are used, 
which usually have relatively narrow frequency responses. Driving these actuators with 
white noise is unlikely to produce a white noise vibration response. 
A similar argument can be made for electrical interventions. The tissue between the 
electrodes and the nerve likely acts as a complex and active filter, with the actual 
voltages and currents reaching the nerves left unknown. Due to physiological time 
constants, it is unlikely that very high frequencies have a meaningful effect, and 
consequently the system can be thought to have a low-pass filter characteristic. This is 
reflected in the 1/f (pink) frequency spectrum choice of Breen et al. [30,31,75,92].  
While no rationale is given for this design choice by Breen et al., it can be inferred that 
this signal is more efficient at transferring energy to the nerves than a white noise 
spectrum, as less energy is dedicated to the potentially inefficient high frequencies. In 
addition, the pink spectrum is likely to include the mechanical frequency response 
range of the receptor itself (as discussed above) while not completely excluding higher 
frequencies that may still create meaningful responses. While it cannot be said that the 
causal relationship between intervention spectrum and efficacy is understood, pink 
noise offers the current “best guess”. 
 
 28 
Long-term effect of treatment 
The “wash-out” period of these treatments seems to be immediate, and in short term 
use there is no apparent learning or adaptation effect [65]. Generally, once you stop 
applying the signal, the effect does not persist (although this was not the case in at least 
one study [86]).  
The lack of persistence would necessitate that any of these therapies would need to be 
used in an on-going basis, however, only one study has examined the effect of applying 
the intervention for more than a few minutes [88], and even here, it is not made clear 
that the device was left on throughout the day of testing. 
It may be desirable to alter the signal characteristics simply to prolong either the 
duration one can engage with the treatment, or the washout period after the signal is 
removed. In the former, the signal may either have long-term adverse effects, or the 
body may learn to ignore the effects of the artificial signal, nullifying the treatment. 
These long-term characteristics have not yet been investigated, however, some studies 
have shown consideration towards them in their design. Seo et al. 2014 postulate that 
one of their null results may have occurred as a consequence of prolonged exposure 
(15-20 minutes) [85]. This outcome emphasises the need long exposure studies. 
The effect on perceived neuropathic pain 
Sensory neuropathy frequently has a neuropathic pain component. It can be argued that 
one could predict that these treatments would either improve neuropathic pain, or 
worsen it. Since pain is so common, it seems an oversight that it has not been questioned 
alongside the neuropathic populations already investigated. 
Non-laboratory trials 
To date none of the trials have attempted an intervention in a non-laboratory setting. In 
a practical environment, aspects such as the size and capacity of power sources, the 
convenience of use, the manner and durability of attachment and many other factors all 
play a much larger role in the design of the intervention. 
While it is important to lay appropriate groundwork in the laboratory for any 
intervention, it seems that this field is now ready for non-laboratory trials. 
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One of the challenges facing research is the development of technology to allow these 
signals to be applied on an ongoing basis. No wearable continuous electric current 
stimulators have been developed that fulfil the requirements of these interventions. 
Several vibratory solutions have been prototyped and tested [16,17,70,79,80,97,106], 
but do not appear to have reached to the point where participants can use the device 
outside of a laboratory setting. 
Dose-response ratio 
To date no attempts have been made to model exactly how the interventions interact 
with the diseased physiology, making it impossible to predict for which diseased states 
particular interventions would work. A very high percentage of participants respond to 
these interventions but inter-patient variability of the dose-response ratio, and indeed 
the occurrence of “non-responders” has not been explained. 
Detailed physiological and mechanical model 
The included studies have not developed a sufficiently detailed model of the 
physiological and mechanical interactions that cause these interventions to be effective. 
While SR as a blanket theory appears to fit well, it does not allow researchers to make 
predictions, such as for what forms of neuropathy these interventions would be 
effective, or how alterations to the intervention signal would affect various outcome 
measures. 
More studies, such the microneurography studies by Breen et al. [75] and Ribot-Ciscar 
et al. [81], exploring the mechanism by which these interventions work would be of 
great benefit to the field. 
1.6 Conclusion 
The data indicates this class of interventions represents a real possibility for 
development into a practical medical device to improve sensation in populations that 
suffer from peripheral sensory neuropathies. 
Future studies should focus on achieving this goal by investigating prolonged exposure 
in everyday settings, as well as conducting more physiological studies to better 
understand the mechanism of the interventions so that its parameters can be optimised. 
In specific regard to the work of this thesis, no studies investigating the effect of 
subsensory signals on patients with HIV-related peripheral sensory neuropathy were 
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found, none of the studies reported on measures of pain, none of the studies investigated 
the perceptual threshold of participants to electrical noise stimuli, and none of the 
studies made use of, or researched a device that could apply electrical interventions in 





VIBROTACTILE SENSITIVITY OF PATIENTS 
WITH HIV-RELATED SENSORY NEUROPATHY 
 
Prior to conducting investigations into improving the vibrotactile sensitivity of patients 
with HIV-related peripheral sensory neuropathy in South Africa, it is important that the 
extent and nature of the sensation loss is first characterised. 
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Peripheral Neuropathic Desensitisation (PND) is a common problem with severe 
consequences (see Chapter 1.1). Over the last 20 years a family of intervention studies 
have sought to improve tactile sensitivity in healthy and neuropathic populations by 
applying continuous electrical or mechanical stimulation delivered at amplitudes below 
the perceptual threshold (e.g. [17,48,83,92]). These studies however, have never 
examined patients with HIV-related peripheral sensory neuropathy (HIV-PN). 
More than 5 million people live with HIV in South Africa [107], up to 60% of which 
suffer from HIV-PN, which may arise as a consequence of the infection or following 
Antiretroviral Therapy (ART) initiation [108,109]. While there is still no cure for HIV, 
ART has significantly reduced HIV-associated mortality. In addition, HIV related 
neurological conditions, such as HIV-PN, have been shown to adversely affect health 
related quality of life [29]. There is a growing need to find interventions to help this 
group manage the consequences of HIV-PN. The above mentioned “subperception 
stimulus” studies present hope that the problem of tactile sensitivity loss in patients 
with HIV-PN may be addressable. Given that these “subperception stimulus” studies 
aim to detect subclinical changes in perception thresholds, the measurements used 
require higher resolution than clinical tools. Before conducting such research, it is 
important to quantify the tactile sensitivity of patients with HIV-PN and compare the 
results to healthy matched control participants. This in turn can be used to justify a 
future intervention with this population. 
This chapter provides a detailed description of the vibrotactile sensitivity of individuals 
with HIV-PN and compares commonly used clinical vibration testing and scoring 
grades with a more robust double-blinded quantitative vibration perception 
threshold (VPT) protocol. 
2.2 Methods and Materials 
2.2.1 Participants 
22 HIV-PN participants were recruited consecutively from a cohort of a larger HIV 
‘inflamm-aging’ neuropathy study [110], which monitored patients after enrolment on 
a government sponsored ART program. These patients were recruited from the HIV 
clinic at Crossroads Community Health Centre in Cape Town, South Africa. A further 
21 control participants (hereinafter referred to as ‘non-HIV’) were also recruited by a 
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fieldworker through word of mouth. In the latter stages of recruitment, favour was given 
to participants that conformed to the age distribution of the HIV-PN participants. All 
participants were required to sign informed consent provided in either English or Xhosa 
(Informed consent documents are contained in the digital appendix folder “SENS 
Ethics”).  
The informed consent form was composed in English with a Fleish Kincaid grade level 
of 8.0. The English version was translated into Xhosa by Dilicom Language and 
Communication, which included a comprehensive translation from English to Xhosa 
and an independent back translation from Xhosa to English and verification. 
This study was approved by the Human Research Ethics Committees of both the 
University of Cape Town (HREC ref: 838/2015) and Western Sydney University (ref: 
H11381) (Both HREC approval letters are contained in the digital appendix in the 
folder “SENS Ethics”). 
A focused neuropathy examination was performed by a neurologist as part of the larger 
HIV ‘inflamm-aging’ neuropathy study (see Chapter 2.2.2). The methods by which this 
data was collected is described, but it should be noted that it was not collected as part 
of this thesis work. 
The HIV-PN group consisted of individuals with one or more neuropathic signs present 
in a symmetrical distribution as determined by neuropathy screening. Patients with 
severe painful neuropathy scoring greater than 6 out of 10 on a visual numeric scale at 
the time of the screening were excluded from the current study. Non-HIV participants 
were age and gender matched as a group, self-reported as HIV negative and had a 
similar demographic background, being recruited from the same geographic region. 
All participants were required to be physically able to perform the study tasks, be 
between 18 and 59 years of age, not be pregnant, have no history of cardiovascular 
disease or epilepsy, have no implants including pacemakers, not suffer from diabetes 
or alcoholism, and not be diagnosed with any illness that affects peripheral sensation 
aside from HIV in the case of the HIV-PN group. 
Participants’ height, weight, date of birth, foot dominance and self-reported sex were 
recorded (Appendix D.1). 
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2.2.2 Clinical neuropathy screening 
The Brief Peripheral Neuropathy Screening tool (BPNS) and a reduced version of the 
Total Neuropathy Screen (TNSr) were used to assess HIV patients for the presence of 
symmetrical neuropathic symptoms and signs [11,111] (Appendix D.2). Symptoms are 
defined as features of a disease that are apparent to the patient, and signs as features 
detected through medical examination. 
The BPNS establishes symptoms of pain, numbness, and “pins-and-needles” on a visual 
numeric scale. It further examines vibration perception in the toes and the presence of 
ankle reflexes. The ankle reflexes are scored as either normal (2), reduced (3) or 
absent (4). Vibration perception was assessed using a standard technique of applying 
the maximally vibrating 128 Hz tuning fork (TF) immediately to the distal 
interphalangeal joint at the hallux [111]. The final result is given as an ordinal variable 
indicating the duration for which vibration was detectable: score 0 for >10 seconds, 
score 1 for 6 to 10 seconds, score 2 for 1 to 5 seconds, and score 3 for no detectable 
vibration, denoting severe loss of vibration perception.  
The TNSr assesses the extent to which neuropathic symptoms and signs progress 
distally (toes/soles of feet (1)) to proximally (ankles (2), knees (3), hands (4)), with 
more proximal abnormalities scoring higher (worse). Five categories are examined: 
sensory symptoms, pin sensibility, vibration sensibility, deep tendon reflexes, and 
strength of plantar and ankle/toe dorsi-flexion. In addition, proprioception was assessed 
at the toes, and >20% mistakes (of 10 trials) bilaterally, was categorised as 
abnormal [109].  
The parameters selected from the HIV ‘inflamm-aging’ neuropathy study [110] for 
comparison with the VPT (see section 2.2.3) were: date since initiating ART, toe 
proprioception, BPNS tuning fork test (BPNS-TF), BPNS evaluation of ankle deep 
tendon reflexes (BPNS-DTR) and the total BPNS score (BPNS-total). Further, VPT 
was compared with the following outcomes from the TNSr: the distal-proximal extent 
of reduced abnormal vibration sensibility (TNSr-TF), pinprick abnormalities, reduction 
in deep tendon reflexes (TNSr-DTR) and the total TNSr score (TNSr-total).  
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2.2.3 Measurement of Vibration Perception Thresholds (VPT)3 
Participants were asked to sit in a chair and place their non-dominant foot on a platform 
as shown in Figure 12. The underside of the big toe was placed over a 20 mm hole in 
the platform that allowed it to contact the 5 mm ball-bearing-tipped probe underneath. 
 
Figure 12. Diagram showing the testing platform and control and instrumentation setup of the vibration 
sensitivity testing. The platform had a 20 mm hole in its surface through which the probe made contact with 
the skin. 
A 10 mm wide hook-and-loop strap, attached at the left and right edges of the platform 
in line with the probe, was placed over the toes and was used to keep the foot in place. 
It also ensured that the hallux was in contact with the probe, depressing the probe by 
50 to 150 μm. Adjustments were made during the experiment, if needed, to ensure that 
contact was maintained in this range. 
Figure 13 shows the modified method of limits protocol, which was conducted almost 
entirely by a custom written Matlab program to ensure double blinding (All program 
 
3 A full and detailed description of the protocol for measurement of VPT is presented 
in Chapter 3. Here, only what is necessary for understanding this chapter is presented. 
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code for this purpose is contained in the digital appendix folder labelled “Hardware and 
data management system”). 
 
Figure 13. Diagram depicting the testing protocol for vibrotactile threshold testing. 
Participants would first hear an easily recognisable audio cue indicating that an “up 
going” vibration ramp was imminent (See digital appendix folder “Hardware and data 
management system / DAQ_handlers / ring_up.wav”). The vibration would then start 
at an imperceptible amplitude and increase until the participant could feel the vibration. 
The participant was instructed to press a hand-held button immediately upon becoming 
aware of the vibration. The vibration would then pause for one second, and a different 
audio cue would sound, indicating the “down going” vibration ramp was imminent (See 
digital appendix folder “Hardware and data management system / DAQ_handlers / 
ring_down.wav”). The vibration would then start from a supra-threshold amplitude and 
decrease toward zero at the same rate as before. The participant would then press the 
hand-held button as soon as they could no longer feel the vibration. The sequence 
repeats until a total of 12 thresholds were collected. This would typically take between 
5 and 10 minutes depending on the participant’s thresholds and the rate of the ramps. 
The average vibration amplitude in the 0.5 seconds leading up to the button press was 
deemed the threshold for that ramp. 
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The protocol was repeated for three different vibration frequencies. These frequencies 
were specifically chosen to selectively activate predominantly low frequency 
mechanoreceptors (25 Hz), predominantly high frequency mechanoreceptors (128 Hz), 
and a combination of the two (50 Hz). Further, 128 Hz allowed for comparison to 
traditional tuning fork measurements. 
2.2.4 Data analysis 
The comparison of the HIV-PN and the non-HIV cohorts was conducted with a two-
sample t-test for each continuous variable, and the Fisher’s exact test comparing foot 
dominance. 
The effects of various parameters on VPT (all three frequencies), was computed as odds 
ratios of linear mixed effects models. This technique considers that it is the same 
participant being measured at each frequency (intra-subject). This allows for greater 
statistical power than analysing each frequency separately. In text we will refer to 
testing for a parameter’s effect on VPT. In all cases this does not refer to causality, but 
rather to the manner in which the statistical tests were conducted, with VPT as the 
outcome measure. Statistics are noted as probability (p), Chi squared value (χ2) and 
degrees of freedom (DF). 
When testing the correlation between only two variables, such as between a single VPT 
frequency and a tuning fork test outcome, Spearman rank order tests were used. This 
tests for a monotonic relationship between the two variables regardless of the shape of 
the relationship. A positive “Rho” value from the test would indicate that VPT threshold 
increases with increases in the secondary outcome and vice versa. The p-value is the 
probability of the null-hypothesis that the data was drawn from a zero correlation. 
Results are regarded as significant if the p-value is less than 0.05. However, results 
below 0.15 will also be discussed in context, and may justify further research. 
All vibration data was analysed and filtered in Matlab. Two-sample t-tests were 
calculated in Excel. Fisher’s Exact test and Spearman Rank Order tests were calculated 




2.3.1 Group characteristics 
Two of the 22 HIV-PN participants recruited were excluded from the results analysis. 
One was not able to learn the task, and the other had vibratory thresholds in excess of 
what the equipment was able to measure (>1000 μm); had severe HIV-PN with absent 
deep tendon reflexes, unable to perceive vibration sense with the TF at the toes only, 
altered proprioception at the toes and loss of pin sensibility extending to the knees. One 
of the 21 non-HIV participants recruited was excluded as their VPT at different 
frequencies were between 4.3 and 12 standard deviations from the mean of the group, 
indicating that the participant possibly had undiagnosed sensory neuropathy, and was 
therefore inappropriate as a control participant. 
The two groups consisted entirely of women. The bias towards female predominance 
is common in sub-Saharan African HIV cohorts [11,109,110]. The HIV-infected group 
were all virally suppressed on ART (viral loads <400 cps/ml)[110] except one 
individual (≈4000 cps/ml).  
Table 3 shows the participant characteristics. The HIV-PN participants and non-HIV 
participants were matched for age, foot dominance and height. Matching for age is 
important since it is expected that age will have an effect on VPT. Weight and BMI 
were significantly different with the average non-HIV participant’s body weight in the 
obese range (BMI>30) which is common for this demographic [112]. The difference in 
weight is likely a result of HIV-infection and its treatment causing weight loss [113].  
In the HIV-PN group, 18 of 20 had two or more neuropathic signs, and 2 had absent 
reflexes only. Table 4 shows the outcomes of the various tests performed on the 
HIV-PN group. In summary, only 2 cases experienced neuropathic symptoms. The 
neuropathic signs in order of frequency included: 18 had altered/absent ankle reflexes, 
14 had reduced distal pinprick sensibility, 10 had altered vibration sensibility by TF, 
and 7 had altered toe proprioception. Of those with altered vibration sensibility, 50% 




Table 3. Participant characteristics (mean and standard deviation in brackets). 
 HIV-PN Non-HIV P-Value 
Age (yrs) 41.6 (7.0) 40.1 (5.1) 0.449 
Height (cm) 156.6 (6.1) 159.4 (5.3) 0.146 
Weight (kg) 66.9 (13.8) 84.7 (23.0) 0.005 
BMI (kg.m-2) 27.1 (4.3) 33.2 (8.3) 0.006 
Foot Dominance (Right:Left) 19:1 16:3 0.342 
ART Duration (years) 8.6 (2.8) - - 
BPNS-total (0-11) 4.3 (1.1) - - 
TNSr-total (0-20) 4.9 (2.5) - - 
BMI: Body Mass Index. ART: Antiretroviral Therapy. BPNS-total: total score of Brief 
Peripheral Neuropathy Screening tool. TNSr-total: total score of the reduced Total 
Neuropathy Screen. 
Table 4. Frequencies of neuropathic signs for the HIV-PN group. A score of zero indicates “normal” unless 
otherwise stated. Higher scores indicate more severe signs of neuropathy. 
 Test Sore 
 0 1 2 3 4 
BPNS-TF 11 7 2 0 NA 
BPNS-DTR NA NA 2* 6 12 
TNSr-TF 10 5 2 2 1 
TNSr-DTR 2 6 2 7 3 
Proprioception 13 7 0 NA NA 
TNSr-pin 
sensitivity 
6 1 7 5 1 
*A score of 2 for BPNS-DTR indicates “normal”.  
“NA” indicates that this score category does not apply to this test 
BPNS-TF and BPNS-DTR: Brief Peripheral Neuropathy Screening tool Tuning 
Fork and Deep Tendon Reflex evaluation.  TNSr-TF, TNSr-DTR and TNSr-pin 
sensitivity: reduced Total Neuropathy Screen Tuning Fork score, Deep Tendon 
Reflexes score and pin-sensitivity score respectively. 
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2.3.2 Comparison of Vibration Perception Thresholds (VPT) between 
participants with HIV-related Peripheral sensory Neuropathy (HIV-PN) 
and non-HIV participants 
Figure 14 shows a comparison of the HIV-PN group and the non-HIV group at each of 
the three vibration frequencies. HIV-PN status significantly affected VPT (p = 0.018, 
χ2 = 5.59, DF = 1) as did vibration frequency (p < 0.001, χ2 = 38.71, DF = 2) 
i.e. sensitivity increased with increases in vibration frequency. Although not 
statistically significant, an interaction effect between vibration frequency and HIV-PN 
status on VPT suggests that HIV-PN may affect VPT differently at different frequencies 
compared to non-HIV participants (p = 0.064, χ2 = 5.51, DF = 2). Post-hoc analysis 
shows that HIV-PN status had a more detrimental effect on 25 Hz than 50 Hz or 128 Hz. 
 
Figure 14. Vibration thresholds of HIV-PN and non-HIV groups at three different frequencies. Sensitivity 
was reduced in the HIV-PN group at all frequencies (p = 0.018) compared to the non-HIV group. 
VPT increased with age when controlling for vibration frequency and HIV-PN status 
(p = 0.004, χ2 = 8.15, DF = 1). However, age did not interact with vibration frequency 
(p = 0.60, χ2 = 1.03, DF = 2), or with HIV status (p = 0.123, χ2 = 2.38, DF = 1). VPT 
did not correlate with participant height when controlling for vibration Hz and HIV-PN 
status, nor did the interaction of height and either vibration Hz or HIV-PN status have 
a significant correlation with VPT (p’s > 0.57). 
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While the audibility of the vibration was not recorded, no participants reported being 
able to hear the vibration. The vibration was only audible to the tester for unusually 
high amplitudes of vibration at 128 Hz. 
2.3.3 Comparison of Vibration Perception Thresholds (VPT) and clinical 
measures 
There was no effect of ART duration on VPT (p = 0.53, χ2 = 0.40, DF = 1), but there 
was an interaction between ART duration and vibration frequency (p = 0.038, χ2 = 6.56, 
DF = 2). Post-hoc analysis shows the patients who have been receiving ART for longer 
have improved sensitivity at 25 Hz. The sensitivity of other vibration frequencies is 
largely unaffected by the number of years receiving ART. 
Figure 15 shows there was no relationship between vibrotactile sensitivity, as 
measured by VPT at different frequencies, and the grading categories using the 128 Hz 
tuning fork at the toes (BPNS-TF) or the length-dependent vibration loss (TNSr-TF). 
We found no significant correlation between 128 Hz VPT and BPNS-TF (p = 0.76, 
rho = -0.08) or TNSr-TF (p = 0.90, rho = -0.03). There was no significant effect of any 
of the clinical measures of large nerve fibre function as graded by BPNS-TF, BPNS-
DTR, TNSr-TF, TNSr-DTR, and proprioception on VPT or small fiber function as 
measured by pinprick sensibility (Table 5, all p’s > 0.28). Neither was there any 




Figure 15. Plot of VPT at three different vibration frequencies versus BPNS-TF (top) and TNSr-TF (bottom) 






Table 5. Statistical outcomes for linear mixed effects models looking at the effect of various clinical bedside 
tests on VPT at all frequencies. DF = 1 for all main effects of the parameter on VPT, and DF = 2 for interaction 







BPNS-TF 0.41 (0.69) 0.79 (0.55) 
BPNS-DTR 0.40 (0.71) 0.98 (0.05) 
BPNS-total 0.50 (0.45) 0.96 (0.07) 
TNSr-TF 0.34 (0.90) 0.99 (0.01) 
TNSr-DTR 0.67 (0.19) 0.90 (0.21) 
TNSr-total 0.99 (0.00) 0.80(0.44) 
PROP 0.28 (1.18) 0.72 (0.66) 
BPNS-TF, BPNS-DTR and BPNS-total: brief 
peripheral neuropathy screening tool tuning fork 
evaluation, deep tendon reflex evaluation and total 
score respectively. TNSr-TF, TNSr-DTR and TNSr-
total:  reduced total neuropathy screen tuning fork 
score, deep tendon reflexes score, and total score 
respectively. PROP: proprioception score. VPT: 
Vibration perception threshold. P, probability, χ2, Chi 
squared value, DF, degrees of freedom. 
 
2.4 Discussion 
This study presents vibrotactile sensitivity of a cohort of selected individuals with 
moderately severe HIV-PN using a robust psychophysics methodology and compares 
results to clinical screening tools commonly used in the study of HIV-PN. The protocol 
used here differs from prior work, averages multiple measurements, uses a method of 
limits in both ascending and descending modes and is double blind, making it more 
robust than currently available vibration testing. Previous studies using quantified 
sensory testing (QST) devices in HIV-PN report their results in terms of mean Z-scores 
based on their cohort controls scores ([114,115]. Therefore, we are not able to compare 
our results with previously reported HIV-PN groups. Nevertheless, our control group 
was recruited using similar strategies to previous reports ([114]). 
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The HIV-PN group had reduced sensitivity, and sensitivity for both groups increased 
with increase in vibration frequency in accordance with previous research in the 
area [116]. We would also expect to observe a decrease in sensitivity with increasing 
age [117]. This was also shown to be the case as age had a statistically significant effect 
on VPT when controlling for HIV-PN status and vibration frequency. However, the 
effect of age did not interact with HIV-PN status, i.e. HIV-PN patients’ and non-HIV 
participants’ VPT was not affected differently by age. 
HIV-PN is known to have length dependent properties [108,109], however we found 
no correlation between height and VPT for either group. Subject heights in the HIV-
PN group were normally distributed with a standard deviation of only 6.1 cm, therefore 
very few participants lay far from the mean to give strength to an analysis of height in 
this context. Although the lack of correlation should not be over-interpreted in this 
small sample, the absence of an association signal with height and HIV-PN has been 
consistently absent in this population [11,109].  
BMI was significantly lower in the HIV-PN group. Past work indicates that BMI most 
likely does not correlate with VPT, but if it does, it is likely to result in increased tactile 
sensitivity with lower BMI [118–120]. Consequently, it is possible, but unlikely, that 
the difference in sensitivity between the groups was even larger than the observed 
difference. 
An interesting result would be to find that HIV-PN affects vibration sensitivity of 
different mechanoreceptor types differently. This could manifest when measuring VPT 
at different vibration frequencies, as different mechanoreceptors populations have 
different vibration frequency responses. Indeed Shy et al. notes that different 
stimulation frequencies hold different diagnostic value under varying circumstances 
(although suggests testing above 128 Hz to more exclusively activate high frequency 
receptors) [121]. We would observe this effect as an interaction between HIV-PN status 
and vibration frequency when assessing VPT. This study was statistically powered to 
find inferences in the primary outcome variables, and interactions require significantly 
more statistical power. The interaction effect between HIV-PN status and frequency of 
vibration on VPT (p = 0.0635) is not significant, but this should not be interpreted as 
strong evidence against an effect, given the low power. Calculating the required number 
of participants sufficient to power the study to determine this outcome is not trivial. It 
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can be said as a rule of thumb, it is likely that four times the number of participants 
would be needed. 
Previous work has shown that neuropathy symptoms and signs improve for some 
patients receiving ART over time and worsen for others [109]. We did not find an 
overall effect of years on ART on VPT, but there was an interaction between ART 
duration and vibration frequency. Post-hoc analysis indicates that duration of ART was 
correlated with an improvement in 25 Hz VPT performance. The observed interaction 
between group (HIV-PN or non-HIV) and vibration frequency, along with the 
significant interaction between ART duration and vibration frequency is suggestive of 
a pathology that does not affect all mechanoreceptors similarly. 
All clinical measures failed to correlate with VPT. This lack of expected correlation 
can be explained through several mechanisms. Past results have shown that clinical 
measures of neuropathy have optimal diagnostic accuracy when combined with each 
other, including VPT [121,122]. In theory, measures that correlate well with each other 
would not add additional diagnostic information and it is expected that they test 
different aspects of the disease or that multiple measures reduce the influence of 
random variation. Further, excluding patients with severe painful neuropathy may have 
reduced the strength of the relationship between clinical measures and VPT, although 
there was no interaction with pinprick, which, like painful symptoms, subserves small 
fibre function. It is also possible that the clinical measurements lack the resolution to 
demonstrate continuous relationships. For example, it has been shown that the 
relationship between the tuning fork vibration time and age only degrades about 
5 seconds from the age of 20 to 60 on average [123]. It is therefore unreasonable to 
expect to see this relationship when tuning-fork time is summarised into 5-second 
blocks.  
A limitation of this study is that the healthy controls did not undergo a neurological 
screen. This does not invalidate the results, but may have resulted in a smaller 
difference in VPT between the two groups than if potential control participants with 
undiagnosed neuropathy were excluded. Testing the control participants for HIV was 
not part of the protocol for ethical reasons. This omission is common for studies of this 
nature (e.g. [114]). 
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Since Subsensory Electrical Nerve Stimulation (SENS) interventions have shown 
promise in improving VPT in the past with other populations that suffer from reduced 
VPT, it is conceivable that an intervention with SENS would be beneficial to this HIV-
PN population and should be explored as an option for therapy. The interaction between 
VPT at 25 Hz and HIV-PN status, and between years on ART and VPT at 25 Hz suggest 
that the response to vibration frequency may hold additional diagnostic value over using 
a tuning fork test only at 128 Hz. 
2.5 Conclusion 
To the best of our knowledge this work presents the first quantitative, double blind 
measurement of VPT in patients with HIV-related sensory neuropathy. The results 
indicate that patients with HIV-PN have reduced vibration sensitivity at all tested 
vibration frequencies compared to age, height and gender-matched non-HIV 
participants, and that sensitivity increased with vibration frequency for both groups. 
Outcomes of tests for interaction with vibration frequency suggest that the pathology 
in subjects with HIV-related neuropathy does not affect all mechanoreceptors similarly. 
Future work should increase the number of participants and should include patients 
with more severe neuropathy. This would allow for a better analysis of interaction 
effects as well as strengthen the relationship between VPT and parameters that degrade 





SUBSENSORY ELECTRICAL NERVE 
STIMULATION FOR THE IMPROVEMENT OF 
VIBRATION PERCEPTION IN PATIENTS WITH 
HIV-RELATED PERIPHERAL NEUROPATHY 
 
In Chapter 2, the adverse effects of HIV-related peripheral sensory neuropathy 
(HIV-PN) on vibration perception thresholds (VPT) were demonstrated. Further, the 
potential of Subsensory Electrical Nerve Stimulation (SENS) as a means of providing 
much needed therapy for this group was discussed. Here, the effect of SENS on HIV-
PN participants and healthy controls is presented.  
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3.1.1 HIV-related peripheral neuropathy 
Peripheral neuropathic desensitisation (PND) is a common problem that can be caused 
by HIV and many other conditions. HIV-related peripheral sensory neuropathy 
(HIV-PN) is highly prevalent condition which adversely impacts morbidity and no 
treatment is currently available (see Chapter 1.1 and Chapter 2.1 for more details 
regarding PND and HIV-PN). 
3.1.2 Neuropathic pain 
Neuropathic pain is a common complication associated with diabetic PND [5] and 
occurs in approximately 70% of patents with symptomatic HIV-PN [11]. Sufferers 
experience paraesthesia (prickling or stinging needles), paroxysmal pain (short 
shooting electrical attacks), superficial pain (on-going pain, often burning), allodynia 
(painful response to non-painful stimuli) and hyperalgesia (disproportionate response 
to painful stimuli) [124]. Symptoms are often worse at night. 
The aetiology of painful peripheral neuropathy is not fully understood, but it is accepted 
that there are several underlying mechanisms. There is evidence from 
microneurography studies for both the idea that pain may be caused by an absence of 
proper nerve function [125] and hypersensitivity of the receptors [126,127], leaving it 
unclear how an intervention increasing tactile sensitivity would affect neuropathic pain. 
3.1.3 Interventions to improve tactile sensitivity 
Chapter 1 presents a detailed review of a family of interventions that seek to improve 
sensation by applying a signal (often in the form of multi-frequency noise) to the site 
where the sensation is to be improved. It is theorised for in the majority of the research 
that the mechanism of the therapy is stochastic resonance (SR) [128,129].  
Research applying these interventions has been performed with participants with a wide 
array of sensory deficits, but never with participants with diagnosed HIV (see Chapter 1 
for a full description of the existing literature). Most studies reported the therapy 
improved parameters between 5% and 30% for a very high percentage of participants 
(mostly exploratory studies with 6≤n≥18). 
Of particular relevance is the work of Breen et al. [30,31,75,92]. Breen et al. applied 
electrical current to healthy young participants, proximal to the fingertip [75] and to the 
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skin medially and laterally, proximal to the malleoli [30,31], and again in the same 
location in older adults [30,92]. In all cases vibration perception was enhanced by 
between 10% and 20%.  
The intervention noise spectrum used by Breen et al. is unique. All other studies have 
used band limited white noise, but Breen et al. used noise heavily weight toward very 
low frequencies. They have coined this modality “SENS” standing for Subsensory 
Electrical Noise Stimulation (see Chapter 1 for more details relating to the spectrums 
used by various studies). Due to physiological time constants, it is unlikely that very 
high frequencies have a meaningful effect, and consequently the system can be thought 
to have a low-pass filter characteristic. This is reflected in the choice 1/f (pink) 
frequency spectrum choice of Breen et al. 
While no rationale is given for this design choice by Breen et al., it can be inferred that 
this signal is more efficient at transferring energy to the nerves than a white noise 
spectrum, as less energy is dedicated to the potentially inefficient high frequencies. In 
addition, the pink spectrum is likely to include the mechanical frequency response 
range of the receptor itself (as discussed in Chapter 1.5.4) while not completely 
excluding higher frequencies that may still create meaningful responses. While it 
cannot be said that the causal relationship between intervention spectrum and efficacy 
is understood, pink noise offers the current “best guess”. 
Since the signal is applied proximally, it is unclear what the mechanism of enhancement 
is. It could be a form of SR in the sensory axons in the limb. Microneurography data 
indicates that the mechanism may be related to reduced variability in action potential 
timing in individual axons, and additional synchronisation of action potentials across 
parallel multiple axons, allowing a greater cumulative effect when summed 
centrally [75]. 
This family of subthreshold interventions has shown great promise in being developed 
into a device that can help those suffering from PND (see Chapter 1.4 for summaries 
of the outcomes of studies of this type). 
3.1.4 Research goals 
SENS has never been studied with HIV-PN or with participants from an African 
context. The primary goal of this research is to assess the effectiveness of SENS in 
improving tactile sensitivity of South African HIV-PN patients. The research also seeks 
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to determine if SENS is effective for healthy participants from South Africa, that have 
a substantially different background to healthy participants previously researched in 
other countries. 
No prior known work using interventions of this type report on measures of pain, a 
common symptom of neuropathy in a variety of contexts. The secondary goal of this 
work is to investigate how SENS effects symptoms of pain. 
Finally, the ability of SENS to improve tactile sensitivity has only been investigated for 
50 Hz vibration frequency in the past. This works aims to investigate the effectiveness 
of SENS at lower and higher frequencies that represent a wider spread of 
mechanoreceptors. 
3.2 Methods and Materials 
Aspects of the study presented in this chapter overlap with Chapter 2, including the 
recruitment of participants, measurement of their characteristics, the clinical screening 
of the HIV-PN participants and the measurement of Vibration perception thresholds. 
Repetition is avoided, but text which ensures the chapter reads clearly has been repeated 
for those who read this chapter in isolation. 
3.2.1 Participants 
22 HIV-PN participants and 21 healthy non-HIV participants were recruited from the 
same community in Crossroads, Cape Town, South Africa. The non-HIV group has 
been included for two reasons. Firstly, they act as validation of this particular setup and 
environment. Should the HIV participants show no effect, it would be natural to 
question the validity of the experimental equipment and design. By testing healthy 
participants, the research can be sure that, should SENS not demonstrate an effect in 
the HIV-PN group, it is a consequence of the population tested rather than the 
experimental design. Secondly, while several prior studies conduct research 
investigations of the effect of SENS on healthy participants, it cannot be ignored that 
the African context is different and sensory perception among healthy participants from 
the townships of Cape Town may be different to those of Sydney for example. The 
quality of the research is thus strengthened by comparing the results of HIV-PN 




All participants were required to sign informed consent, which outlined the 
experimental protocol and exclusion criteria, provided in either English or Xhosa. This 
study was approved by the Human Research Ethics Committees of both the University 
of Cape Town (HREC ref: 838/2015) and Western Sydney University (ref: H11381). 
A focused neuropathy examination was performed on the HIV-PN participants (see 
Chapter 2.2.2). The HIV-PN group consisted of individuals with one or more 
neuropathic signs present in a symmetrical distribution. Patients with severe painful 
neuropathy scoring greater than 6 out of 10 on a visual numeric scale were excluded 
from the current study (15% of the total cohort). Those with severe painful neuropathy 
were excluded for two reasons: because pain may confound the measurement of VPT, 
and because the hypothesis is that SENS, which aims to improve tactile sensitivity, may 
also increase perceived pain in these patients. 
Non-HIV participants were age and gender matched as a group, self-reported as HIV 
negative and had a similar demographic background, being recruited from the same 
geographic region. 
Participants’ height, weight, date of birth, foot dominance and self-reported sex were 
recorded. Foot dominance is the foot (left or right) most likely to be used for dexterous 
tasks. This was measured to arbitrarily standardise which foot was used for VPT 
measurements. 
3.2.2 Study design 
In this study, vibration perception threshold (VPT) was evaluated at 50 Hz during the 
application four different SENS amplitudes as well as a sham condition. Each of the 
five conditions was tested double blind in a random order for each participant (phase 
one, Figure 16) to match the work done by Breen et al. on other populations 
[30,31,92,93]. While the study design choice of Breen et al. to test 50 Hz was not 
explicitly justified, it is a consequence of the test equipment (biothesiometer used) 
operating only at 50 Hz. Notably, 50 Hz is a vibration frequency that does not 
exclusively activate only fast acting or slow acting mechanoreceptors [116]. 
Breen et al. found that there was an optimal SENS amplitude for each participant. 
Consequently, after the 50 Hz testing the most effective SENS amplitude was selected 
for the second phase of testing (phase 2, Figure 16). The rationale in their research is 
that once this optimal SENS amplitude is found, that SENS should be applied at this 
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amplitude for general tactile sensitivity improvement. To test this hypothesis VPT was 
then evaluated at 25 Hz and 128 Hz vibration frequencies with this best performing 
SENS amplitude and in a sham condition (for each frequency), in a randomised 
crossover design. 25 Hz was selected to evaluate predominantly low-frequency 
mechanoreceptors, and 128 Hz to evaluate predominantly high-frequency 
mechanoreceptors [116] and to compare results to clinical 128 Hz tuning fork tests 
[122,123,130]. 
A constant SENS RMS amplitude was applied throughout each VPT test and the full 
VPT testing protocol described in Chapter 3.2.5 was conducted for each 
vibration-frequency and SENS-amplitude pairing. In the text below the 50 Hz vibration 
frequency trials are individually identified by the amplitude of SENS used (e.g. 45A), 
whereas the 25 Hz and 128 Hz vibration frequency trials are identified using the 
vibration frequency and not the amplitude of SENS. 
 
Figure 16. Study design overview. In phase 1, VPT is evaluated for 50 Hz vibration at 4 different SENS 
amplitudes and one control condition, double blinded in a randomised order for each participant. Upon 
completion of phase 1, the SENS amplitude associated with the most sensitive VPT relative to the control 
condition is selected for use in phase 2. In phase 2 VPT is evaluated for 25 Hz and 128 Hz vibration 
frequencies, each in a control condition, and with SENS (applied at the best performing amplitude from 
phase 1 for that participant). The four test conditions of phase 2 are completed in a double blinded random 
order. 
3.2.3 Calculation and generation of SENS 
In some publications the electrical noise used as “SENS” is referred to as pink noise, 
or 1/f in frequency characteristic. In reality the noise used in SENS publications is a 
variation of brown noise with a frequency characteristic closer to 1/f2. The waveform 
is calculated using a random walk algorithm first referred in the context of SENS in 
Breen et al.[75]. 
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Here they describe the generation of SENS as having been produced from equations 
in [131], which in turn references the book [132]. The equations are included here as 
reference as they are not easily found in the literature. 
The original equation for SENS at any sample point xi, can be notated as: 
 𝑥𝑖 = 𝐶 × 𝑥𝑖−1 + 𝑑𝑖  1 






which is a constant between 0 and 1 for positive 𝜏, and 𝑑𝑖 is a random value drawn 
from a Gaussian distribution at step 𝑖. 
The signal can also be more efficiently generated in vectorised software with the 
equivalent equation: 
 
𝑥𝑖 =  𝐶






The noise was generated by a custom written Matlab program (See digital appendix 
folder “Hardware and data management system”) and converted to a stimulation current 
via a digital to analogue converter and an A-M Systems 2200 current stimulator (see 
Figure 17 for an example waveform). The digital appendix folder “SENS signal 
generation code” contains examples of how to generate SENS signals in both the 
iterative and vectorised methods. 
The final signal is dependent on the sample interval used. The design choice to generate 
the intervention signal in this manner was made to match the successful work of Breen 
et al. and consequently the same sample rate of 100 Hz was selected. 
3.2.4 Application of SENS and measurement of electrical perception 
threshold 
Signal amplitudes of 30 µA, 45 µA, 60 µA (RMS) and 90% of electrical perception 




Figure 17. Typical SENS stimulation current waveform. 
In order to apply the intervention signal, and establish electrical perception threshold, 
two Axelgaard UltraStim® Snap SN2040 10 cm × 5 cm adhesive surface electrodes 
were applied to the skin medially and laterally, proximal to the malleoli on the non-
dominant leg (see Figure 18). The non-dominant leg was chosen arbitrarily for 
consistency. The location of the electrodes was designed to stimulate the tibial nerve 
that sub-serves the tactile receptors of the plantar aspect of the foot [31]. The electrodes 
themselves were selected to repeat the work of Breen et al. [31]. The manufacturer 
advertises high quality current density uniformity. Current density uniformity is 
desirable as it minimises current “hotspots” on the skin which may be damaging to the 
user. 
Electrical perception threshold was established using a single blind method of 
levels [121]. Threshold was defined as the highest amplitude at which the participant 
could not feel the electrical stimulation. Given that past studies found the intervention 
to be effective for currents in the range of 30 to 60 µA, an upper limit of current 
threshold was set at 555 µA, resulting in a maximum of 500 µA applied when using 
90% of threshold. This was done as currents beyond 500 A are very likely to be supra-
threshold at a neuronal level even if not at a perceivable level. Further, currents in the 




3.2.5 Measurement of vibration perception thresholds 
To measure vibration perception thresholds (VPT) psychophysics experiments often 
use a controllable vibration device such as a biothesiometer (Bio-medical Instrument 
CO., Newbury, OH), neurothesiometer (Horwell Scientific, London, UK) or a custom 
electronic “tactor” which are driven in ascending and/or descending amplitudes to 
establish the sensory threshold [133]. The participant is required to indicate when they 
cannot perceive the vibration as the amplitude is reduced. The amplitude can also be 
increased from a subperception level to get an ascending threshold. Individual 
participants can have different decision criteria for identifying the onset or offset of 
sensation, requiring different levels of certainty. Using both ascending and descending 
thresholds allows the experiment to control for reaction speed of the participant and the 
effect of the decision criteria. 
Shy et al.[121] highlight the importance of double blinding in quantitative sensory 
testing. Testing VPT inevitably has a psychological component unlike nerve 
conduction velocity (for example) [121]. Clinical VPT testing and many psychophysics 
tools such as the Neurothesiometer use single blinding or no blinding at all. This is 
likely to lead to unreliable or unrepeatable results. 
By double blinding the testing, interleaving ascending and descending ramps, 
calculating the final threshold value controlling for the effect direction (ascending or 
descending) has on threshold, and performing the test multiple times, the influence of 
reaction time and many of the biases that lead to potentially unreliable outcomes are 
avoided [121,134]. 
To measure VPT, participants were asked to sit in a chair and place their non-dominant 
foot on a platform as depicted in Figure 18. The underside of the big toe was placed 
over a 20 mm hole in the platform that allowed it to make contact with the 5 mm ball-




Figure 18. Diagram showing the testing platform and control and instrumentation setup of the vibration 
sensitivity testing. The platform had a 20 mm hole in its surface through which the probe made contact with 
the skin. 
A 10 mm wide hook-and-loop strap, attached at the left and right edges of the platform 
in line with the probe, was placed over the toes and was used to keep the foot in place. 
It also ensured that the hallux was in contact with the probe, depressing the probe by 
50 to 150 μm. Adjustments were made during the experiment, if needed, to ensure that 
contact was maintained in this range. 
Figure 19 shows the modified method of limits protocol, which was conducted by a 
custom written Matlab program with minimal user input to ensure double blinding (See 




Figure 19. Diagram depicting the testing protocol for vibrotactile threshold testing. 
Participants would first hear an easily recognisable audio cue indicating that an “up 
going” vibration ramp was imminent. The vibration would then start at an imperceptible 
amplitude and increase until the participant could feel the vibration. The participant 
was instructed to press a hand-held button immediately upon becoming aware of the 
vibration. The vibration would then pause for one second, and a different audio cue 
would sound, indicating the “down going” vibration ramp was imminent. The vibration 
would then start from a super-threshold amplitude and decrease toward zero at the same 
rate as before. The participant would then press the hand-held button as soon as they 





Figure 20. Typical vibration amplitude ramps during a subset of VPT measurement. Left is unfiltered 
vibration displacement data. Right is the band-pass filtered data with the participant responses marked as 
vertical dotted lines. 
The sequence repeats until a total of 12 thresholds were collected. This would typically 
take between 5 and 10 minutes depending on the participant’s thresholds and the rate 
of the ramps. The average vibration amplitude in the 0.5 seconds leading up to the 
button press was deemed the threshold for that ramp. 
The subthreshold start value for up going ramps, and the supra-threshold start value for 
down going ramps was calculated by the computer based on past results for that 
participant and thus was slightly different each time, creating natural variability in the 
time to each button press. This can be thought of as increasing the effectiveness of the 
blinding, as participants, even though unaware of the amplitudes, may want to respond 
within common time periods if they perceive time-to-response as a predictor of 
vibration amplitude.  
The supra-threshold vibration amplitude was the largest of three possible values: 20% 
greater than the current threshold estimate, 10 m greater than the current threshold 
estimate, or a minimum lead magnitude greater than the current estimate. The lead 
magnitude was based on the rate of amplitude fall selected for this set of trials, and can 
be thought of as a minimum time before expected crossing of the threshold. This value 
was set to 5 seconds with an additional random variability of 0 to 3 seconds for each 
ramp. The amplitude was limited to 500 m as this was the limit of the equipment. The 
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current estimate was calculated as the mean of the preceding thresholds for the current 
SENS amplitude and vibration frequency pairing. 
There was no visual feedback of the vibration amplitude, or explicit measurements of 
the results available to the investigator or the participant. Only a scale-less 
representation of the raw measured vibration signal was available to the investigator 
after each button press to ensure that no errors were being made in the protocol. These 
errors included responding prior to initiation of vibration, responding long after the 
amplitude had reduced to zero, or excessive movement artefact. The participant was 
also permitted to declare that they had responded erroneously. These ramps were noted 
and were excluded from analysis. 
Participants were familiarised with a reduced version of the protocol using only 6 
thresholds as opposed to the 12 used in the testing stage. This was done at least once 
for each vibration frequency, but was repeated until it was clear that the participant was 
fully competent in the task. This often took many repetitions, which possibly indicates 
that the task was particularly alien to most participants. 
The rate of vibration amplitude increase or decrease was set between 0.7 μm/s and 
1.2 μm/s immediately after or during the familiarisation to ensure that the average time 
to perception was not too long or too short. With such a slow rate, even a several second 
delay in reaction time by the participant would only result in an error of a few μm in 
the measurement. 
Valid ramps were those where the participant performed the task without error and the 
offset of the toe remained between 50 and 150 μm with minimal movement artefact. 
The data was then passed through a zero phase 15 to 135 Hz band-pass filter to further 
remove movement artefact and electronic noise (see digital appendix folder “Hardware 
and data management system/Misc/BPF15to135.m” for full filter details). 
3.2.6 Measurement of pain 
For each test condition, upon completion of the VPT measurement, the participant was 
asked to rate any symptoms of pain felt during the test in the evaluated limb, in three 
separate categories, on a visual numeric scale from 0 to 10. 
An extract from the SA Brief Peripheral Neuropathy Screening exam (BPNS) was used 
(see Appendix D.2). Pain was recorded for Pain A: Pain, aching, burning in feet or legs, 
Pain B: “Pins-and-needles" in feet or legs, and Pain C: Numbness (lack of feeling) in 
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feet or legs. The scale starts at 0, ‘normal’ (i.e. no pain), stipulates 1 as ‘mild’, and 
extends to 10, ‘Severe’. 
3.2.7 Data analysis 
The comparison of the HIV-PN and the control cohorts was conducted with a two-
sample t-test for each continuous variable, and the Fisher’s exact test comparing foot 
dominance. 
The effects of SENS condition, HIV-PN, the direction of the VPT ramp (ascending or 
descending) on VPT and separately on symptoms of Pain, was computed as odds ratios 
of linear mixed effects models. This allows the analysis to use every recorded threshold 
to gain greater statistical power than a traditional paired comparison. In text we will 
refer to testing for a parameter’s effect on VPT or pain. In all cases this does not refer 
to causality, but rather to the manner in which the statistical tests were conducted, with 
VPT as the outcome measure. Statistics are noted as probability (p), Chi squared 
value (χ2) and degrees of freedom (DF). For significant outcomes, the direction of the 
correlation will be noted. 
An additional analysis comparing VPT of the best 50 Hz SENS results (optimal, per 
participant SENS amplitude) to the 50 Hz sham condition was conducted. Because this 
data is inherently “cherry picked” a traditional statistical test would provide a skewed 
result. The probability of the null hypothesis, that SENS had no effect, was evaluated 
using a Monte Carlo simulation of the experiment [135–137] (see Appendix A for a 
full description of how this was derived and performed). 
Where appropriate data was evaluated for normality using a one-sample Kolmogorov-
Smirnov test or KS test. All data subgroups were not statistically significantly different 
to a normal distribution unless otherwise stated. 
All vibration data was analysed and filtered in Matlab. VPT thresholds were log 
transformed as is traditional for threshold data of this form [50–52,116]. Two-sample 
paired and unpaired t-tests were calculated in Excel, Fisher’s Exact test was calculated 
in Matlab and linear mixed effects models were calculated in R. 
Power analysis indicated that in a crossover trial we can expect to find a significant 
result, should one exist, with intra-participant variability of 16% if there is a difference 
of 15% in the outcome measure for a group size of 20. These figures are in accordance 
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with predicted intra-participant variability shown in Breen et al. for elderly neuropathic 
individuals using a similar testing paradigm [30,92]. Pain measures are recorded on a 
scale of 0 to 10, thus it seems reasonable that intra-participant variability and detectable 
difference in this case will both be the same (≈9%) thus necessitating a minimum 
sample size of 18. 
In general, averaging multiple measurements of the same parameter reduces intra-
participant variability by 1/√𝑛 (where 𝑛 is the number of measurements made of the 
same sample set). In our design, we record multiple data points (up to 12 repetitions) 
for each test condition, much more so than Breen et al. (3 repetitions), thus we can 
expect to see lower intra-participant variability. Adjusting for this, the study is powered 
to find a difference of 7.5%. Having 20 participants in each group exceeds the groups 
sizes of other studies in the field by a reasonable safety margin. 
Results are regarded as significant if the p-value is less than 0.05. However, results 
below 0.15 may be discussed in context, and may justify further research. 
3.2.8 Exclusion of data 
In some cases, data needed to be excluded before analysis. Three participants were 
excluded entirely, and the reasons for this are discussed in the group characteristics 
results below (Chapter 3.3.1). Multiple individual thresholds were excluded because 
the amplitude of SENS did not appear to be below threshold. 
When SENS is supra-threshold, it has the effect of inducing a “pins-and-needles” 
sensation on the skin under the electrode. Since this sensation was documented as part 
of the pain measurements (Pain B), the participants were asked if the Pain B was under 
the electrodes or elsewhere. If the participant could feel this sensation, then it is possible 
that the SENS intervention signal was now supra-threshold (see Chapter 4 for a 
description of the stability of electrical perception thresholds). It seems best that trials 
be excluded where SENS was applied, and participants reported any Pain B scores 
under the electrode, as those trials cannot be said to be blind or subthreshold. 
However, some participants reported the sensation even when the SENS signal had 
been switched off for some time, indicating it may be a placebo effect, possibly caused 
by psychological priming or just by the presence of the adhesive electrodes. Given the 
propensity for participants to report Pain B under the electrode when SENS was not 
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active, trials were only excluded if Pain B was reported at a higher level than the highest 
of the three sham conditions for that participant. 
3.3 Results 
3.3.1 Group characteristics 
Two of the 22 HIV-PN participants recruited were excluded from the results analysis. 
One was not able to learn the task, and the other had vibratory thresholds in excess of 
what the equipment was able to measure (>1000 μm). One of the 21 control participants 
recruited was excluded as their VPT at different frequencies were between 4.3 and 12 
standard deviations from the mean of the group, indicating that the participant possibly 
had undiagnosed sensory neuropathy, and was therefore inappropriate as a control. 
Chapter 2.3 presents a detailed description of the group characteristics. It further 
analyses how baseline VPT varied between groups and interacted with participant 
height, age, and for the HIV-PN group, years on Antiretroviral Therapy (ART) and 
various clinical measures of neuropathy. Here we present a summary of relevant results 
from that chapter, and analyse the effect of SENS on VPT and pain under different 
conditions. 
The two groups were not statistically significantly different in age, height, gender or 
foot dominance. Weight and BMI were significantly different with the average 
non-HIV participant’s body weight in the obese range (BMI>30) which is common for 
this demographic [112]. Past work indicates that BMI most likely does not correlate 
with VPT, but if it does, it is likely to result in reduced tactile sensitivity with increases 
in BMI [118–120]. 
The HIV-PN participants were found to have less sensitive baseline vibration 
perception at all three vibration frequencies. An interaction with frequency (P = 0.064) 
is suggestive that the HIV-PN participants had particularly poor 25 Hz responses in 
comparison with the control group. Increasing age was found to correlate with reduced 
sensitivity. Years on ART correlated with improved sensitivity at 25 Hz only. The two 
results that applied specifically to 25 Hz suggest that the disease and its treatment have 
a stronger effect on low vibration frequency mechanoreceptors than other vibration 
frequencies. Participant height, and all clinical screening outcomes measured did not 
correlate with baseline VPT (see Chapter 2.3 for further details). 
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The Electrical Perception Thresholds (EPT) of the groups were not found to be different 
(p>0.64). This result is somewhat corrupted in that EPT were not measured above 
555 A. Four individuals in the HIV-PN group had thresholds in excess of 555 A, and 
three individuals in the non-HIV group. Truncating these thresholds to 555 A, the 
average electrical perception threshold of the HIV-PN group was 164 A and 142 A 
for the non-HIV group. It was noted for several participants that measuring the EPT 
was difficult and that there was not a high degree of confidence in the final value. This 
is reinforced in that during the testing, participants often reported the sensation of the 
electrical stimulation even when it was below the previously measured threshold for 
that participant (Chapter 4 addresses this problem, and shows the EPTs are not stable). 
3.3.2 Effect of SENS on Vibration Perception Thresholds (VPT) 
Figure 21 depicts the effect of SENS on VPT relative to the sham condition for the 
HIV-PN group and healthy non-HIV control group. Both groups had a statistically 
significantly beneficial effect of SENS for 45 A at 50 Hz. Only the non-HIV 
participants had a beneficial response at 30 A and 90% of threshold (both 50 Hz). The 
HIV participants responded with a detrimental effect at 90% of threshold (50 Hz) and 
non-HIV participants responded with a detrimental effect of SENS in the 128 Hz test 
condition. 
Table 6 provides all the numerical results of the statistical tests for the effects of SENS 
on VPT. The effect of the direction of the vibration ramp on VPT (ascending or 
descending) is controlled for. The full numerical outcomes of all the statistical tests is 
contained in the digital appendix folder “Effects of SENS statistical outcomes”. The 
full set of individual results is contained in the spreadsheet “Final results.xlsx”, within 




Figure 21. Graph demonstrating the effect of SENS on VPT compared to the matched sham condition for 
different SENS amplitudes and vibration frequencies. First SENS was tested at 30 A, 45 A, 60 A and 90% 
perception threshold all for 50 Hz vibration frequencies. Then the best performing 50 Hz SENS amplitude 
was retested against sham conditions at 25 Hz and 128 Hz vibration frequencies. * indicate results statistically 
significantly different from zero (p<0.05). 
 
 65 
Table 6. Statistical results of the effect of SENS on VPT. * indicates significance p < 0.05. All degrees of 
freedom are 1. Negative percentage changes are beneficial and positive changes are detrimental. 
Test 
Condition 
Group p (χ2) Percentage Change 
30 A, 50 Hz HIV-PN 0.79 (0.07) 0.7 
 Non-HIV 0.01 (6.06) -7.2* 
45 A, 50 Hz HIV-PN 0.02 (5.58) -7.5* 
 Non-HIV <0.001 (14.08) -13.6* 
60 A, 50 Hz HIV-PN 0.56 (0.33) -1.9 
 Non-HIV 0.57 (0.33) -2.3 
90%, 50 Hz HIV-PN 0.01 (7.82) 8.6* 
 Non-HIV <0.001 (18.77) -17.5* 
25 Hz HIV-PN 0.99 (0.0) 0.0 
 Non-HIV 0.2 (1.65) 3.6 
128 Hz HIV-PN 0.08 (3.04) 7.4 
 Non-HIV 0.01 (6.3) 11.7* 
 
The effect of the direction of the VPT ramp (ascending or descending) was also 
evaluated. Ascending ramps were found to have a lower threshold than descending 
ramps at 25 Hz for both groups (p’s<0.001), and at 60 A (50 Hz) for the non-HIV 
group (p = 0.007). 
The effect of SENS was not found to interact with the effect of direction for any test 
condition (p’s > 0.18), i.e. there is no evidence to suggest that SENS affected ascending 
and descending ramps differently. 
The interaction of SENS and group (HIV-PN or non-HIV) was also assessed. The effect 
of SENS was found to be different between the groups for 30 A (p = 0.043) and 90% 
(P<0.001) (50 Hz). The remaining conditions were not significantly different between 
the groups (p’s>0.17). 
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While the audibility of the vibration was not recorded, no participants reported being 
able to hear the vibration. The vibration was only audible to the tester for exceptionally 
high amplitudes of vibration at 128 Hz. 
3.3.3 The effect of “optimal amplitude” SENS 
In Chapter 2.3.2 we found that HIV-PN participants would require an improvement of 
45% at 25 Hz, 29% at 50 Hz and 53% at 128 Hz in their VPT scores to match the 
baseline scores of the healthy control participants. This indicates that even for the best 
performing SENS condition, tactile sensitivity was not fully restored in HIV-PN 
participants. 
Breen et al. [92] found that SENS at 30 A improved the tactile sensitivity of elderly 
participants, but not at other amplitudes. They performed an additional analysis asking 
the question: what if there is not a global optimal amplitude for SENS, what if each 
participant has a different intervention amplitude that works best for them? They found 
this to be the case, with a 16.2% improvement in performance when the best outcome 
for each participant was cherrypicked from the data. It is possible that by performing a 
similar analysis, the effect of SENS on HIV-PN can be shown to be larger than the 
7.5% seen above, if applied at an optimal amplitude. 
The study design presented here served only to answer this same question regarding 
optimal SENS amplitude for 25 Hz and 128 Hz vibration frequencies. The amplitude 
of SENS that worked best at 50 Hz for each participant was tested at 25 Hz and 128 Hz 
vibration frequencies, double blind, against new sham conditions. There was no effect 
of SENS at 25 Hz, and SENS was actively detrimental for the non-HIV participants at 
128 Hz. 
To replicate the finding of Breen et al. we extract the best response to SENS for any of 
the 50 Hz test conditions for each participant separately. Figure 22 shows the response 
of this new category compared to the sham 50 Hz condition. To test for a statistically 
significant effect, conventional statistics require the study design to have a separate 
sham condition matched to each amplitude of SENS at 50 Hz. However, matching the 
design of Breen et al., this work only had one sham condition for all 50 Hz tests. This 




Figure 22. Effect of SENS on VPT at 50 Hz vibration frequency, for an amplitude of SENS optimally 
individualised for each participant. The dotted lines indicate the boundary of statistical significance as 
determined by Monte Carlo simulation (see Appendix A). 
Monte Carlo simulation indicated that the effect of SENS seen in Figure 22 was 
statistically significant for both the HIV-PN group and the non-HIV group, and was not 
the consequence of the study design. Table 7 provides the numerical results of the 
analysis. The p-value is the output of odds ratios of linear mixed effects models (see 
Chapter 3.2.7), and suffers from the selection bias created when picking only the best 
outcomes. The simulated 5 percentile p-value is the limit under which the p-value must 
fall in order for the optimal SENS condition to be said to have a statistically significant 
effect at 5%. 
Table 7. Experimental and simulated outcomes of statistical tests with the “optimal” SENS condition. 
 Effect of optimal 
SENS on VPT 
Simulated 95 percentile 
effect of optimal SENS on 
VPT 
p-value Simulated 5 
percentile p-value 
HIV-PN -17.8% -9.2% 4.54e-13 1.26e-5 
Non-HIV -24.3% -11.4% 6.22e-15 8.93e-6 
 
Since the biased “p-value” is smaller than the “simulated 5 percentile p-value” SENS 
can be said to have had a beneficial effect on VPT in both groups in this condition. The 
effect seen on the HIV-PN group for optimal SENS (17.8%) is very similar to that seen 
by Breen et al. on elderly individuals (16.2%). 
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3.3.4 Effect of SENS on pain 
The data recorded for pain was very sparse, with most participants reporting no pain in 
many conditions. Because the data is so sparse, all non-zero pain data is presented here 
and identified per participant rather than creating summary data, although some 
summary data is still provided at the end of the analysis. HIV-PN participants are 
identified as ‘H’ followed by a unique identifying number, and all non-HIV participants 
are identified with a ‘C’ followed by a unique identifying number. The identifiers 
remain consistent throughout this chapter. 
In Table 8, Table 9 and Table 10 the data for symptoms is reported as “sham” : “SENS” 
for each test condition. Because only one sham condition was recorded for the four 
50 Hz vibration frequency test conditions, that sham data is repeated for each 50 Hz 
column. In a small number of cases participants reported measures as being a range of 
consecutive outcomes, e.g. ‘6’ or ‘7’. In these cases, the data was summarised as the 
midpoint e.g. ‘6’ or ‘7’ becomes ‘6.5’ in the data analysis. 
Table 8 presents the results for the only two HIV-PN participants and one non-HIV 
participant who reported any sensation of “pain, aching, burning in feet or legs” during 
the VPT testing. Participant H1 reported the pain over the top of the foot and at the back 
of the lower leg. H2 reported pain below the ankle for one trial. The tester noted for 
that trial: “Same place as numbness. I think she reported pain, she meant numbness,…”. 
The participant did report numbness in other trials. Notes from the trials of C1 indicate: 
“very difficult to get number off scale. Estimates vary wildly.” And that the pain varied 
from lameness on the foot, to cramps, that were not painful, above the electrodes below 
the knee, and on the front of the tibia. 
Table 8. Participants reporting “Pain, aching, burning in feet or legs” above zero for any test condition, on a 
scale of 0 (normal) to 10 (Severe). Data shown as ‘sham’ : ‘SENS’ conditions. No pain reported in either 
condition is noted as ‘-’. 
ID 30A 45A 60A 90% 25 Hz 128 Hz 
H1 6:5 6:4 6:6 6:6 3:4 3:6 
H2 - - - - 0:4 - 




Table 9 present the results for participants who reported any sensation of “Pins-and-
needles" in feet or legs” during the VPT trials. Most participants reported the sensation 
under the electrodes. These trials are included here only where the sense under the 
electrodes was equal or lower than during the sham conditions. Where the sensation 
was reported exclusively under the electrodes is marked with a “†” symbol in the table. 
The notes from the individual trials indicate: 
• The rating of ‘5’ given by H3 in the 50 Hz sham condition was originally rated 
as a ‘10’, but was lowered after it was explained to the participant the severity 
of a ‘10’ rating. 
• C2 felt the sensation in the whole foot, but slightly stronger under electrodes. 
• C3 felt the sensation up the shin above the electrodes for 50 Hz sham trials, and 
behind the heel for 45 A trial, and only at the start of the trials for both the 
45 A trials and the 25 Hz trial. 
• C6 could feel pins-and-needles during testing and after the VPT test as well. 
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Table 9. Participants reporting “Pins-and-needles" in feet or legs” above zero for any test condition, on a 
scale of 0 (normal) to 10 (Severe). Data shown as ‘sham’ : ‘SENS’ conditions. No symptoms reported in either 
condition is noted as ‘-’. ‘NA’ indicates a trial was excluded. “†” indicates the sensation was noted to be under 
the electrodes and nowhere else. 
ID 30A 45A 60A 90% 25 Hz 128 Hz 
H1 - 0:3 0:3† - - 3†:4 
H2 - - - - - 0:2 
H3 5†:0 5†:0 5†:0 NA NA NA 
H4 - 0:1† - - - 3†:0 
H5 1†:0 1†:0 1†:0 1†:1† - - 
H6 NA - 0:1 - NA NA 
C2 3:1† 3:2 3:1† NA 1†:3 NA 
C3 1:2 1:2 NA NA 0:1.5 NA 
C4 NA - NA 0:3 - - 
C5 0:1 - NA NA NA NA 
C6 - - NA NA - 0:1 
 
Table 10 presents the results for the participants who reported any sensation of 
“Numbness (lack of feeling) in feet or legs” during the VPT testing. 
In general, the reporting of numbness seemed unreliable, which is not unexpected since 
the participant is sitting for a long period with their leg and foot completely stationary. 
The notes for the individual trials indicate that: 
• H2 felt numbness below ankle. 
• H4 felt numbness below the ankle and under the foot. For the 25 Hz trials it was 
also above the electrodes and could feel the numbness outside of the testing 
period. 
• H7 felt the numbness in foot. 
• H8’s rating of ‘5’ is for a cold sensation that could not be classified as Pain A 
or Pain B, located around the electrodes. The sensation went away between 
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trials. The rating of ‘3.5’ was also not explicitly for numbness, as the participant 
had difficulty describing the sensation and said it to be like vibration under the 
foot. 
• H10 felt the numbness on top of foot. 
• For C1 the numbness is noted as lameness on top of the foot. The ‘6’ rating of 
C1 is noted as “very difficult to get number off scale. Estimates vary wildly.”. 
• C6 felt a little numb on the toe, and noted that the 25 Hz vibration felt different 
to the other frequencies. 
• C7 felt the numbness covered the whole foot during and after the VPT tests. 
• C8 felt numbness outside of testing period as well as during the VPT test. The 
50 Hz control condition denoted as sensation of cramps and not numbness. The 
sensation of numbness for the 25 Hz condition was felt under the foot. 
• C9 felt numbness along front of leg from above the electrodes and down, and 
felt it was stronger during the testing. 
• C10 reported a sensation of coldness as numbness during trial at the toes only. 
• C11 felt numbness on the leg. 
Table 10. Participants reporting “Numbness (lack of feeling) in feet or legs” above zero for any test condition, 
on a scale of 0 (normal) to 10 (Severe). Data shown as ‘sham’ : ‘SENS’ conditions. No symptoms reported in 
either condition is noted as ‘-’. ‘NA’ indicates a trial was excluded. 
ID 30A 45A 60A 90% 25 Hz 128 Hz 
H2 1:0 1:0 1:0 1:3 5:0 - 
H4 2:0 2:0 2:2 2:0 5:4 2:3 
H7 - - - - 8:7.5 - 
H8 - - 0:5 0:3.5 0 0 
H9 - - 0:3 NA NA - 
H10 - - NA NA 1:0 - 
C1 0:1.5 0:6 0:1 - 1:0 0:2.5 
C6 - - NA NA 0:1 - 
C7 - - - - 5:0 - 
C8 3:0 3:0 3:0 3:0 2:0 NA 
C9 - - NA NA 0:3 - 
C10 - 0:1 - - - - 




The effect of SENS on each the three measures of pain were assessed for each test 
condition for the HIV-PN and non-HIV groups. No effects of SENS on pain were found 
(all p’s>0.14). 
The effect of group (HIV-PN or non-HIV) on pain scores, and the interaction between 
group and SENS on pain scores was also analysed. No effects were found (p’s>0.13). 
This is to say that pain level was not affected by the group a participant was in, nor did 
SENS have a different effect on pain for the different groups. 
Table 11, Table 12 and Table 13 summarise the pain outcomes. Table 11 shows the 
number of participants who reported any amount of each kind of symptom in the sham 
condition. The table indicates that very few participants reported pain in the baseline 
measurement, but comparatively more indicated “Pins-and-needles” or numbness in 
both the HIV and non-HIV cohorts. 




HIV 1 4 4 
non-HIV 1 2 3 
 
Table 12 shows the number of participants who experienced more severe symptoms in 
the sham condition than in the SENS condition. High numbers would indicate that 
SENS may have had a role in reducing the severity of symptoms. The table indicates, 
in accordance with the statistical analysis, that there were very few occurrences where 
SENS improved symptoms, and there was little difference in the response between the 




Table 12. Number of participants who reported more severe symptoms in the sham conditions than the SENS 
condition. Data displayed as “number of HIV participants” : “number of non-HIV participants”. 
ID 30A 45A 60A 90% 25 Hz 128 Hz 
Pain 1:1 1:0 0:0 0:1 0:0 0:0 
Pins-and-
needles  
2:1 2:1 2:1 0:0 0:0 1:0 
Numbness 2:1 2:1 1:1 1:1 4:3 0:0 
 
Table 13 shows the number of participants that experienced more severe symptoms in 
the SENS condition than in the SHAM condition. High numbers would indicate that 
SENS may have had a detrimental effect on symptoms. The table indicates, in 
accordance with the statistical analysis, that there were very few occurrences where 
SENS worsened symptoms, and there was little difference in the response between the 
groups. This does not present strong evidence that SENS has a detrimental effect on 
symptoms in either group. Together, Table 12 and Table 13 provide reasonable 
evidence that even if SENS has an influence on symptoms of pain, it is not sufficiently 
strong to be measured in this context. 
Table 13. Number of participants who reported more severe symptoms in the SENS conditions than the 
SHAM condition. Data displayed as “number of HIV participants” : “number of non-HIV participants”. 
ID 30A 45A 60A 90% 25 Hz 128 Hz 
Pain 0:0 0:1 0:1 0:0 2:0 1:1 
Pins-and-
needles 
0:2 2:1 2:0 0:1 0:2 2:1 
Numbness 0:1 0:2 2:2 2:0 0:2 1:1 
 
3.4 Discussion and Conclusions 
This work presents the first known data assessing the effect of SENS on patients with 
HIV-PN, and the first data exploring the effect of SENS on perception thresholds for 
vibration frequencies other than 50 Hz. Finally, it presents the first known data on 
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symptoms of pain when using a subthreshold intervention signal for the purposes of 
enhancing tactile sensation. 
The results present evidence that SENS can improve tactile sensitivity in this population 
without increasing perceived peripheral neuropathic symptoms, but also indicate that 
SENS has limitations that need to be further explored before it can be implemented as 
a clinical intervention for participants outside of the research environment. 
The primary goal of this study is to assess the effectiveness of SENS in improving VPT 
of HIV-PN patients and healthy controls participants. 
3.4.1 Efficacy of SENS for 50 Hz Vibration Perception Thresholds (VPT) 
SENS improved tactile sensitivity of both groups at 50 Hz when SENS was applied at 
an optimal amplitude for each person. SENS was also effective in improving 50 Hz 
vibration sensitivity when applied at pre-set low amplitudes (45 A RMS for both 
groups, and 30 A RMS for the non-HIV group). This is mostly consistent with past 
research by Breen et al. which had a similar experimental design, but a different 
population group [92]. 
There are several unexpected results. Firstly, that both groups responded positively to 
SENS at 45 A and not 30 A as in previous work. It has been established here, and in 
previous work that the best amplitude of SENS is participant specific. With such low 
participant numbers in previous work (n = 8) and here (n = 20) it is not surprising that 
there is variability in this outcome. What is important is that it was low amplitudes of 
SENS that worked globally over the groups. In a potential therapeutic use of SENS, it 
may not be practical to measure the optimal amplitude of SENS for each user or apply 
the signal at a percentage of the electrical perception threshold (EPT). In this case, 
having an amplitude of SENS that works for all participants, even suboptimally, may 
be a practical solution. 
The second unexpected result was the response to SENS at 90% of EPT. In these 
circumstances one could expect the stimulation at this amplitude to be effective, since 
90% of threshold in subthreshold interventions has been shown to be effective in many 
prior studies. This was the case for the non-HIV participants. One could also argue that 
it should not be effective, since electrical thresholds were very high and consequently 
90% of EPT for most participants was a much higher amplitude than what has worked 
in the past. This was the case for the HIV-PN group. It is certainly unexpected that the 
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non-HIV participants would respond so strongly to such a high amplitude of SENS, and 
that the HIV-PN group would have such a different response to the non-HIV group. 
This, and that EPT between a healthy group and a group with known tactile deficiencies 
were not found to be different, call into question the validity of the EPTs measured for 
the HIV-PN participants. The data provides little explanation for this result and further 
exploration is recommended.  
3.4.2 Efficacy of SENS for 25 Hz and 128 Hz Vibration Perception 
Thresholds (VPT) 
The research also investigates the effectiveness of SENS at previously unresearched 
vibration frequencies. An unexpected result was that SENS applied at the amplitude 
that created the most benefit for 50 Hz vibration was actively detrimental for the 
non-HIV group, and possibly detrimental for the HIV-PN group (p = 0.08) at the high 
vibration frequency (128 Hz). Further, SENS had no significant effect at the low 
vibration frequency (25 Hz) making results fairly consistent for both groups.  
There are three possible explanations for this result. It could be a result specific to these 
population groups. This is unlikely since the 50 Hz results are relatively similar to 
previous research outcomes. It could be that the whole paradigm of using subthreshold 
electrical stimulation has a different effect on low and high frequency 
mechanoreceptors. This too is unlikely since 50 Hz does not represent a set of 
mechanoreceptors that respond exclusively to frequencies in this range, but rather a 
combination of both high a low frequency receptors [116], suggesting a positive 
response to 50 Hz should translate at least to either higher or lower frequencies of 
vibration, and possibly both.  
The most likely reason is that the combinations of the spectrum of the SENS signal 
itself and the electrical filtration of that signal when passed through the tissue to the 
nerve axons carrying the vibration signals, results in an intervention that has a 
frequency response curve. It is difficult to measure this response noninvasively, without 
the use of tools like microneurography. The shape of this curve could start off near zero 
for low vibration frequency signals, and has a peak beneficial response somewhere in 
the range of 50 Hz, and then becomes actively detrimental to higher vibration frequency 
signals. The hypothesis that altering either the amplitude or the spectrum of SENS could 
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result in a different frequency response curve is testable and should form part of future 
work. 
Regardless of what the reason for the discrepancy in response at different vibration 
frequencies is, the result sheds light on the mechanism of SENS. In most subthreshold 
interventions, the mechanism is said to be stochastic resonance (SR). This rationale is 
often maintained when the intervention is applied proximally to the intervention site. 
However, the model of classic SR does not predict that the extent of the enhancement 
should be sensitive to vibration frequency. It is therefore likely that SENS does not 
operate through SR. Chapter 1.5.2 offers alternative explanations found in the literature 
for enhancements seen through the application of SENS-like signals. 
The results regarding vibration frequency dependence represent a very important 
finding. If SENS is to be used to improve quality of life, it must improve tactile 
sensitivity for a wide range of tasks. Further research must be done into this frequency 
response and strategies for overcoming this limitation. 
3.4.3 Effect of SENS on symptoms of pain 
The secondary goal of this work is to investigate how SENS affects symptoms of pain. 
Previous SENS studies and other subthreshold studies have not investigated the effect 
of the intervention on perceived pain. If these interventions, which improve tactile 
sensitivity, also increase the amount of pain perceived in neuropathic populations, it 
could severely limit the use of SENS as therapy. Conversely, should SENS reduce the 
amount of pain experienced, it would become strong motivation for the further 
investigation of SENS as therapy. 
There was no evidence to suggest that SENS exacerbates existing “Pain, aching, 
burning in feet or legs” or causes it to occur when none previously existed. Neither was 
there evidence to suggest that SENS alleviated symptoms of pain. The qualitative 
description of pain for the three participants was not consistent between them, further 
re-enforcing the idea that SENS does not have an effect on neuropathic pain. 
Similar results occurred for symptoms of “Pins-and-needles” and “Numbness (lack of 
feeling) in feet or legs”. While many more participants reported these sensations, the 
data was still very sparse and demonstrated no consistent anectodical or statistical 
pattern that would imply that SENS impacted the scores reported for these symptoms. 
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The exception to this was the sensation of “Pins-and-needles" that was frequently 
reported as being felt under the electrodes, and was likely a result of SENS being 
applied at a supra-threshold level. This does present a problem for the application of 
SENS as therapy, since it appears that EPTs cannot be relied upon to remain stable. 
No statistical difference in any of the three measures of pain were found between the 
groups, i.e. it cannot be said that the HIV-PN participants experienced more pain than 
the non-HIV group in these circumstances. This is likely a result of excluding HIV 
participants with high levels of neuropathic pain. This reduces the external validity of 
the result and must be noted as a limitation when stating that SENS likely does not 
cause pain in HIV-PN patients. 
3.4.4 Limitations of this study 
A limitation of this study is that the healthy, non-HIV participants did not undergo a 
neurological screen or HIV testing, and consequently may have suffered from 
undiagnosed diseases that affect VPT. One potential control participant was excluded 
for this reason. That there was a significant difference in baseline VPT between the 
groups indicates that it is unlikely that the results were compromised by this limitation. 
Further, participants were recruited from an area where HIV awareness campaigns are 
prominent and HIV testing is freely available. 
Participants with severe painful neuropathy were excluded from the HIV-PN group and 
this limits the extent to which we can claim the results apply to HIV-PN participants 
with severe painful neuropathy. However, given that the results indicate SENS did not 
have an adverse effect on pain, this evidence can be used to justify the inclusion of 
participants with severe painful neuropathy in future studies. 
The reports of “Numbness” and “Pins-and-needles” were generally noted as being 
unreliable. It is possible that a more robust protocol investigating pain would have led 
to more consistent results and that simple numeric scales are insufficient. A more 
significant limitation is that the study did not evaluate the effect of SENS on noxious 
stimuli. Thus, it cannot be said if SENS has an hyperalgesic effect. 
EPTs were found to be unstable, and therefore the results of SENS at 90% of threshold 




The ultimate goal of this field of work is to provide a therapy to improve the symptoms 
of HIV-PN. Showing an improvement in VPT is an important step towards that goal, 
but it is ultimately a laboratory measure used as a proxy for overall tactile sensitivity. 
Research should eventually progress to assessing performance in functional tasks and 
reduction of known risk factors for health-related quality-of-life, such as falls. 
Finally, pain and VPT was only assessed over a period of a few minutes at a time. The 
effect of SENS when used for extended periods remains unstudied. This is likely a 
consequence of the technology to apply SENS as a wearable device being unavailable. 
Chapters 5 and 6 attempt to address this problem by developing the electronics required 
for a wearable SENS stimulator. 
3.4.5 Clinical implications for the use of SENS as therapy 
SENS continues to show promise to be developed into a therapy for patients suffering 
peripheral neuropathic desensitisation. Here we showed that past results of VPT benefit 
also apply to HIV-PN. Results also indicate that SENS is unlikely to have an adverse 
effect on neuropathic pain, which could have been a big stumbling block in its use as 
therapy. 
However, while SENS was shown to be beneficial for 50 Hz VPT, it was not shown to 
benefit 25 Hz or 128 Hz VPT. This casts doubt on its ability to be beneficial for 
functional tasks and reducing risk factors. The reasons for this are unknown and more 
research should be conducted into the spectrum of both the SENS signal itself and the 
physiological mechanism of the benefit it provides, so that it may be optimised for a 
wider range of tactile benefit. 
The largest benefit in VPT observed with SENS for the HIV-PN participants was 17.8% 
improvement at 50 Hz for individualised optimised SENS amplitudes. This represents 
roughly half of the gap in baseline VPT performance between the HIV-PN group and 
the non-HIV control group. Whether this difference is clinically significant should be 
investigated. 
Future work should include participants with higher levels of neuropathic pain and 
should focus on investigating the effect of SENS on the perception of noxious stimuli, 
the effect of SENS on different vibration frequencies and the physiological mechanism 





MEASUREMENT OF PERCEPTION 
THRESHOLDS FOR ELECTRICAL NOISE 
STIMULI 
 
Subsensory therapeutic signals often rely upon the application of a mechanical or 
electrical signal at amplitudes that are a particular percentage of the participant’s 
perceptual threshold. The ability of one to detect the perceptual threshold, and for it to 
remain stable is vital to the operational paradigm of these interventions. 
  
The work in this chapter was published in part as a paper and presentation in the 
2017 Annual International Conference of the IEEE Engineering in Medicine and 
Biology Society (EMBC): 
Karpul D, McIntyre S, Van Schaik A, Breen PP. Measurement of perception 
thresholds for electrical noise stimuli. Proc. Annu. Int. Conf. IEEE Eng. Med. 




Richardson et al. were the first to demonstrate the use of Subthreshold Electrical Nerve 
Stimulation (SENS) to improve peripheral sensitivity in vivo in humans [63]. SENS has 
since been shown to successfully improve sensitivity and related outcome-measures in 
multiple populations (see Chapter 1 for a full description of existing literature). 
The therapy consists of two surface skin electrodes driving current into the participant 
near where sensitivity is to be enhanced (e.g. the fingertip), or proximal to the 
enhancement site (e.g. lower leg for improvement at the big toe) (Figure 23). The 
current usually has the spectral characteristics of ‘white’ or ‘pink’ band limited noise, 
and a carefully chosen amplitude between 60% and 90% of the participant’s electrical 
perception threshold (EPT). 
 
Figure 23. Typical application of SENS proximal to the site where tactile sensitivity is to be tested. 
In this chapter the therapeutic signal is referred to as the “intervention” or just SENS. 
This is not to be confused with the “stimulus” which is the signal to be detected by the 
participant, thus demonstrating increased sensitivity. When implementing a SENS 
experiment, first the intervention signal is treated as a stimulus, and its perception 
threshold is established. The intervention amplitude is then set to some pre-determined 
subthreshold value. 
Chapter 1.5.2 presents a detailed discussion of the potential mechanisms of effect for 
interventions of this type. In most interventions of this type, the amplitude of the 
intervention relative to the perception threshold of the intervention signal is regarded 
as important. Wells et al. demonstrated that both the intervention and the stimulus 
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amplitudes affect the efficacy of the intervention (in this case for vibratory noise) [67]. 
The effect is maximal when the intervention amplitude, relative to both the perception 
threshold and the amplitude of the stimulus, are appropriately matched. A smaller 
stimulus would require a larger SENS amplitude and vice versa. 
Regardless of the method employed and the underlying mechanism, it is clear that 
controlling the SENS amplitude relative to the EPT is vital to allow the intervention to 
function optimally. Despite this, little focus has been dedicated in the literature to 
methods used to determine EPTs and the factors that influence their variability. The 
SENS studies cited in Chapter 1 determined EPTs using “self determination”, a method 
of levels or limits, or failed to provide information on the matter. The studies gave no 
indication that this aspect of the experiment was double blinded. The actual EPT or 
variability data were not provided. This is understandable since EPT was not meant as 
an outcome measure in these studies. 
A major drawback to using the method of limits for measuring perceptual thresholds is 
that it can be biased by the decision criterion adopted by the participant when uncertain 
whether the stimulus is present. A participant who adopts a liberal criterion may 
indicate she detected the stimulus when uncertain, while a more conservative 
participant may wait until she is more certain. If the two participants had identical 
sensitivity for detecting the stimulus, the liberal observer would appear to have a lower 
threshold. Furthermore, the criterion adopted can change during testing, and can be 
influenced by a desire to perform well or to please the experimenter, or by impatience 
or boredom. In order to measure sensitivity independently of response bias, a ‘two-
interval forced choice’ (2IFC) paradigm was employed. This involves participants 
judging which of two successive time intervals (indicated by audio cues) contained the 
stimulus. 2IFC is a psychophysical procedure commonly used in perceptual science 
(see Chapter 4.2 for more details regarding 2IFC). 
In most SENS applications little attention is given to the characteristics of the electrode 
skin interface, however, the electrode impedance, surface areas and connection quality 
have a large effect on the voltage applied to the skin as well as the current density and 
distribution in the tissue. Most studies simply cite the total current applied (e.g. 60 μA 
RMS [92]) since measuring electrode characteristics and current density is either 
difficult or impossible in some circumstances. 
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Rosell et al. investigated electrode impedances at ten placements around the 
body [138]. They found significant differences in impedance at difference locations, 
especially at frequencies below 100 kHz, which includes the frequencies used for 
SENS. 
Bîrlea et al. performed a study that investigated participants who wore electrodes for 
seven days without removal and monitored the changes in impedance over time [139]. 
They found 14% decrease in the resistance of the surface electrode connection and a 
15% decrease in the resistance of the underlying tissue. They also found a reduction in 
the capacitance of the connection after exercise, but not over the week. This experiment 
has implications for a final therapeutic version of SENS as a product that may be worn 
on a long-term basis. If impedance and SENS threshold are related, and impedance 
changes over time, then it is vital that this be considered when adjusting SENS 
amplitude during long-term use. 
Bîrlea et al. modelled the impedance formed between the stimulation electrodes as a 
network of a single small resistor (r) in series with the parallel combination of a large 
resistor (R) and capacitor (C) (Figure 24). ‘r’ is typically in the order of 2 kΩ, and can 
be thought to roughly represent the resistance of the limb itself. ‘R’ and ‘C’ are usually 
in the order of 20 kΩ to 60 kΩ and 30 nF to 600 nF and represent the resistance and 
capacitance of the electrode connection to the skin respectively. At high frequencies 
and in pulsatile applications, ‘C’ effectively shorts out ‘R’ and thus ‘r’ dominates the 
impedance of the network. However, close to DC conditions, ‘C’ is open circuit and 
‘R’ dominates. 
 
Figure 24. Effective network impedance of two electrodes connected to a human appendage driven by a 
current source. 
McAdams et al. review the effects of electrode site preparation on the network 
impedance [140]. It is noted that when the stratum corneum, or more generally the 
epidermis is partially eroded by abrasion or aggressive cleaning, R can be reduced 
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‘dramatically’ and ‘C’ increases. While this is desirable for isolated experiments, this 
is not desirable as a long-term solution to the problem of contact impedance, as this 
form of electrode site preparation can be damaging to the skin. 
This chapter describes an experiment designed to examine the effects that electrode 
location and characteristics have on EPT. The effects of signal frequency characteristics 
on EPT are also examined. Finally, the stability of EPTs under consistent conditions is 
also evaluated. 
4.2 Methods 
The experimental protocol was approved by the Human Research Ethics Committee of 
Western Sydney University and conformed to the Declaration of Helsinki. We 
investigated the SENS perception thresholds in two healthy participants, one female 
aged 34 and one male aged 30. 
4.2.1 Experiment setup 
EPTs were determined for every permutation of the following variables: 
• Electrode Location – electrodes pairs were medially and laterally 
placed, proximal to either the left ankle or the left wrist. Referred to as 
‘Ankle’ or ‘Wrist’. 
• Electrode type – Axelgaard UltraStim® Snap SN2040 10 cm × 5 cm 
rectangular electrode, Axelgaard UltraStim® Snap SN2020 5 cm × 
5 cm square electrode, and BIO Protech electrode T716 standard round 
ECG electrodes, approximately 2 cm diameter were used. Referred to 
as ‘Large’, ‘Medium’ and ‘Small’ respectively. 
• SENS frequency characteristics – either Gaussian white noise or pink 
noise (with a 1/f characteristic), both low-pass limited to 250 Hz in 
software. Referred to as “White” and “Pink” respectively. 
This made for 12 experiments per participant. A further 5 permutations, making use of 
only the Large and Medium electrodes, were then selected at random to be repeated in 
both the Pink and White conditions making for 10 repeated trials in total. 
The participants were single blinded to the SENS frequency characteristics, which was 
always tested in consecutive but randomly ordered pairs. Participants were not blinded 
to the electrode location or type. 
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The experiments were run using a custom Matlab program interfacing through a 
NI USB 6218. The current was generated using Digitimer DS5 bipolar constant current 
stimulator. Participant responses were acquired via push buttons connected to the 
NI USB 6218. 
4.2.2 Electrical perception threshold determination 
EPTs were measured using the ‘two-interval forced choice’ (2IFC) paradigm. 
Participants were asked to attend to two successive 1-second intervals, indicated with 
an audio cue. They were told that the electrical stimulation would be applied throughout 
one of these two intervals, and not the other. Their task was to indicate which interval 
contained the stimulus (Figure 25). This means that any bias to respond ‘first’ or 
‘second’ is independent of performance on the task, since the stimulus was presented 
equally often in each of the intervals. 
 
Figure 25. Illustration of the two-interval forced choice paradigm. Audio cues indicated the start and end of 
each time interval. Illustration by co-author Sarah McIntyre [134]. 
Repeatedly presenting a stimulus at different intensity levels produces a psychometric 
function relating stimulation level and detection performance. 
In order to efficiently estimate the threshold, we used a Bayesian adaptive psychometric 
procedure known as QUEST [141–143], implemented in Psychtoolbox-3 for 
MATLAB [144]. For each threshold estimate, 44 trials were conducted. The intensity 
of the electrical stimulation was fixed for the first 4 trials, and determined by the 
QUEST algorithm for the remainder. An example experiment using this procedure is 
illustrated in Figure 26. We defined the threshold as the intensity at which the stimulus 
would be correctly identified for 82% of trials (the default setting for the quest toolbox). 
The prior threshold estimate was set to 200 μA rms and the final threshold was given 
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by the mean of the posterior distribution function. The QUEST algorithm adapts the 
test level to best extract information about the threshold on each test. Incorrect answers 
carry more weight as a false negative is relatively rare, whereas a false positive (a 
correct answer when the participants could not detect the signal) occurs 50% of the 
time. 
 
Figure 26. An example of the sequence of trials in a threshold estimation experiment. After the first four 
trials, the intensity of the electrical stimulation (in μA rms) was determined by QUEST based on performance 
on previous trials. The final estimate of the threshold is shown as the dotted line (71 μA rms). Correct and 
incorrect responses are indicated as circles and crosses. Figure by co-author Sarah McIntyre [134]. 
4.2.3 Electrical impedance determination 
After every EPT determination the electrical impedance of the electrode-skin 
combination was measured. This was not done for the ten additional repeat trials. 
A custom written Matlab program interfacing with an Agilent digital signal generator, 
which in turn drove the current generator, created a sinusoidal current, approximately 
210 μA rms through the electrodes and limb. The frequency was varied logarithmically 
in 39 steps from 10 Hz to 10 kHz. The resulting current (measured over a series resistor) 
and driving voltage were measured using an Agilent digital oscilloscope, interfaced by 
the Matlab program. 
The effective network component values were then calculated by using a least squares 
fit of the model of the resistor network shown in Figure 24 to the 40 resulting total 
impedance values for each test condition. This resulted in estimations of ‘r’, ‘R’, and 




4.3.1 Electrical perception determination 
The EPT of the initial test under each condition is shown in Figure 27. A repeated 
measures ANOVA indicated that threshold was not associated with electrode type, 
participant, or location (p’s > 0.6), but was associated with SENS frequency 
characteristic (p < 0.01). When controlling for electrode type, participant, and location, 
frequency characteristic caused an average reduction of 117 μA RMS when changing 
from white to pink noise. 
 
Figure 27. Plot of electrical perception threshold for explanatory variables of electrode type, electrode 
location, participant, and noise frequency characteristics. 
Figure 28 shows the percentage change in EPT when thresholds were re-measured 
under the same condition on a different day. Despite controlling for location, electrode 
type, participant and SENS frequency characteristics, changes in excess of 650% 
occurred, with an average change of 195.8 %. Most changes being positive indicates 
that the underlying distribution is asymmetric, and there is a higher probability of data 




Figure 28. Plot of the percentage change in electrical perception threshold when re-tested under the same 
participant, frequency characteristic, location, and electrode type conditions. 
4.3.2 Impedance measures 
Figure 29 shows ‘r’, ‘R’, and ‘C’ plotted against the associated EPT. While participant 
level and electrode level clustering can be seen in parts of the graphs, no clear 
correlations between any of the three impedance outcomes and perception threshold 
emerged, even when controlling for participant or electrode type. 
The mean ‘r2’ for the multiple fits of the network model to the 40 voltage and current 
data points for each impedance measurement was > 0.99 indicating an excellent fit to 
the data. ‘r2’ in this context refers to the statistical strength of the fit, and not the square 




Figure 29. Plot of the three impedance measures for the electrode-limb combination vs. electrical perception 
threshold. 
Single factor ANOVA’s testing the effect of electrode type on r, R, and C, indicated all 
three were significantly associated (each p < 0.001). This is not an unexpected result 
and serves to confirm the hypothesis that electrode type affects the impedance of the 
network. 
4.4 Discussion and Conclusion 
EPT varies much more widely than originally thought (Figure 27), under a variety of 
conditions. We considered participant, electrode type, electrode location, the network 
impedance of the electrode-limb combination, and the frequency characteristics of the 
applied current as possibly explanatory variables. Of these only the frequency 
characteristic of the applied signal was shown to reliably influence EPT. This is usually 
held constant for a given application and would not serve to reduce EPT variability in 
practice. 
Figure 28 shows how EPT varies when measured a second time, when controlling for 
the variables measured here. The magnitude of these variations far exceeds the 




Together, these data indicate that not only is EPT highly variable, but that the 
explanatory variables measured here do little to explain this variability. This presents a 
very serious conundrum for the application of classic stochastic resonance in this 
context. Stochastic resonance requires precision control of the amplitude of the 
intervention relative to the sensory threshold of the intervention signal. If the EPT is 
indeed a moving target, or even not a target at all, this may prohibit the use of SENS 
for stochastic resonance purposes. However, these interventions have been shown to 
have beneficial effects despite the instability of EPTs. This further illustrates that the 
underlying mechanism is unlikely to be Stochastic Resonance (SR). 
The failure of the explanatory variables investigated here to correlate with EPT 
indicates that other factors are more instrumental in determining the variability. Future 
work should focus both on how to implement SENS without the need for a stable 
threshold, and investigate other factors that may influence the threshold. 
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LOW-POWER TRANSCUTANEOUS VOLTAGE 
TO CURRENT STIMULATOR FOR WEARABLE 
APPLICATIONS 
 
While there are multiple exploratory studies published on how Subsensory Electrical 
Nerve Stimulation (SENS) can be used to improve sensation, these studies all use large 
benchtop equipment to provide the stimulation signal. 
This chapter documents the design of the base circuitry for voltage to current 
conversion at high voltages from a low voltage battery so that SENS can be applied as 
a wearable device.  
 
  
The work in this chapter was published in part in BioMedical Engineering OnLine: 
Karpul D, Cohen GK, Gargiulo GD, van Schaik A, McIntyre S, Breen PP. 
Low-power transcutaneous current stimulator for wearable applications. 




Peripheral neuropathic desensitisation is a prevalent condition which adversely affects 
morbidity, and there is no available treatment (See Chapters 1.1 and 2.1 for details on 
the prevalence and effects of peripheral neuropathic desensitisation). 
Chapter 1 describes a family of exploratory studies that seek to improve tactile 
sensitivity in these populations. A subset of these interventions use Subsensory 
Electrical Nerve Stimulation (SENS) as their intervention, a particular form of which 
is investigated in Chapter 3. SENS-type interventions usually take the form of a 
continuous signal, typically band-limited white noise, which is applied at amplitudes 
between 60% and 90% of perception threshold. The interventions have shown no ability 
to have lasting effects once removed, thus necessitating a wearable version for 
continuous use. This methodology is contrary to previous interventions that applied 
supra-threshold signals in an attempt to create lasting effects, such as Transcutaneous 
Electrical Nerve Stimulation (TENS) [145]. Chapters 1, 3 and 4 all make contributions 
to the understanding of the mechanism of the effect of SENS. 
Studies have not yet progressed to experiments outside of laboratory conditions but 
there is scope to start investigating more long-term application and to adapt the 
interventions for the practical considerations of everyday use. While the majority of 
previous experiments investigated the application of a vibratory intervention, the 
electrical stimulation variant would in theory allow a smaller, cheaper, and lower power 
solution.  
Electrical stimulator designs with similar constraints often make use of a simple op-
amp feedback current source (transimpedance amplifier), where the voltage over a 
current sense resistor is used to drive a power transistor or MOSFET which in turn 
provides current to the load [146–148]. This architecture is most commonly 
implemented as unipolar pulsatile current drives, and are often fed into an H-Bridge 
circuit to allow for polarity switching in a discontinuous manner. 
Two factors cause the design of a low-power, continuous, current stimulator for human 
applications to be challenging beyond the pulsatile applications referenced above. First, 
driving small currents into large loads requires a very high output impedance current 
drive. Secondly, the load itself, two conductive electrodes attached across a limb, has a 
very large series resistive component at low frequencies, necessitating substantial 
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voltage compliance to drive current into the limb if an arbitrary signal is required. This 
substantial voltage compliance is not required in pulsatile applications that take 
advantage of the lower impedance at higher signal frequencies. 
The possible magnitudes of the impedance connected to a current stimulator have a 
dramatic influence on the design specifications of the device. Bîrlea et al. performed a 
study that investigated participants who wore electrodes for seven days without 
removal and monitored the changes in impedance over time [139]. The impedance 
formed between the stimulation electrodes was modelled as a network of a single small 
resistor (r) in series with the parallel combination of a large resistor (R) and 
capacitor (C) (Figure 30). r is typically in the order of 2 k, and can be thought to 
represent the resistance of the limb itself. R and C are usually in the order of 20 k to 
60 k and 30 nF to 600 nF and represent the resistance and capacitance of the electrode 
connection to the skin respectively. This model of r, R and C accurately fits 
experimental impedance measures of different electrode types (see Chapter 4). At high 
frequencies and pulsatile applications, C effectively shorts out R and thus r dominates 
the impedance of the network. However, close to DC conditions, C is open circuit and 
R dominates, resulting in a high-impedance that requires large voltages to achieve the 
desired currents. An arbitrary signal current pump would need to be able to drive a 
worst-case load of 60 k. To drive a 60 k load, 60 V is needed for every mA of 
current, thus requiring 120 V in total to facilitate + 1 mA to -1 mA range. 
 
Figure 30. Effective network impedance of two electrodes connected to a human appendage driven by a 
current source. r is typically in the order of 2 k, and can be thought to roughly represent the resistance of the 
limb itself. R and C are usually in the order of 20 k to 60 k and 30 nF to 600 nF and represent the resistance 
and capacitance of the electrode connection to the skin. 
The transimpedance amplifier architecture used in previous designs is adequate for low 
voltage bidirectional applications, or high voltage unidirectional applications. Standard 
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bidirectional transimpedance designs require that one side of the load be connected to 
the 0 V point of the circuit, or a virtual 0 V point. An improved Howland current 
generator  [149] does not have this requirement, and allows for both sides of the load 
to be actively driven without compromising performance. This feature of the Howland 
current generator is used below (see 5.2.3) to double the compliance of the circuit.  
The need for a high voltage power supply can be solved by using a switching boost 
converter to generate a high voltage power supply from a battery. High voltage op-amps 
can then be used in the design of the Howland current pump. However, switching 
converters, which often use inductors, are noisy, often draw excessive quiescent 
current, and are difficult to implement, often not producing the expected output. High 
voltage op-amps are expensive and draw larger quiescent currents than their low 
voltage counterparts. 
Here, a solution to these problems, specifically tailored for continuous subthreshold 
transcutaneous neural stimulation, is presented. 
5.2 Design of circuitry for a wearable current stimulator 
5.2.1 Design specifications 
The device needs to be sufficiently compact and lightweight so that it can be worn in 
every day circumstances. It should be able operate continuously for at least 10 hours 
without the need for recharging or replacing batteries, and it should be capable of 
applying electrical stimulation consistent with that used in previous studies (e.g. [31]). 
10 hours was selected as this is the upper limit of the average workday, and would allow 
interventions to be investigated for continuous effect over the periods where improved 
sensation would have the most impact on function. Consequently, the proposed circuit 
needs the following attributes: 
• Capable of driving a continuous current of +1 mA to -1 mA under 
worst-case load conditions. 
• Have a frequency range of at least 0-1 kHz. 
• Draw sufficiently little power so that 10 hours of operation can be 




• Consist of parts with sufficiently small form factors such that the 
overall device is compact and practical. 
• Have a low manufacturing cost and be easy to implement. 
The volume and weight of a “practically compact” device varies according to opinion 
and application, but a device as large or larger than the stimulator used in laboratory 
testing, the A-M Systems 2200 current stimulator, would certainly be considered to 
have failed the design requirements. The A-M Systems 2200 current stimulator 
measures 154 mm × 175 mm × 65 mm and weighs 1.27 kg. Similarly, the low 
manufacturing cost requirements, and ease of implementation are difficult to quantify. 
The device should be affordable, and thus should cost less than a premium cellular 
telephone (roughly 1000 USD). The device should be reproducible by other research 
laboratories, and thus all parts should be available from standard retailers, and the 
circuit able to be assembled by a standard Printed Circuit Board (PCB) manufacturer 
offering such a service. 
5.2.2 Design of the High Voltage Power Supply Unit (HVPSU) 
The worst-case load impedance can be estimated as 60 k when driving DC currents. 
This necessitates a HVPSU voltage of at least -60 V to +60 V, given the minimum 
output current requirements of +1 mA to -1 mA. The “inverted-reference” design of the 
current pump presented below allows for half this voltage to be used to achieve the 
same output current, necessitating a HVPSU capable of producing 60 V when under 
load. 
In theory, any boost converter with a sufficiently low quiescent current, capable of 
delivering more than 1 mA at 60 V from battery packs, would be appropriate. Of course, 
the HVPSU needs to supply additional current to power the subsequent circuitry. 
Our design uses a cascaded series of TC962 voltage inverters to construct the desired 
HVPSU (Figure 31 and Figure 32). These inverters offer low quiescent current, are 
stable and efficient. The TC962 is a pin-for-pin replacement for the industry standard 
voltage inverter: the ICL7662. While the two chips are similar in most respects, the 
TC962 has a lower output impedance, which improves the performance of the circuit. 





Figure 31. Design of a 9 V to 72 V converter using cascaded voltage inverters. The positive terminal of the 
input supply becomes the high voltage output, and the most negative output of the inverters, -63 V, is 72 V 
below the positive terminal and forms the negative output of the high voltage supply. The blocks A, B, C and 
D are each independent voltage inverters capable of inverting a maximum of 18 V. 
 
Figure 32. Explanatory diagram of the HVPSU. Four inverters, U1-U4, convert 9 V from the battery to a 72 
V power supply with a midpoint tap at 36 V. Each inverter takes the difference between REF and IN as an 
input and inverts it below the REF input. The inverters can accept a maximum of 18 V as an input. The labels 
A, B, C and D correspond to the circuitry blocks with the same labels in Figure 31. 
In this application, a 9 V battery and four inverters were used to achieve an HVPSU 
voltage of 72 V. A 9V battery was selected as it is a readily available battery voltage, 
is sufficiently small as to be wearable and requires less boost circuitry than lower 
voltage batteries to achieve the high voltage output. The 9 V battery is first inverted to 
create -9 V using a TC962 in its standard configuration (shown in block A of Figure 31 
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and Figure 32). The new total available voltage of 18 V above the -9 V rail is then 
inverted around the -9 V rail to create -27 V (shown in block B of Figure 31 and 
Figure 32). The total 36 V available is now too large to apply to a further TC962, which 
only allows an input voltage of 18 V. The next stage inverts the -9 V rail around the 
lowest available rail of -27 V to create -45 V (shown in block C of Figure 31 and 
Figure 32). Finally, the -27 V rail is inverted around the -45 V rail to create -63 V 
(shown in block D of Figure 31 and Figure 32). Treating the positive terminal of the 
battery as V+ and the most negative voltage available as V-, a total of 72 V is now 
available (9 V - (-63 V) = 72 V). The -27 V rail is midway between V+ and V- and can 
act as a pseudo split-rail 0 V for subsequent circuitry (9 V - (-27 V) = 36 V). 
The actual voltage achieved will depend on the current drawn by the subsequent current 
pump due to the output impedance of the HVPSU. 22 µF capacitors, as opposed to the 
standard design using 10 µF capacitors, were used throughout the design to reduce the 
final output impedance. Protection diodes were also added to each stage to prevent 
over-voltage inputs. 
As the output voltage is now eight times the input, and power is conserved throughout, 
the current drawn from the output of the HVPSU will be scaled up when traced back to 
the battery. If 1 mA is drawn from the HVPSU, then 8 mA will be drawn from the 
battery. This emphasises the importance of the low quiescent current in the current drive 
circuitry. This will hold true for any boost HVPSU. 
5.2.3 Current source design 
Figure 33 shows the design of the High Voltage Current Pump (HVCP). A differential 
input voltage applied to the positive and negative inputs of OA1 (via a differential 
low-pass filter, block A in Figure 33), at the “IN” header, and is converted to a 










Figure 33. Schematic for a high-voltage, low-power transcutaneous current stimulator for wearable 
applications. Block A is a differential low-pass filter. Block B is a modified Howland current pump. The 
circuit takes advantage of bootstrapping transistors to enable low voltage differential amplifiers to operate at 
high voltage. Furthermore, the addition of an inverting amplifier (Block C) driving the reference electrode, 
allows the full supply voltage to be applied over the load in both directions, halving the requirement for the 
supply voltage. 
This current is output via one electrode connection at pin 1 of the "OUT" header, and 
returns at electrode connection pin 2 of the "OUT" header. OA1 is a difference amplifier 
with internal laser-trimmed resistors and OA3 is a voltage follower, such that OA1 and 
OA3 form the modified Howland current pump covered in detail in [149] (block B in 
Figure 33). The differential low-pass filter is added to reduce high frequency steps 
created by digital controllers potentially used to drive the HVCP. 
The electrode connection at pin 2 of the "OUT" header would typically just be kept at 
0 V, or in this case HVGND. Since the current pump does not require feedback from 
this reference electrode, its voltage is free to be manipulated to improve compliance. 
Here the positive drive signal has been inverted via OA2 and the signal is applied to 
the reference electrode (block C in Figure 33). This allows the full voltage of the power 
supply to be applied positively and negatively over the load in a similar fashion to an 
H-bridge motor driver. This halves the maximum voltage required from the HVPSU 
for the circuit to achieve a desired alternating current through a specific load. OA2 is a 
unity gain inverter. 
T1 to T4 bootstrap the op-amps’ power supplies as described in [150] and [151]. The 
op-amps’ power rails are adjusted as needed by the circuit and only ever see the portion 
of the supply voltage they require at that instant, linking their output voltage to the 
supply voltage. This allows the use of low voltage op-amps for high voltage 
applications simply by adding low-cost, high-voltage transistors (in this case BC546 
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and BC556 transistors). Any transistors with sufficient frequency, current gain, and 
voltage tolerances will suffice. 
The bootstrapping solution creates a new problem in that the inputs of the op-amp can 
now fall well outside the power supply at any one time, even though the differential 
input voltage may be small.  
Consequently, both OA1 and OA2 need to be specialised differential amplifiers capable 
of handling common mode inputs beyond their supply rails. Various commercially 
available amplifiers exist with this feature. Here a Texas Instruments INA148 is used. 
The device can handle 200 V common-mode difference and draws a quiescent current 
of only 260 µA, making it ideal for this application. In contrast, a high-voltage op-amp 
such as the OPA454, which operates to 100 V, draws 3 mA to 4 mA quiescent current. 
OA3 provides the required feedback voltage for the HVCP without drawing current 
from the load. It is vital that this op-amp has a high input impedance and it is preferable 
that the op-amp draws low quiescent current and has similar supply rail limitations to 
OA1 (in this case an OPA244). OA3 does not need independent bootstrapping, nor does 
it need to handle common-mode signals beyond its rails, as its input is only slightly 
different to OA1’s output, so OA3 can share OA1’s floating supply. 
5.3 Results 
The HVPSU and HVCP test circuits were designed as two separate printed circuit 
boards (PCB’s), each with additional voltage test points and ammeter insertion points 
included in the design (Figure 34 and Figure 35). No attempt was made to minimise the 
size of these circuits in this initial test stage, as ease of access to signals was required 
for characterisation. The schematic and PCB files for these circuits are available within 
the digital appendix, in the folder “Prototype PCBs”, and can be viewed using the free 




Figure 34. Photo of the HVPSU prototype PCB. Limited surface mount components are on the underside of 
the PCB. 
 
Figure 35. Photo of the HVCP prototype PCB. Limited surface mount components are on the underside of 
the PCB. 
5.3.1 High Voltage Power Supply Unit (HVPSU) results 
Figure 36 shows the output voltage of the HVPSU, when supplied with 9 V from a 
benchtop power supply, at various current draws. Current draw and efficiency are also 
plotted.  
When drawing 20 mA from the HVPSU, the current output of the first voltage inverter 
is 80 mA, the maximum rated current for a TC962. The circuit was not tested beyond 
this limiting point. 
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The HVPSU produced 71.7 V with no load. Progressively increasing the current load 
on the HVPSU up to 20 mA showed a near linear reduction in voltage consistent with 
a constant output impedance of 1.470 k. 
 
Figure 36. Various HVPSU parameters plotted against output current. Top: shows how the output voltage 
drops linearly with current draw, consistent with an output impedance of 1.47 k. The linear fit has an 
R2> 0.998. The switching converters produce voltage ripple on the output that increases with current drawn. 
Bottom: shows the efficiency of the circuit with respect to output current. For low currents the quiescent 
current of the circuit dominates the output power. At higher currents the loss over the effective output 
impedance dominates. Current drawn from the battery is also shown to rise at approximately 8 times the high 
voltage output current in accordance with theory. The typical operating current range of the subsequent 
HVCP is shown as the shaded region. 
5.3.2 High Voltage Current Pump (HVCP) results 
The HVCP, supplied by the HVPSU, was evaluated using both a 60 k resistive load 
as a worst-case impedance test, and a complex load in the same form as Figure 30. with 
R = 58 k, r = 2 k, and C = 30 nF. Figure 37 shows the output gain amplitude and 
phase offset at various frequencies when driving a maximum of +1 mA to -1 mA 




The circuit was able to drive the required current over the entire frequency range with 
negligible phase offset and no clipping, in accordance with Equation 4 under all load 
conditions. 
 
Figure 37. Graphs of relative output magnitude and output phase shift at various frequencies. The resistive 
load was 60 K. The complex load was a 58 k resistor with a 30 nF capacitor in parallel, both in series with 
a 2 k resistor in the configuration of Figure 30. Both loads were tested for a constant drive amplitude of 
2 mA peak to peak. 𝒓𝒆𝒍𝒂𝒕𝒊𝒗𝒆 𝒐𝒖𝒕𝒑𝒖𝒕 𝒎𝒂𝒈𝒏𝒊𝒕𝒖𝒅𝒆 = 𝟏𝟎𝒍𝒐𝒈𝟏𝟎 (
𝑨𝒎𝒑𝒍𝒊𝒕𝒖𝒅𝒆
𝑨𝒎𝒑𝒍𝒖𝒕𝒖𝒅𝒆 𝒂𝒕 𝟏𝟎 𝑯𝒛
). The output had minimal 
attenuation and phase response, especially at lower frequencies. 
The current consumption of the circuit was measured under various conditions and is 
shown in Table 14. 
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Table 14. HVPSU and HVCP current draw under various signal drive conditions for a load of 60 k. 
Load 0 mA 1 mA -1 mA 2 mAa 2 mAa 
Current DC DC DC 100 Hz 1 kHz 
HVCP only 
1.02 2.53 3.07 2.15 2.14 
(mA) 
9 V supply 
11.69 25.6 25.9 20.6 20.5 
Current (mA) 
apeak to peak 
 
Figure 38 shows the output of OA1 driving a sinusoidal signal of 60 V peak to peak, 
without its supply rails exceeding the maximum rating for that chip of 36 V difference. 
It further shows the full + 60 V and -60 V being applied across the load terminals. 
 
Figure 38. Test voltages of HVCP. The traces demonstrate: 1) how the bootstrapping of OA1's supply lines 
allow it to output a range beyond its usual limits, and 2) how inverting the current pump output onto the 
second electrode allows for the full 60 V to be applied bidirectionally over the electrodes. Test conditions were 
driving a 2 mA peak to peak sinusoidal current into a 60 k load at 500 Hz. 
The two circuits were redesigned as a single small form factor, two-layer PCB 
(Figure 39). In this design the smallest package component versions available were 
 
 103 
used, and all test points were removed. The final PCB design measured 46 mm x 
21 mm. This circuit performed as expected, with the change in form factor having no 
impact on performance. The schematic and PCB files for this circuit are available 
within the digital appendix, in the folder “Prototype PCBs”, and can be viewed using 
the free version of eagle CAD available online:  
www.autodesk.com/products/eagle/overview. 
The total cost of the parts for this small version from online vendors is less than 35 
USD when purchased in low quantities. 
 
Figure 39. Top and bottom views of the compact version of low-power transcutaneous current stimulator for 
wearable applications. 
5.4 Discussion 
The HVPSU had poor efficiency for currents below 0.5 mA, but had efficiencies above 
75% for currents between 1.5 mA and 10 mA. It is important to consider quiescent 
current when looking at the efficiency outcomes. The circuit only draws a quiescent 
current of ~3.6 mA when under no load. Consequently, when supplying power in the 
same range of the quiescent power, the subsequent efficiency calculation will be very 
poor, around 50%. This improves as more power is drawn, but will peak when the load 
reaches the internal impedance of the HVPSU.  
One can subtract the quiescent power before calculating efficiency to get a metric of 
conversion efficacy alone. Doing this, the efficiency is then 100% at no load and 
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steadily decreases to 91.7% at 4 mA and 78% at 10 mA and then follows the original 
efficiency curve. 
The HVPSU showed an increase in voltage ripple with current draw. As more current 
is drawn this voltage ripple would act to reduce minimum guaranteed output voltage of 
the HVPSU, and thus compliance of the HVCP. The operating range of the subsequent 
HVCP however keeps the HVPSU voltage ripple under 0.5 V, which allows the HVCP 
to operate unaffected. 
The HVCP only draws 1.02 mA when under no load, far superior when compared to 
the current draw of just one high voltage op-amp. The worst 9 V (battery) current 
consumption of 25.9 mA occurred when driving a DC current of -1 mA into the load. 
The full circuit would therefore require a battery of at least 260 mAh at 9 V in order to 
operate for 10 hours without recharging or replacement under worst-case conditions. A 
standard 9 V battery has a capacity of between 300 mAh and 500 mAh. Dividing this 
by the worst-case current consumption of 25.9 mA yields a charge life of 11.6 hours to 
19.3 hours. 
The deviation in output magnitude and phase at frequencies above 500 Hz for the 
resistive load, did not occur when testing with small loads, or the complex load, 
requiring smaller voltages to drive the required currents. Changing the values of the 
stabilising capacitors C16 and C18 or the values of the transistor biasing resistors R1 
to R8 had no effect on this phenomenon. The effect is likely caused by the op-amp 
supply bootstrapping. This creates very large common mode swings for both the supply 
voltage, and the relative input voltages to OA1 and OA2 under these conditions. The 
data-sheet for the INA148 indicates that both the common mode rejection ratio and the 
power supply rejection ratio start to fall as these signals approach 1 kHz. This problem 
is unlikely to affect actual stimulation applications, as the impedance of a typical skin 
electrode pair drops quickly with frequency. This means that the high frequency 
components will not induce these large common mode swings. 
The “inverted reference” design was shown to be stable and did not impede the 
performance of the Howland current pump. However, for small loads bellow 2 k high 
frequency oscillations may occur. While this is unlikely to occur in practice, the 
problem can be solved by inserting low pass filter in-line with the input of OA2. This 
inverted reference configuration also improves the safety of the circuit, as the largest 
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voltage in the device is now 72 V as opposed to at least 120 V if electrode B were held 
at HVGND as a constant reference voltage. 
To our knowledge, no Application Specific Integrated Circuits (ASICs) exist that would 
achieve the design requirements of this application, and the only example of a 
stimulator designed with similar application in mind was created by Yamamoto et al. 
[152–154]. Three wireless stimulators which have similar design constraints to those 
used here are also compared [146–148]. While there are many differences created 
through differing needs of the end application, it is vital to note that these wireless 
stimulators are designed for pulsatile applications. These are much more common, but 
cannot be used for continuous signal stimulation needed for subthreshold interventions. 
It is important to consider the power consumption of control circuitry not included in 
our design. Many appropriate microcontrollers are available that do not consume 
significant power, and have a small form factor. For example, the PIC24FJ128GC006, 
which has built in Digital to Analog Converters (DAC's), Analog to Digital Converters 
(ADC's) and analogue circuitry. This chip consumes less than 13 mW at 8 MHz. The 
results of the comparison are contained in Table 15. The weight and dimensions of a 
standard 9 V battery (46 g and 48.8 mm x 26 mm x 16.9 mm) have been added to our 
design in the figures of Table 15. 
Table 15. Comparison to designs with similar constraints in the literature. 
 This work Yamamoto et al. 
[152–154] 
Wang et al. 
[146] 
Farahmand 
et al. [147] 
Jovičić et al. 
[148] 
Voltage compliance (V) 72 10a 60 23 85 
Power Consumption 
(mW) 
233 312a 720 51.2 >700 
Use Duration (hours) >10 >24a 8 Unknown Unknown 
Current Output (mA) 1 1 60 0.4 70 
Volume (cm3) 28.2 210.1 127.5 90 52.5 
Weight (g) 52 200 85 60 45 
Signal Type Continuous Continuous Pulsatile Pulsatile Pulsatile 
a Approximate values based on information directly from the author. 
 
The table indicates that our design has a smaller form factor and higher compliance 
than those with which it is compared. The power consumption of the circuit is also 




Here a current stimulator designed to overcome the challenges associated with 
continuous, low-power transcutaneous current stimulation for the improvement of 
peripheral sensitivity is presented. It has been shown that the circuit performs within 
specifications under worst-case load conditions. What makes the design most unique is 
its low power consumption, high voltage compliance, and small form factor making it 
specifically appropriate for wearable applications. 
To the best of our knowledge, this is the first work to demonstrate a full design 
specifically targeting subthreshold electrical stochastic stimulation in wearable 
applications, with high voltage compliance, continuous-signal output, and sufficiently 
low power operation to be used in wearable applications. A list of specifications to be 
met in this application is proposed. The design adds to previous work by including an 
inverting reference to double the voltage compliance, a differential input filter to reduce 
noise from DAC's, a change of various components to reduce current consumption and 
ensure the circuit is appropriate for the application, and the inclusion of a low quiescent 
current HVPSU that is compact and simple to construct. Finally, a characterisation 
specifically focusing on aspects that apply to the intended application is presented. 
The next step is to allow for the driving and instrumentation of the circuit using 
additional low power analogue and digital circuitry. Finally, the circuit must be tested 





A COMPLETE CONTINUOUS-CURRENT 
STIMULATOR FOR TRANSCUTANEOUS 
WEARABLE APPLICATIONS 
 
Chapter 5 demonstrates a design that fulfils the basic requirements of a device to be 
used for the applications of Subsensory Electrical Nerve Stimulation (SENS), however, 
several limitations were noted. Firstly, the circuit is simply a voltage to current 
converter; there is a need for microprocessor-based waveform generation to allow the 
circuit to be a stand-alone device. Secondly, the circuit requires a means to monitor the 
current outputs accurately, both for functional and safety reasons. Finally, the circuit 
still requires in vivo testing to establish that the characterisation performed on artificial 
loads persists when stimulating human participants. 
  
The work in this chapter has been submitted to be published in IEEE Transactions 
on Biomedical Circuits and Systems (TBioCAS): 
Karpul D, Jayarathna T, Cohen GK, Gargiulo GD, van Schaik A, Breen PP. 
Continuous-current stimulator for transcutaneous wearable applications. 




Millions of people suffer from conditions that cause peripheral desensitisation such as 
diabetes [5], ageing [10] and HIV [11]. Currently there is little to no treatment that 
improves peripheral sensitivity in these populations [30]. Chapters 1 and 2 discusses 
the problem further and highlights a class of potential interventions seeking to improve 
tactile sensitivity using Subsensory Electrical Noise Stimulation (SENS). 
No studies to date have conducted long term investigations using these interventions, 
possibly because the technology to apply the required signals in a wearable fashion has 
not been developed. Chapter 5 provides a list of criteria such a device would require 
based on the reviewed literature, “The device should be: 
• Capable of driving a continuous current of + 1 to − 1 mA 
under worst-case load conditions. 
• Have a frequency range of at least 0–1 kHz. 
• Draw sufficiently little power so that 10 hours of operation 
can be achieved on a single battery charge, without the need 
for large cumbersome batteries. 
• Consist of parts with sufficiently small form factors such that 
the overall device is compact and practical. 
• Have a low manufacturing cost and be easy to implement.” 
The impedance of the skin at low frequencies (~20 k to 60 k, see Chapter 4 
and [138]) necessitates operating voltages in the order of 60 V to achieve the desired 
1 mA at DC. Pulsatile stimulators that use waveforms that penetrate the skin’s 
effective capacitance more easily, transmit through a much lower effective impedance 
and thus require much lower operating voltages than arbitrary waveform stimulators 
with low frequency components. 
The primary difficulty in designing a high voltage continuous current stimulator or high 
voltage current pump (HVCP) is power consumption. Generating the high voltage itself 
is often highly inefficient, and further, the analogue amplifiers that can operate at high 
voltages often have large quiescent currents. 
The primary purpose of this chapter is to address the limitations noted by Chapter 5 and 
produce a tool that is ready for research requiring a wearable device. 
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The final design presented here further makes necessary improvements to the power 
supply and adds a variety of safety and interface features not present in the previous 
design. 
6.2 Methods and Materials 
6.2.1 High voltage power supply design 
In Chapter 5 we achieved the required high voltage power supply (HVPSU) using a 
cascaded series of Microchip TC962 capacitive voltage inverters to generate 72 V from 
a 9 V alkaline battery. This design was compact, low-power and efficient. In practice, 
the design had one significant shortcoming.  
The design offers no voltage regulation and relies on a constant 9 V from the battery: 
as the battery discharges from 9 V, the HVPSU voltage tracks it proportionally and the 
high compliance of the subsequent HVCP is lost. Both Lithium-Polymer (Li-Po) 
batteries and Alkaline 9 V batteries lose approximately 25% of their output voltage over 
their discharge curve, which results in at least 25% loss in compliance of the HVPSU. 
The design of a small form factor boost supply that is both regulated and efficient for 
output currents in the range of 1 to 3 mA (0.072 to 0.36 watts) is not trivial.  
For comparison, off-the-shelf module solutions like the Econoline DC/DC converter 
R1D**-xx24 [155], and the Kylinchip XL6009 [156] boast high efficiencies (74-84% 
and 94% respectively). This only occurs for output power in the order of 1 watt. For 
lower output power, with output currents of 1 to 3 mA, efficiencies are typically in the 
order of 50% or lower. Inductive switching boost converters do not efficiently produce 
high output voltages at low currents. 
Using the switched capacitor inverters from the previous design is the most energy 
efficient way to solve the problem, but these are not regulated, or versions that include 
internal regulation sacrifice efficiency (e.g. MAX868). Regulation would need to be 
introduced and would need to be done using a switching regulator instead of a linear 
regulator to achieve high efficiency. 
The paradox of requiring high output current for a switching regulator to operate 
efficiently, but only needing a low current at the HVPSU output, is solved by using the 
switching regulator only at the battery, to produce a low, but regulated bucked or 
boosted voltage. While we draw low currents (1-3 mA) from the high-voltage side of 
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the power supply, we are drawing high currents from the low voltage side (for a 3.6 V 
Li-Po battery at least 20 to 60 mA). Many parts offer high efficiency regulation from 
the full input range from a Li-Po battery (3 V to 4.2 V) for this output current range if 
producing low voltages. The TPS61028 by Texas Instruments offers efficiencies in 
excess of 90%. 
The subsequent architecture of switched capacitor doublers and inverters must carefully 
balance multiple trade-offs. The ultimate output impedance of the HVPSU and each 
part affects regulation and efficiency. The quantity and quiescent power of parts used 
affects the total quiescent power of the HVPSU. Finally, the form factor in which each 
part is available affects the physical size of the HVPSU. 
Not only can many potential voltage converters perform these tasks, each carrying a 
trade-off of some kind, but they can be connected in a multitude of configurations to 
achieve the high-voltage output. These parts are not readily available in libraries for 
modelling software such as SPICE [157,158]. Consequently, to investigate different 
architectures and optimise the design, we created a circuit-modelling framework in 
Matlab (See Appendix B for a full description of the modelling framework developed, 
and the results of power supplies simulated). 
The framework allows the creation of any buck, boost, or voltage-inverter part based 
on its datasheet, and its connection into an HVPSU architecture. Correctly modelling 
the flow of the quiescent and output currents [159] was essential to modelling the 
efficiency of multiple interacting chips. We could then simulate connecting various 
parts together in feasible configurations to investigate the effect of different parts, 
different system architectures, different battery discharge-voltages and different 
numbers of cells on total battery life. 
The dominant design goal was to reduce the battery capacity required to run the high 
voltage current pump (HVCP) circuit for the required 10 hours under worst-case 
conditions. 
Figure 40 is an explanatory diagram of the various voltage inversion and boost stages 
in the final design. The TPS61028 at “A” regulates the Li-Po battery voltage from 




Figure 40. Explanatory diagram of a high efficiency power supply that regulates a 3 to 4.2 V battery output 
to +36 V and -36 V supply. The part at “D” uses the ICL7662 in both its doubling mode and inverting mode. 
The 4.5 V is then inverted at “B” to create -4.5 V by a MAX660, which has superior 
output impedance and quiescent current draw than most capacitive inverters, but can 
only operate at low voltages. The total available voltage of 9 V (4.5 – -4.5) is now too 
large to invert using a second MAX660. 
The +4.5 V is now inverted around the -4.5 V at “C” to create -13.5 V using an 
ICL7662. The total available voltage is now 18 V (4.5 – -13.5 = 18 V). The ICL7662 
has superior quiescent current and form factor to the previously used TC962 but has 
poor output impedance. Simulation showed once the output voltage had reached 18 V, 
the output current had dropped sufficiently that output impedance was not a significant 
contributing factor to performance. 
The 18 V is then inverted and doubled in one step (“D”) with another ICL7662 to create 
4.5 + 18 = 22.5 V and -13.5 – 18 = -31.5 V. The doubling mode of the ICL7662 comes 
at the cost of two forward-voltage diode drops, which reduces both efficiency and final 
output voltage. Using low forward-voltage Schottky diodes reduces this impact. 
Further, doubling and inverting in one step comes at the cost of increased output 
impedance compared to using two chips to perform each operation separately. 
Simulation indicated that using a single part for both the doubling and inversion 
significantly improved the circuit’s performance over using two cascaded inverters 
despite the diode drops and increased impedance. This is partly due to powering a 
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reduced number of chips, but it also reduces the “depth” of the cascade, which has a 
multiplicative effect on output impedance. 
Finally, the -13.5 V is inverted around the -31.5 V at “E” using another ICL7662 to 
create -49.5 V and a total voltage of 22.5 - -49.5 = 72 V with -13.5 V at the midway 
between the two extremes, 36 V from the highest and lowest voltages. 
The final output voltage (72 V) is proportional to the output voltage at “A” (4.5 V). The 
output voltage of the TPS1028 can be manually increased from 4.5 V to compensate 
for the voltage losses at the final output when the subsequent current pump is drawing 
its quiescent current of 1 mA. An output of 4.7 V is typically what is needed to produce 
a final output of 72 V. 
6.2.2 Instrumentation of the High Voltage Current Pump (HVCP) 
It is desirable, but not essential to instrument the outputs of the HVCP. Bench-top 
stimulators like the Digitimer DS5 Bipolar Constant Current Stimulator include outputs 
that allow for the monitoring of the output current and voltage. 
Monitoring the output current allows the driving hardware to check if the circuit is 
functioning properly. The most likely fault is current or voltage “clipping” when the 
circuit fails to have sufficient compliance to drive a given load. Table 15 shows the 
compliance of designs with similar applications. Several of these have less than the 
required supply voltage. These circuits do not report clipping, but also do not monitor 
the output and so are unable to detect voltage saturation. Clipping can be considered 
undesirable or even dangerous simply because the desired current is not flowing in the 
tissue. 
Error states that cause a difference between the desired current and the achieved current 
are unsafe. Monitoring the achieved current with accuracy in the order of 2 μA allows 
the driving circuitry to monitor the HVCP for accurate operation.  
Current being diverted away from the stimulator to other parts of the body can be 
extremely dangerous. As little as 100 μA across the heart is enough to cause micro-
electric shock [160]. Monitoring the current on both stimulation-leads separately would 
improve the safety of the circuit further (Figure 41). The circuit should be able to 




Figure 41. Diagram depicting the dangerous diversion of current to elsewhere in the body. The magnitude of 
the diverted current can be calculated by the difference in current between the two stimulation leads. 
Unlike laboratory settings, in wearable applications it is expected that the quality of the 
electrode connections will change considerably over time [139]. The HVCP will adjust 
its drive accordingly, but having feedback information about the impedance of the 
electrode connection would further improve safety. The electrode impedance can be 
calculated by monitoring the drive voltage as well as the drive current. 
In order to measure the current in each lead and the voltage applied to the participant, 
a relatively small resistor is placed in series with the leads and the voltage on either side 
is buffered (Figure 42). Signals a, b, c and d are all voltage-buffered signals, and 
drawing small currents from these points does not affect the current drive into the 
participant. OA1, OA2, BUFF1 and SENSE1 form the modified Howland current pump 
described in Chapter 5. Only BUFF2 is added to the previous design so as not to draw 




Figure 42. Representative schematic showing how the various currents and voltage signals are made available 
for instrumentation. OA1, OA2, BUFF1 and SENSE1 form the modified Howland current pump described 
in Chapter 5. 
The current in each stimulation lead connected to the participant can be measured by 
the differential voltages Va-b and Vc-d. The voltage applied to the participant is given by 
Vb-c. 
Measuring these voltage differences and conditioning the signals for analogue-to-
digital conversion is not trivial. All of these signals draw their power from the HVPSU 
and they have a significant effect on battery life. Thus, the input impedance of any 
circuitry used is critical to reducing power consumption. Further, very high common 
mode rejection is required since Va-b and Vc-d have a maximum of a 50 V common 
mode signal relative to the battery voltage, and a minimum differential resolution of 
3 mV for 1 µA drive current if a 3 k sensing resistor is used. 
To measure the three voltage differences required we step each voltage (a, b, c and d) 
down to the range of the battery voltage / microcontroller supply using a standard 
resistor-divider circuit (Figure 43). The differences are then measured using ultra-low-
power instrumentation amplifiers (INA333) powered directly from the battery and not 
the HVPSU. Gains G1, G2 and G3 are set to rescale the outputs to achieve maximum 




Figure 43. Representative schematic of instrumentation circuitry to monitor the current into and out of the 
participant, as well as the voltage applied to the participant. a, b, c, d represent the same signals as in 
Figure 42. G1, G2 and G3 are gains set to scale the voltage to maximise resolution. 
This solution is more power efficient than using high common-mode voltage difference 
amplifiers such as the INA148 or the LT6375. These amplifiers would need supply 
voltages greater than the battery voltage in order to operate and an additional circuitry 
stage transferring their outputs to the microprocessor ADC would be required. They 
have higher quiescent current than the INA333 and often worse input impedance than 
the resistor divider that is used here. 
The challenge is that any imbalance in the resistor-dividers creates large common mode 
gain at the output. Using the best commercially available precision resistors 
(0.1% 1 M and 0.05% 20 K) limits the imbalance, but tuning is still required. Four 
tuning resistors inserted during a calibration stage bring the DC common mode 
measurement error down to less than 1 µA output. Two capacitors (C1 and C2), in the 
order of 1-20 pF, adjust for capacitive mismatch, largely created by the inputs of INA2. 




6.2.3 Microprocessor and interfacing 
The final device is controlled by a Texas Instruments CC2640F128R Bluetooth® low 
energy Wireless MCU. The chip has a powerful ARM® Cortex®-M3 core processor 
and a second ultra-low-power independent “Sensor Controller”.  
The chip’s primary purpose is to drive a precision 12-bit dual Digital to Analogue 
Converter (DAC) (AD5687) to generate the differential signal required by the HVCP. 
Driving differentially has three benefits over using a single channel: the common mode 
noise is not transferred to the output of the HVCP, an additional bit of resolution is 
achieved, and negative signals can be generated without the need for a known zero 
reference voltage. 
Seven ADC lines monitor the three instrumented analogue outputs from the HVCP, as 
well as the mid-supply reference voltage used by the instrumentation as a zero point, a 
precision 3 V reference used by the DAC, and the voltage on a potentiometer which 
can be used by the user to make adjustments as needed. 
The microprocessor has Bluetooth® low energy wireless capabilities that were not used 
in this design but could be added at a later stage for user interfacing and data transfer. 
An SD cardholder is connected to allow the saving of recorded data and time stamps, 
as well as reading of pre-loaded drive signals if they are not to be algorithmically 
generated in real-time.  
Logic lines control two status LEDs and can activate the shutdown logic of the 
TPS61028 disabling the entire high voltage side of the circuitry. Logic lines also control 
two solid-state relays (LH1525) (Figure 44), one disconnects the participant from one 
of the stimulation-leads preventing drive current into the participant. The second can 
short circuit the two drive leads, either discharging voltage on the participant if 
connected, or allowing current to pass from one lead to the other when the participant 
is not connected. This current bypass allows the circuit to perform a system check prior 
to connecting the participant. The relays can handle voltages up to 400 V on their 




Figure 44. Schematic of output solid-state relays that can disconnect the participant from the device, 
discharge charge from the participant and allow current from the drive circuitry to circulate internally. 
Finally, the circuit also has built-in USB charging for the Li-Po battery with indicator 
LEDs. Built in charging is more than just a convenience, it enables the circuit to be 
sealed in its enclosure with no need to have a removable battery.  
The USB charging cable presents a potential risk to the participant as it may provide an 
earth reference to the circuit if the cable is connected while the participant is being 
stimulated. To mitigate this risk the circuit employs three safety measures. Firstly, the 
USB power is only physically connected to the charging circuitry when the main power 
switch is in the “off” position, thus the battery will never be charged while the device 
is in operation. Secondly, even in the “on” position, the 5 V from the USB directly 
drives a transistor that activates the shutdown pin of the HVPSU. Finally, this shutdown 
signal also activates an interrupt routine on the microprocessor allowing further 
shutdown actions to be taken, including disconnecting the participant via the solid-state 
relays. 
6.2.4 Human testing 
In Chapter 5 the HVCP was tested using purely resistive loads and a complex load that 
approximated the impedance of the limb-electrode combination. In order to ensure the 
circuit operates correctly on human participants, which present a more complicated and 
possible active load to the circuit, 5 participants were recruited and required to sign 
informed consent. This work was approved by the Human Research Ethics Committee 
of Western Sydney University (ref: H10922). 
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Two Axelgaard UltraStim® Snap SN2020 5 cm × 5 cm square adhesive electrodes 
were applied medially and laterally, proximal to the malleoli of the right leg of the 5 
participants. The electrode site was not prepared using abrasion, cleaning or shaving in 
order to deliberately create an inferior connection. 
Currents of +1 mA DC, -1 mA DC, 500 µA RMS at 500 Hz sine wave, and white noise 
low-pass filtered to 100 Hz with an RMS amplitude of 100 µA were tested. 100 Hz 
low-pass-filtered white noise of this amplitude is commonly used for SENS-type 
experiments. 
6.3 Results 
The workings of the HVCP are not changed from Chapter 5 and will not be 
characterised here. 
6.3.1 High Voltage Power Supply Unit (HVPSU) results 
The HVPSU was designed onto a two-layer Printed Circuit Board (PCB) (Figure 45). 
The test PCB (100 mm × 27 mm) was more spread out than the final version allowing 
more extensive testing and debugging of internal signals. The schematic and PCB files 
for the test PCB are available in the digital appendix, in the folder “Prototype PCBs”. 
 
Figure 45. HVPSU testing PCB showing the various voltage conversion stages. The testing PCB allowed easy 
access to all the output voltage stages and currents flowing in the circuit. 
The HVPSU produced a voltage of 72.75 V without load and regulated to within 50 mV 
for an input battery voltage range of 3 to 4.2 V. 
The output voltage dropped linearly as more current was drawn consistent with an 
output impedance of 1956  (linear fit R2 = 0.997) compared to a simulated value of 
1834  using typical component values. The output voltage was 66.42 V under 
worst-case load conditions, a current draw of 3.17 mA. 
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Figure 46 shows power conversion efficiencies of the HVPSU for the two extreme 
battery voltages and current output conditions. 
 
Figure 46. Power conversion efficiency for HVPSU at various output currents and battery voltages. The 
simulated values for battery voltages of 3 V and 4.2 V are indistinguishable at this scale. 
The improvement in battery current consumption over a typical off-the-shelf module 
with an efficiency of 50% in this output current range can be calculated. The HVPSU 
uses between 34% and 39% less battery current than off-the-shelf solutions (see 6.2.1 
and [155,156]), over the tested battery voltage and output current ranges from 
Figure 46. 
6.3.2 High Voltage Current Pump (HVCP) instrumentation testing 
The balancing of the instrumentation circuitry was challenging. The circuit would not 
function correctly when prototyped on breadboard due to capacitive mismatched in the 
breadboard tracks. The circuit was then tested and shown to work correctly on a 
separate 2-layer PCB connected by wires to the HVCP signals. More extensive testing 
was then conducted on a larger PCB which included all the circuit components, except 
the microprocessor, which allowed for simple signal driving using an external signal 
generator. The larger PCB allowed the performance of the instrumentation to be 
assessed when all the circuitry components where operating in concert, but to still allow 
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access to individual signals which would be difficult once the circuit was miniaturised. 
The final testing was performed on the full miniaturised device, discussed in 6.3.4. 
In Chapter 5, the current consumption of the HVCP when driving -1 mA into a 60 k 
load was 3.07 mA. With instrumentation circuitry added, the peak current draw was 
also during maximal DC operation, and was 3.17 mA. 
The outputs of INA1, INA2 and INA3 (Figure 43) were measured directly using a 
bench-top multi-meter to establish the accuracy of the analogue instrumentation 
circuitry. Figure 47 shows the output error of the three instrumented signals for a variety 
of amplitude and frequency conditions. Current line A and current line B refer to the 




Figure 47. Output error in instrumentation circuitry over full range of output current and frequency. Top: 
error in the instrumentation of the current flowing into (Line A) and out of (Line B) the load. Bottom: error 
in instrumentation of voltage applied to the load. AC signals are measured as RMS and consequently cannot 
be negative. The four AC load current values measured roughly correspond to peak-to-peak load currents of 
0.5 mA, 1 mA, 1.5 mA and 2 mA. 
The maximum measurement error was 1.34% on line A and 2.08% on line B. The 
voltage measurement over the load never exceeded 0.31% error. 
The actual difference in current between line A and line B is zero. Any difference in 
the measurements is thus the error in measurement of leakage current. The largest such 
difference occurs for maximal current at 1000 Hz and is less than 8.2 µA. The sum of 
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the worst error magnitudes is a conservative estimate of how bad this error could get if 
the circuit were built multiple times. This also occurs for maximal current at 1000 Hz 
and is less than 16.5 µA. 
6.3.3 Battery testing 
The final circuit (see Chapter 6.3.4) was tested using a 60 k load running from a fully 
charged 1000 mAh battery. The large resistive load is selected to force the device to 
operate under worst-case power conditions.  
When driving the worst-case -1 mA DC current into the load, the circuit operated for 
more than 15 hours. However, this waveform is not representative of a signal likely to 
be used in practice. A second test using a 1 kHz, 1 mA peak-to-peak signal is more 
representative of a practical worst-case scenario. Under these conditions the circuit 
operated for more than 18 hours from a single charge. 
As a best-case scenario, a DC current of 2 µA was driven. A non-zero DC current was 
chosen so that failure of the device was clearly apparent. Under these conditions the 
device operated for more than 33 hours. 
The datasheet of the particular battery used does not specify cycle life. However, 
datasheets for similar batteries indicate that Li-Po batteries have more than 80% 
capacity after 300 cycles, which equates to more than 1 year of use at 10 hours per day. 
Even at 80 percent capacity, the battery can be expected to last 12 hours under worst 
case conditions. 
6.3.4 Final device 
The final device (Figure 48) was designed on a 6-layer PCB populated with parts placed 
on both surfaces. The circuit was designed to have similar dimensions to a standard 
1000 mAh Li-Po battery and together they measured 33 mm × 55 mm × 15 mm and 
weighed less than 37 g. For comparison, the weight and dimensions of the benchtop 
currents sources used in Chapter 3 and Chapter 4 were measured. The Digitimer DS5 
bipolar constant current stimulator measured 225 mm × 253 mm × 98 mm and weights 
3.2 kg. The A-M Systems 2200 current stimulator measured 154 mm × 175 mm × 
65 mm and weighs 1.27 kg. The schematic and PCB files for the full circuit is available 




Figure 48. The topside (top) and underside (centre) of the assembled PCB, as well as the battery (bottom) 
used in testing. Together the PCB and battery measure 33 mm by 55 mm by 15 mm and weigh less than 37 g 
when the battery is placed on top of the PCB. 
The indicator LEDs, output solid state relays, USB charging, HVPSU shut down 
control and interrupts, and the micro-SD card reading and writing were all tested to 
function as designed. 
6.3.5 Human testing 
The five participants recruited were all male. The device drove +1 and -1 mA DC, as 
well as 500 µA RMS at 500 Hz into the right leg of all participants with less than 2% 
error.  
Figure 49 shows the recorded current signals when driving the same arbitrary white 
noise signal (100 µA RMS low-pass-filtered to 100 Hz) into each participant. Each 
signal overlaps making it difficult to distinguish between them, however, the figure 
inset shows the variation in the measured current signals. With the circuit disconnected 
the baseline noise amplitude and offset on the oscilloscope used to measure these 
waveforms was established. The amplitude of this measurement noise and offset was 
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large enough to account for most of the variability between recorded signals and the 
offset between recorded signals and the desired current. 
 
Figure 49. Desired current and achieved current plotted over time when stimulating 5 participants with the 
same white noise stimulus. The 6 signals lie over each other. Inset: A portion of the signals scaled so as to see 
the small variability between the 6 signals. Testing indicated that this variability could largely be attributed 
to measurement noise. 
6.4 Discussion 
The HVPSU was able to produce the required output voltage from a standard Li-Po 
battery for the full range of battery outputs produced as the battery discharges. Even 
though some output voltage is lost as a consequence of the internal resistance of the 
HVPSU, the worst-case conditions still offer sufficient compliance to drive 1 mA 
through the impedance of the worst-case electrode connection. 
The HVPSU circuit’s performance was consistent with simulations. The small 
deviation in output impedance is likely a consequence of individual part output 
impedances being stipulated as ranges in the datasheets, whereas the simulation made 
use of only the typical values for each part. 
The improvement in the efficiency of the HVPSU over simulated values, especially for 
higher input voltages is most likely a consequence of the TPS61028 being simulated 
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with a constant conversion efficiency (92%), whereas the datasheet does indicate the 
efficiency improves for higher input voltages. The exact efficiency values for the 
voltages and currents used in our design cannot be practically extracted from the 
datasheet, and a lower simulated efficiency was used regardless of input voltage. 
The HVPSU is substantially more efficient than commercially available power supply 
modules facilitating a battery that is 34% smaller to achieve the same battery life 
(see [155,156]). Using a larger battery, to account for the power difference between the 
commercial solutions and the HVPSU presented here, is a feasible option. A 2000 mAh 
battery would increase the mass of the device by at least 14 g (an increase of 38% of 
the device weight), and the volume of the device by 8.9 cm3 (an increase of 33% of the 
device volume). These values, while not the best solution, are not prohibitive. 
The instrumentation circuitry produced accurate outputs in both AC and DC conditions. 
A key concern in the design of this circuitry was drawing current from the high voltage 
circuitry, which has a significant effect on battery life. The added current draw was in 
accordance with predicted values and is lower than what would be expected in simpler 
designs using high-voltage difference amplifiers. 
The current measurement in the second electrode lead is only implemented to improve 
safety by monitoring for a condition where the current in the electrode leads differ more 
than 50 µA. The sum of the worst-case errors in the measurement of both currents was 
16 µA, which guarantees that the error in the measured difference between the two 
electrodes will always be less than 50 µA. 
Battery-life tests successfully demonstrated that the device can be used at full output 
power for an entire working day without the need for recharging. 
It is not common to design portable stimulators for continuous application of current as 
opposed to pulsatile stimulation. Table 16 compares the design presented in this chapter 
to the design presented Chapter 5, as well as the only other known design for a similar 
application by Yamamoto et al. [152–154]. Three wireless stimulators are included, 
which have similar design constraints, but are designed for pulsatile applications and 
thus should be compared with caution. 
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Table 16. Comparison to designs with similar constraints. 
 This work Karpul  




Wang et al. 
[146] 
Farahmand 
et al. [147] 








123 - 272 106 - 233 312a 720 51.2 >700 
Use duration (h) 15 to 33 >10 >24a 8 Unknown Unknown 
Current output 
(mA) 
1 1 1 60 0.4 70 
Volume (cm3) 27.3 28.2 210.1 127.5 90 52.5 
Weight (g) 37 52 200 85 60 45 
Signal type Continuous Continuous Continuous Pulsatile Pulsatile Pulsatile 
Self –
instrumentation 
Yes No Yes No No No 















a Approximate values based on information directly from the author 
b Device has Bluetooth® low energy wireless capabilities but this functionality was not implemented as part of 
this work. 
 
Despite the addition of multiple additional circuitry blocks, device weight and volume 
are lower than all other designs. This reduction in weight and volume is partially a 
consequence of using a much more energy dense Li-Po battery technology, which is 
both lighter and smaller for the same capacity as alkaline batteries. 
The circuit accurately drove a variety of current waveforms into 5 participants. Until 
now, the HVCP has been tested extensively with artificial loads. The results of the 
human testing validate that these results transfer to using the circuit to apply currents 
to participants in vivo. 
6.5 Conclusion 
This chapter presents a novel stimulator specifically targeted at subthreshold 
continuous current stimulation for wearable applications. The research extends the 
work in Chapter 5, adding on-board device and signal control, instrumentation, safety 
and battery charging circuitry. Further, updates to the circuit’s power supply mean the 
circuit is lighter and smaller than all known published designs with similar constraints. 
This is achieved without compromising battery life or high voltage compliance. 
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This work also presents the first instance where this design architecture has been tested 
in vivo. Human experiments indicated that the device is ready to be used in research 
applications. Research into the use of SENS-type interventions has previously been 
limited to short-term experiments, primarily due to the lack of a suitable wearable 
stimulator. This novel design opens new research opportunities. Future work should 
focus on exploiting this technology to perform long-term validation studies of 







Each of the chapters of this thesis make important contributions to the current body of 
literature. 
Chapter 1 presents the first numerical analysis of the outcomes of studies using 
subthreshold interventions similar to Subsensory Electrical Nerve Stimulation (SENS). 
The review provides a cohesive picture of this field of research, and offers some 
considered guidance as to where it should head. Aside from identifying short fallings 
of the current body of work and making recommendations for future research, the 
review identifies 3 gaps in knowledge that are addressed in this thesis.  
First, no studies investigating the effect of this type of intervention on patients with 
HIV-related peripheral sensory neuropathy (HIV-PN) were found, and none of the 
studies reviewed reported on measures of pain. Second, none of the studies investigated 
participants’ Electrical Perception Thresholds (EPTs) to electrical noise stimuli. While 
EPT has often been used as a means of determining the appropriate amplitude of SENS 
to apply, the reliability of this EPTs was unknown. Finally, none of the studies made 
use of, or researched, a device that could apply SENS-type interventions in a wearable 
fashion outside of a laboratory setting. 
Chapters 2 and 3 address the first gap. Chapter 2 presents the first quantitative, double 
blind measurement of Vibration Perception Threshold (VPT) in patients with HIV-PN 
at different vibration frequencies. The adverse effects of HIV-PN on VPT are 
evidenced, which both justifies the need for an intervention, and validates the extensive 
VPT protocol used. An unexpected result was that outcomes of tests for interaction with 
vibration frequency suggest that the pathology of HIV-PN and its treatment may not 
affect all mechanoreceptors similarly. 
Chapter 3 presents the first investigation into the effect of SENS on VPT and measures 
of pain in participants with HIV-PN. Beneficial outcomes similar to previous studies 
with other population groups were observed, however, likely because the protocol was 
more extensive than previous SENS work, several conditions where SENS was 
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ineffective or even detrimental were also observed. In this regard, the research raises 
important questions for the use of SENS as therapy, and more research is 
recommended. The analysis of pain outcomes did not indicate that SENS had a 
detrimental or beneficial effect. This is a very important outcome that can be used to 
justify future research with participants who experience higher levels of neuropathic 
pain, whereas previously this was avoided for ethical reasons, as the effect of SENS, or 
similar interventions, on pain was unknown. 
Chapter 4 addresses the second gap in knowledge by providing the first investigation 
into participants’ EPTs to noise stimuli under various conditions. Most subthreshold 
interventions claim to rely on the idea that the perceptual threshold of participants is 
stable with regard to the intervention signal. We show that this is not the case, and the 
perception thresholds are highly variable. This is an important finding because it either 
indicates that these interventions do not actually rely on applying the signal relative to 
threshold as claimed, or further research into how to adapt the signal for potentially 
dynamic thresholds is required. The results of Chapter 3 and Chapter 4 together present 
strong evidence that the mechanism of the beneficial effects seen with SENS 
specifically, are unlikely to occur through classic stochastic resonance, as is often 
claimed in the literature. This in itself is an important finding. Either way, the work 
strongly motivates that a better understanding of the effect of subthreshold 
interventions is required before proceeding. 
The final gap is addressed in both Chapter 5 and Chapter 6 which together develop a 
constant current stimulator that is smaller, lighter and more powerful than designs 
presented in the literature. The device will facilitate future research into the long-term 
effects of SENS which are not understood, but vital for its development as potential 
therapy. 
In addition to the gaps addressed in the main body of the thesis, Appendices A and B 
demonstrate the power of simulation to solve scientific questions in different contexts. 
Appendix A provides an uncommon statistical analysis that is vital to answer a valid 
scientific question regarding the “per-participant” optimal amplitude of SENS, without 
the false statistical bias seen in several previous works. Appendix B documents the 
implementation of a simulation framework which was then used to design a power 




7.1 Key findings 
The key findings of this thesis are:  
The body of literature regarding subthreshold interventions for the improvement of 
peripheral sensitivity is extensive and demonstrates this type of intervention to hold 
promise in reducing symptoms associated with peripheral sensory neuropathy. 
However, the literature lacks consistency and good quality scientific reporting, does 
not investigate the long-term effects of these interventions, may suffer from publication 
bias and does not properly understand the mechanisms by which these interventions 
interact with the underlying physiology. Further, we present evidence that SENS does 
not have beneficial effect though the mechanism of stochastic resonance, as is often 
claimed in the literature. 
HIV-PN participants have reduced VPT compared to matched control participants, 
especially at 25 Hz. SENS improved VPT but only for 50 Hz vibration and only for 
certain amplitudes of SENS. SENS was not shown to have an effect on perceived 
measures of pain. 
In contradiction to the manner in which it is treated in the literature, EPT is a highly 
variable measure and correlated little with potential explanatory variables when 
evaluated in a forced choice, double-blind manner. 
Finally, the developed continuous current stimulator for wearable application of SENS 
is suitable for research into the long-term effect of SENS and similar subthreshold 
electrical stimulation interventions. 
7.2 Future work 
Each chapter makes specific recommendations of future work that should follow the 
conclusions made there, and should all be carried out in due course to progress this 
field. Here we answer the question more broadly: based on the whole thesis what should 
be done next? 
The thesis as a whole demonstrates that the biggest barrier to developing SENS into a 
meaningful intervention for neuropathic populations is understanding the mechanism 
by which it has an effect on sensation. Understanding the mechanisms would allow the 
signal to be optimised and reduce the amount of exploratory work required. 
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Such investigations can take both a holistic and reductionist approach. Carefully 
designed studies that alter the location of the applied intervention can answer questions 
regarding where the intervention signal and sensory signal integrate: centrally, 
peripherally, or a combination. Studies carefully controlling and altering the nature of 
the intervention signal and its frequency spectrum, as well as the nature of the sensory 
signal to be detected, can answer questions regarding what physiological systems are 
involved and how to best interreact with them.  
Reductionist approaches will also be essential. Studies looking at isolated nerve fibres 
in vivo, in vitro and in simulation will allow the perceptual component to be removed 
from the research. Finite element models can begin to answer questions of how 
individual nerves are affected, how bundles of nerves interact when exposed to a broad 
electric field and how the surrounding tissue influences the transmission of the signal 
to the axons. These models however must be based on realistic physiological data which 
does not currently exist for peripheral sensory nerves. 
Ultimately, it is not necessary for the system to be treated as a “black box”, where we 
“prod” the system and attempt to explain the outcomes. It may be technically more 
difficult and complex to open the box and understand how it works, but ultimately much 
more effective and efficient. 
7.3 Final remarks 
The results of this work demonstrate the potential viability of SENS as a therapy for 
HIV-PN, reveals the variability of electrical perception thresholds, explores the 
measures of pain for SENS interventions, and provides a complete and thoroughly 
tested design and implementation of an unparalleled electronic stimulator for 
non-laboratory environments. The conclusions of this work form both a strong 
theoretical and practical basis for future SENS intervention research. 
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APPENDIX A HYPOTHESIS TESTING FOR DATA THAT HAS 
UNDERGONE BIASED SELECTION 
A.1 Background 
In Chapter 3 we conducted a study that took a group of participants, tested them under 
four test-conditions and one control condition in an attempt to find a test condition that 
improved our outcome measure: vibrotactile sensitivity (Figure 50). 
 
Figure 50. Diagram depicting the experimental design testing for improvement in 50 Hz VPT at various SENS 
amplitudes. 
While analysing this data a very natural question arose: “What if each participant had 
an individualised test-condition that was optimal for sensitivity?”, i.e. what if each 
person requires a different stimulation condition to get an effect? Then analysing the 
group response to each stimulation condition might weaken the effect sufficiently 
rendering the overall result null. 
Standard test-statistics applied to intervention trials typically ask the simpler question: 
“Did ‘this’ work or not?”. Further, an ANOVA style analysis can ask: “Did one or more 
of the intervention categories have an effect on the group that distinguished it from 
rest?”. We can check for the effect of stimulation-condition on the outcome and 
conclude if there was indeed a condition that had an effect on the group. 
The question of individualised optimal treatment itself superficially seems very 
scientifically valid. Applying the common medical “dose-response” nomenclature, 
would we expect there to be a single dose that creates optimal response in every person? 
Testing a variety of conditions, matching participants to their optimal condition, and 
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creating theory to best predict what the optimal dose should be without difficult and 
costly testing, seems like a very reasonable way of developing any sort of treatment. 
The simple numerical solution is to select the best response condition for each 
participant, create a new intervention category called “optimal”, and compare the 
results for “optimal” to the control condition with an appropriate comparison test, such 
as a paired student’s t-test. This often yields the desired positive result, but such ‘cherry 
picking” is an invalid approach. However, research with this methodology has been 
published [69,73,77,92,94]. 
To demonstrate the bias this approach creates, we can plot the distribution of final 
outcomes, when selecting the best sub-outcome from “k” conditions, under the null 
condition when the difference is truly zero. We can calculate these distributions using 
statistical “extreme value theory” or simulate this condition in a Monte Carlo analysis 
(Figure 51). Extreme value theory derives for the probability distribution of 
outcomes x, when selecting the maximum from k selections from a normal distribution 
as:  
 𝑃(𝑥𝑘) = kΦ(𝑥)
𝑘−1. Φ′(𝑥) . 5 
Where Φ(𝑥) is the cumulative distribution function of a normal distribution, and Φ′(𝑥) 
just returns the normal distribution. 
 
Figure 51. Plot of simulated and calculated probability, P(x), distribution functions for selecting the best 
outcome value from a set of k draws from a normal distribution. The two methods align with a high degree 
of accuracy.  
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In a hypothetical “t-test” like examination where the base control condition (k=1) is 
compared to the “optimal” condition (k>1), we can see the test will likely observe a 
difference in the data even when both datasets are generated from the same base 
distribution (i.e. the null condition). 
A standard statistical test or correction factor is sought to answer the hypothesis 
regarding the “optimal” condition without the bias demonstrated above. Monte Carlo 
hypothesis testing can calculate test statistics against any null hypothesis that can be 
simulated and is consequently well suited to this situation [135–137]. 
A.2 Construction of the null hypothesis for cherry picked treatment 
amplitude 
To apply the Monte Carlo hypothesis test, first we must construct our experiment’s 
dataset under null conditions. In Chapter 3 we tested the “Optimal” SENS condition at 
a vibration frequency of 50 Hz for each participant against the no-SENS condition 
using the odds ratio of linear mixed effects models. This yields a p-value and an effect 
amplitude of percentage change from control. Table 17 summarises the result of the test 
on this skewed data. 
Table 17. Summary of results for “Optimal” SENS condition for each participant for 50 Hz vibration. 
 Effect of optimal SENS on VPT p-value 
HIV-PN -17.8% 4.54e-13 
Non-HIV -24.3% 6.22e-15 
   
To appropriately test the null-hypothesis we must construct a dataset that simulates our 
experiment, however with a known zero effect of SENS. We then run the dataset 
through the same statistical test and see if the results of the actual experiment lie outside 
of the distribution of many such null simulations. 
To mimic the distribution of the participants more accurately, sub-datasets are 
generated for each participant with the same mean VPT as the average of the VPT from 
the no-SENS and the Optimal SENS conditions for that participant, and the same SD 
as the mean of the SD’s from the two conditions for that participant. This is repeated 
five times for each participant in a cohort. The first of the five iterations acts as the 
no-SENS condition and the “Optimal SENS” condition is cherry picked from the 
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remaining four iterations. The data is saved to a separate file and the process repeated 
10 000 times. 
The statistical outcomes of the 10 000 files where we know there is no effect of SENS 
is then analysed. This can be done programmatically in the statistical package “R”. 
Figure 52 shows the distribution of the effect of Optimal SENS when we know there to 
be no effect. It demonstrates the extent of the bias created but also the limits of the bias. 
If the experimental data has a larger effect than the 95th percentile of this distribution 
we can say that the p-value for our data is less than 5%. Figure 53 shows the 
distributions of the p-values from the null hypothesis. Again, if the p-value from our 
dataset is lower than the 5th percentile of this distribution then we can then again state 
that the experimental data is indeed unlikely to come from the null distribution. 
 
Figure 52. Distribution of the calculated effect of SENS in 10 000 simulated experiments under the null 




Figure 53. Distribution of the calculated p-value of the effect of SENS in 10 000 simulated experiments under 
the null condition where the real effect of SENS is zero. The 5th percentile for the HIV-PN null hypothesis is 
at p = 1.26e-5 and p = 8.93e-6 for the non-HIV group. Only ~15% of the p-values lie above the p = 0.05 mark, 
which demonstrates the extent of the p-deflation. 
We can now extend Table 17 to include the outcomes from the simulation (Table 18). 
Table 18. Experimental and simulated outcomes of statistical tests with the “optimal” SENS condition. 
 Effect of optimal 
SENS on VPT 
Simulated 95 percentile effect 
of optimal SENS on VPT 
p-value Simulated 5 percentile 
p-value 
HIV-PN -17.8% -9.2% 4.54e-13 1.26e-5 
Non-HIV -24.3% -11.4% 6.22e-15 8.93e-6 
     
Table 18 clearly shows that the experimental data lies outside of the null distribution 
and thus can be considered statistically significantly different. We can go one step 
further and ask what percentile in the simulated data lies beyond the values of our 
experimental data. The data indicates that none of the 10 000 simulated experiments 
had data that exceeded the effects seen experimentally, indicating the true p-value is 
likely less than 0.0001. 
A.3 Conclusion 
The above work makes use of a Monte Carlo null hypothesis test to determine that the 
data presented in Chapter 3 is statistically significant, whereas conventional statistics 
would have led to a strongly biased outcome. 
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APPENDIX B SIMULATION OF MULTI-COMPONENT BUCK 
AND BOOST HIGH VOLTAGE POWER SUPPLIES 
B.1 Background 
Chapter 5.2.2 documents the design of a High Voltage Power Supply Unit (HVPSU) 
that cascaded several voltage inversion stages to generate 72 V (36 V) from a 9 V 
battery. The design had a very low quiescent current and high efficiency for low output 
currents. During the development of the circuit, a bench-top 9 V supply was used, and 
in testing, a standard 9 V battery. However, after publishing the circuit [4], during 
further testing which involved discharging the battery, the assumption that the circuit 
would receive a constant 9 V failed as most battery technologies loose approximately 
25% of their output voltage over their discharge curve. The HVPSU design had no 
regulation and consequently the output voltage would proportionally track the battery 
voltage as it discharged. This resulted in reduced compliance of the subsequent High 
Voltage Current Pump (HVCP) and may cause “voltage clipping” in practice, an 
undesirable output from the device. 
This appendix deals with the design of the replacement HVPSU used in Chapter 6.2.1. 
First, the specifications and trade-offs in design architectures of this nature are 
discussed. Then, a Matlab framework, devised to simulate various HVPSU 
architectures, is presented. This framework enables the prediction of performance for 
various architectures and reduces time and cost in the design process. The results of 
several architectures are presented. Finally, the discussion focuses on design principles 
that emerged in the process and led to the final design. 
B.2 Design specifications and trade-offs 
The HVCP is required to drive 1 mA into a worst-case 60 k load. This requires an 
HVPSU voltage of at least 60 V. Because the HVCP can invert the supply voltage, 
only a single sided +60 V or -60 V is required from the HVPSU. The HVCP however 
does not operate rail-to-rail and requires approximately 2.5 V additional “headroom” 
on each voltage rail. Thus, an HVPSU voltage of 65 V is required under maximum 
current draw. Due to the quiescent current of the HVCP and the circuit’s conversion 
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efficiency, the maximum current drawn by the HVCP from the HVPSU is 3.17 mA, 
with a quiescent current of 1 mA when under no load. 
The ultimate goal of the HVPSU and battery combination is to power the HVCP for the 
required minimum of 10 hours under worst-case operating conditions (3.17 mA). A 
more efficient power supply will allow for a smaller battery capacity to be used 
reducing the size and weight of the overall circuit. However, if a hypothetical circuit is 
more efficient, but the circuitry itself is large, the gains in reduction of battery size may 
be negated by the increase in physical circuitry size. 
The design in Chapter 5, which uses a cascaded series of inverter chips produces a 
small, efficient circuit and forms the foundation of a potentially improved design. In 
making alterations, many trade-offs must be considered that influence the final 
efficiency and physical size of the circuitry. 
B.2.1 Input voltage and battery selection 
The input voltage of the circuit largely defines what types of batteries should be used. 
This can also be seen in reverse, which batteries offer the best trade-offs can define the 
input voltage of the subsequent HVPSU. Lithium-Polymer (Li-Po) batteries offer 
considerably superior energy density to alkaline batteries and are used in the vast 
majority of wearable devices available on the market [161]. Using a more energy dense 
battery technology would reduce battery size and weight for the same energy 
requirements. Single cell Li-Po batteries are easy to charge using USB power and small 
off the shelf chips. They also come in a multitude of capacities with various forms of 
protection circuitry built-in. However, the battery voltage available is limited by the 
battery chemistry and is generally between 2.7 V and 4.2 V depending on the 
technology and level of charge (most being between 3 V and 4.2 V). 
Multiple battery cells can be placed in series to create higher voltages. For example, 
three cells stacked would create ~9 to 12 V (depending on the charge level of the 
batteries), which is similar to the original design which used a 9 V input. Charging 
multiple batteries in series is more difficult, and can result in suboptimal charge levels 
or damage to the Li-Po batteries if not controlled carefully. The advantage of using 
higher voltage batteries is that less “boost” is required by the HVPSU to get to the final 
output voltage. This would be more efficient. 
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Thus, there is a trade-off between the convenience of using a single cell and the 
efficiency of using multiple cells. 
B.2.2 Placement of the reference voltage relative to the battery voltage 
The initial HVPSU design multiplies the input voltage by a factor of minus eight. For 
every 1 mA of current drawn from the maximum HVPSU output, 8 mA is drawn from 
the battery. In the design, it was required that the control and instrumentation circuitry 
be ‘placed near’ the HVCP reference (~ -27 V). Simply connecting the control circuitry 
here will also draw several times its operation current from the battery. To combat this, 
a second battery can be used for the control circuitry, with the two references joined. 
This improves efficiency and has the added benefit of creating a certain amount of 
separation between the control circuitry and the HVCP. 
However, if the HVPSU had a mid-supply reference that was ‘close’ to the battery 
voltage, then the effect of inserting the control circuitry at this point would no longer 
have a multiplicative effect on current consumption. A single battery could be used 
which would reduce the size and complexity of the circuit. Careful Printed Circuit 
Board (PCB) design would then be required to prevent the transfer of electrical noise 
between the low-voltage and high-voltage circuitry. 
The benefits of using a single battery (system size) encourage the design of a supply 
that both boosts the voltage up from the battery and bucks the voltage negatively in 
order to maintain a mid-supply reference close to the battery voltage. This architecture 
is not a requirement, but simply a trade-off to be considered when evaluating 
architectures. 
B.2.3 Conversion efficiency of each chip 
The conversion efficiency of each chip in most architectures is multiplicative with the 
final efficiency always being lower than the worst chip in the sequence. Voltage 
conversion chips often have different efficiencies at different output currents. The 
required output current of each chip is defined by where in the circuit that chip is 
inserted. Chips with low output voltages will have higher output currents and vice 
versa. Few conversion technologies are efficient for low output currents in the range of 
1-3 mA. Unregulated switched capacitor converters appear to be the most consistently 
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efficient for output currents in this range, whereas switched inductor converters appear 
to work well for regulated conversion requiring higher output currents. 
B.2.4 Quiescent current of each chip 
As stated above, drawing current from the high voltage stages of the HVPSU has a 
greater influence on battery life than drawing the same current from low voltage stages. 
Consequently, reducing the quiescent current of chips at the high voltage stages carries 
more weight than the same at low voltages. 
Further, the number of chips used has an influence on power consumed. Again, this is 
less important at low voltages, but reducing the total number of chips required at higher 
voltages would improve the efficiency of the HVPSU design. 
B.2.5 Output impedance of each chip 
Each power conversion chip has an associated output impedance. The loss of power 
over the output impedance accounts for almost all of the conversion inefficiency in 
switched capacitor converters. In this case the power lost is: 𝑃𝑙𝑜𝑠𝑡 = 𝐼
2𝑅𝑜𝑢𝑡𝑝𝑢𝑡, where 
I is the current output by the chip and Routput is output impedance of that chip. From this 
we can see that it is very important that chips with higher output currents have lower 
output impedance. Further, the voltage lost over the output impedance is also greater 
for higher output currents and has an adverse effect on the final compliance of the 
circuit. 
From this and from B.2.4 we can see that the design trade-offs dictate that chips near 
the final output stage of the cascade have low quiescent current, but consider output 
impedance as a less important factor, whereas chips near the battery voltage require 
lower output impedance and regard quiescent current as a less important factor. 
B.3 Simulation of cascaded HVPSU architectures 
The HVPSU architecture will fundamentally be created from three different forms of 
power converters: linear regulators, regulated buck/boost switched inductive 
converters, and unregulated switched capacitor converters. Each of these converters 
come in a wide variety of forms, each offering a trade-off of some kind with regards to 
the above factors. This is such a common problem that major manufacturers offer 
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design tools on their websites to aid with selection of parts. However, these tools were 
not able to provide any appropriate single chip solutions to the problem described here 
and are too simple to evaluate complex designs. 
A second option is to use a circuit simulator package like SPICE [157,158]. While 
premade SPICE or SPICE-like parts are available for a multitude of electronic 
components, none could be found for the potential components of this design. Further, 
learning how to create parts and use them in SPICE is not straight forward and would 
potentially require more time than creating a custom, purpose-built simulator. 
The Matlab objects outlined in the following sections were created to facilitate steady 
state simulation of any buck or boost circuit component based on information from the 
datasheet for that component. The components can then be connected together to 
simulate any architecture without the need to physically construct each circuit. 
All simulated circuits are made of ‘Parts’ which interact with the circuit’s current and 
voltages through its ‘Pins’. ‘Pins’ connect together outside of a part through a ‘Net’ 
which transfers currents and voltages to other ‘Pins’ and subsequently ‘Parts’. An 
overview of the structure is presented in Figure 54, and each object type is described in 
more detail in the following sections. 
B.3.1 Pins 
‘Pin’ objects are associated with a single part and a single net and are specified as either 
input or output. Input pins draw current from their connected net. How much current is 
drawn is defined by the associated part. While the part defines the current draw of the 
input pin, the net defines the voltage on the input pin. If the part updates the current 
draw of the pin, this triggers the update function of the attached net (see B.3.2). 
Output pins have their voltage specified by the part, and impose their voltage onto the 
net. A change to the voltage of the pin causes an automatic update of the voltage on the 
net to which it is connected. Only one output pin can be connected to a net at a time 
(see B.3.2). The current drawn from an output pin, is defined by the net (and in turn the 




A net object stores a list of the pins connected to it. It has three main functions. Firstly, 
a ‘connect’ function which adds a specified pin to the net. The pin is checked for 
compliance before adding, i.e. it must be a pin object, and it may not be a second output 
pin. 
The second function is to update the net. A net update causes the net to query the current 
requirements of all the input pins connected to it. It then updates the current draw from 
the output pin connected to it, it then queries the output voltage on the output pin, which 
may have been adjusted by the part based on the new current demands, and finally it 
sets the voltage at all the input pins based on the voltage output of the output pin. 
Finally, a pin can be removed from net. If the pin specified in the function call is a valid 
pin that is part of the net then the pin is removed and the net update function is called. 
Otherwise an error is thrown. 
B.3.3 Parts 
Parts define a collection of input and output pins upon instantiation. Each part must 
define an update function which queries the required current on all output pins, the 
available voltage on all input pins and then calculates and updates the output voltage 
on outputs pins and the required current of all input pins, each of which triggers an 
update of the attached nets. 
The manner in which the signals on the pins interact defines the behaviour of the part. 
This can range from a simple ideal battery which has two output pins whose voltages 
are not dependent upon any calculation, to a more complex battery whose voltage is 
dependent on the current drawn by the net, to extensively complex operation with 




Figure 54. Diagram of the circuit simulation framework object relationships. Left, a generic Part object which 
defines an update function. The update function dictates the behaviour of the Part receiving information from 
and sending information to its associated Pin Objects (either input or output). Centre, each Pin object can 
connect to a single Net object. The structure of a Net object is shown in the diagram, allowing one Output Pin 
object to be connected, and multiple Input Pin objects. Right, multiple other Part objects can connect to the 
nets to model the flow of currents and voltages through complex interaction of Parts and Nets. 
B.3.4 Simple simulation example 
An example of a simple demonstrative simulation using this framework, which 
connects a resistor to a battery and measures the resulting current flow is as follows (all 
parts are predefined and available in the digital appendix in the folder ‘HVPSU 
simulation code’): 
Create two nets: 
positive_rail = Net; 
positive_rail.name = 'Positive Rail'; 
negative_rail = Net; 
negative_rail.name = 'Negative Rail'; 
Create a predefined battery object with a battery voltage of 9 V: 
my_battery = Battery(9); 
my_battery.name = '9V battery'; 
Create a resistor with a value of 9 : 
my_resistor = Resistor(9); 
my_resistor.name = 'The resistor'; 
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We then update the parts: 
my_battery.update(); 
my_resistor.update(); 
“my_resisitor.pins.pin_one.current_sink” provides the current in the pin: 
display(['The current flowing into pin 1 of the resistor is: ' num2str( 
my_resistor.pins.pin_one.current_sink ) ' A.' ]) 
 
This generates the following console output: 
Connected output pin: 9V battery_V_plus to net: Positive Rail. 
Connected input pin: The resistor_pin_one to net: Positive Rail. 
Connected output pin: 9V battery_V_minus to net: Negative Rail. 
Connected input pin: The resistor_pin_two to net: Negative Rail. 
The current flowing into pin 1 of the resistor is: 1 A. 
 
We can change the resistance of the resistor to see the effect: 
my_resistor.resistance = 18; 
And then update the parts: 
my_battery.update(); 
my_resistor.update(); 
display(['The current flowing into pin 1 of the resistor is: ' num2str( 




This generates the following console output: 
The current flowing into pin 1 of the resistor is: 0.5 A. 
 
Naming the parts and nets with text labels is not necessary, but does increase the 
readability of the console output. 
Provided the steady state interaction for the currents and voltages inside a part can be 
defined, we are now able to model the voltages and flow of current in a system of 
arbitrary complexity. That the system sits within a programing/scripting environment 
easily facilitates examining a circuit under a range of conditions. 
Documenting how every part used was modeled is beyond the scope of this appendix, 
however, the following section presents one of the key components as an example. All 
parts are available in the digital appendix in the folder ‘HVPSU simulation code’. 
B.3.5 Simulating a generic switched capacitor voltage inverter 
The most difficult part to simulate was a switched capacitator inverter required for the 
HVPSU architecture. Rather than defining a specific part, a generic part was created 
that can perform this function and model the flow of power and current accurately, 
allowing a whole family of parts to inherit from the object. 
Understanding the flow of current as multiple inverters are cascaded is not intuitive. 
Application note AN051.1 from Intersil, which deals with the ICL7660 voltage 
inverter, provides a good model for the flow of load current and quiescent current when 
cascading devices [159]. We can adapt this formulation to demonstrate the current paths 
with cascaded inverters in general (Figure 55). The model also demonstrates how the 
load current and quiescent current increase as more stages are added between the 




Figure 55. Representative diagram of three cascaded capacitive voltage inverters. Based on information 
from [159]. For each chip, the input (IN) and output (OUT) current match in magnitude, except an additional 
quiescent current is drawn into the input. Current out of the reference pin (REF) is then the sum of these two 
currents (in accordance with Kirchhoff's circuit laws). IL is the current in the load (RL) and IQ is the quiescent 
current of each chip which is assumed to be the same for all the chips. The best way to trace the current flow 
in the diagram is to work backward from ‘C’. Note that the REF pins of A and B have two connections each 
that supply current to both preceding parts and subsequent parts. 
The generic inverter part has three pins, two input pins, ‘IN’ and ‘REF’, and one output 
pin, ‘OUT’.  
Using the pin names as subscripts and V and I denoting the voltage and current at the 
pins, we have available to the part’s update function from the connected nets: VIN, VREF 
and IOUT. We need to define in the part’s update function the assignment of IIN, IREF 
and VOUT. By convention, current directions are into input pins and out of output pins. 
In Figure 55 the current is depicted as flowing into the OUT pin, which is an output pin. 
Consequently, IOUT in the equations below is always referred to as -IOUT. 
The ideal inverter, with no output impedance, perfect conversion efficiency and no 
quiescent current defines that  
 VOUT = VREF − (VIN − VREF), 6 
 IIN = −IOUT, 7 
 IREF = −(IIN + −IOUT). 8 
The flow of current matching that in the model of Figure 55.  
We can now adjust the ideal model to represent a more realistic inverter. The datasheet 









If we wished, we could make IQ and PCE values dependant on the input voltage as 
specified by the datasheet, but for our purposes single values will suffice. 
Datasheets also define a Voltage Conversion Efficiency (VCE) and an output 
impedance (RO). Therefore:  
 VOUT = VREF − (VIN − VREF)VCE + (−IOUTR𝑂). 10 
The part must therefore define: IQ, PCE, VCE and RO, and then input voltage limits and 
output current limits to be evaluated on each update. With these parameters most 
capacitive inverters can be simulated. 
In practice, some inverters can also perform voltage doubling either as an independent 
function, or instead of an inversion. This can be added to the model in the similar way 
as above with an additional output pin. The final object was the most frequently used 
simulation component: a generic doubler/inverter which can be adjusted to model most 
switched capacitor inverters (see digital appendix folder ‘HVPSU simulation code’: 
DoublerInverter.m). The doubling mode can be ignored, or used, and when used, can 
include diode drop inefficiencies as specified in the datasheet. The diode model adjusts 
the forward voltage as a function of current in accordance with the datasheet of a 
Schottky rectifier diode. 
B.4 Simulated architectures 
Off-the-shelf solutions that boost battery voltages to produce high voltages in the range 
required, have efficiencies in the order of 50% for output currents in the required range 
(1-3.17 mA) (See Chapter 6.2.1). Any improvement beyond 50% would reduce the size 
of the battery required to operate the stimulator for a given period. 
Many permutations of parts and configurations were simulated in an attempt to find a 
solution that appropriately balances the design trade-offs. Simulation results for four 
architectures (PSU-1, PSU-2, PSU-3 and PSU-4) are demonstrated. These designs were 
not selected for implementation, but demonstrate particular principles of this form of 
HVPSU design. Finally, simulation results for the original HVPSU from Chapter 5 
(hereinafter referred to as PSU-5) and the replacement HVPSU from Chapter 6 




PSU-1 (Figure 56) attempts to make as few alterations to PSU-5 (Figure 31 and 
Figure 32 or Figure 60) as possible to gain the required voltage regulation. First the 
battery voltage which ranges from approximately 9.5 V to 6.5 V is regulated to 4.5 V 
by a high efficiency buck converter (TPS62122). That voltage is then doubled to 
generate a total available regulated voltage of 9 V by a MAX660. The MAX660 is an 
efficient voltage doubler for voltages and currents in this range, but is limited to 
multiplying a maximum of 5.5 V. From this regulated 9 V supply, the voltage is stepped 
up to 72 V using the same architecture as PSU-5. 
 
Figure 56. Representative diagram of PSU-1. U1 bucks the battery voltage to 4.5 V, U2 then doubles that 
voltage to a regulated 9 V. This is then used as the input for the architecture of PSU-5 (Figure 31 and Figure 32 
or Figure 60). 
B.4.2 PSU-2 and PSU-3 
In PSU-2 (Figure 57) and PSU-3 (Figure 58) a combination of doublers and inverters 
in a ‘winged’ architecture is compared to a solution using the same number of parts, 
but only as voltage inverters. Not many parts perform efficient voltage doubling, and 
inputs are typically limited to lower voltages. The MAX660 performs well with low 
quiescent current and low output impedance. A Li-Po battery voltage of between 3 and 
4.2 V is boosted to 5.15 V using an efficient boost converter (TPS61028). This voltage 
is then doubled and inverted as needed by a cascading series of inverters and doublers. 
Both designs produce the same relative outputs, and use the same parts, but the cascades 




Figure 57. Representative diagram of PSU-2. U1 boosts the battery voltage to 5.15 V. From there DBL1 
through DBL6 increase the voltage to 36.05 V. At the same time, INV1 through INV7 repeatedly invert the 
lowest available 5.15 V to finally produce -36.05 V. 
 
Figure 58. Representative diagram of PSU-3. U1 boosts the battery voltage to 5.15 V. That voltage is then 
inverted in steps of 5.15 V 13 times by INV1 through INV13 to ultimately produce a total voltage of 72.1 V. 
PSU-2 and PSU-3 produce the same relative voltage outputs and have the same circuit components, but in 




PSU-4 (Figure 59) investigates using a high efficiency low voltage buck converter 
(MAX1920) from a single LiPo cell (3-4.2 V) to produce a very low regulated 
voltage (2.7 V). This voltage is then converted to produce the required output using 
several chips in various configurations. The hypothesis of this design being that the 
improved efficiency of using buck conversion at low voltages and therefore high 
currents may be sufficient to justify the additional multiplications required to attain the 
final output voltage. We will compare PSU-4 to PSU-6 (Figure 40 or Figure 61) which 
has a similar architecture but boosts the battery voltage instead of bucking it. PSU-4 
and PSU-6 make use of ICL7662’s instead of TC962’s because they are available in a 
smaller package and can operate at higher voltages. 
 
Figure 59. Representative diagram of PSU-4. The battery voltage is bucked to a regulated 2.25 V by U1. U2 
then acts as a doubler to produce 4.5 V. U3, U4, U5 and U6 then act as inverters to produce -49.5 V. U5 also 
acts in its inefficient voltage doubling mode to produce a positive 22.5 V. This architecture is very similar to 
PSU-6 (Figure 40 or Figure 61) except the initial 4.5 V is generated in a different manner. 
B.4.4 PSU-5 and PSU-6 
Figure 60 and Figure 61 are representative diagrams of PSU-5 and PSU-6, repeated 
from Chapter 5 (Figure 32) and Chapter 6 (Figure 40) for convenience. For more detail 




Figure 60. Explanatory diagram of the PSU-5 repeated from Figure 32. Four inverters, U1-U4, convert 9 V 
from the battery to a 72 V power supply with a midpoint tap at 36 V. Each inverter takes the difference 
between REF and IN as an input and inverts it below the REF input. The inverters can accept a maximum of 
18 V as an input. The labels A, B, C and D correspond to the circuitry blocks with the same labels in Figure 31. 
Figure 61. Explanatory diagram of PSU-6, repeated from Figure 40, a high efficiency power supply that 
regulates a 3 to 4.2 V battery output to +36 V and -36 V supply. The part at “D” uses the ICL7662 in both its 
doubling mode and inverting mode. 
B.5 Simulation results 
B.5.1 PSU-1 
PSU-1 (Figure 56) seeks to implement the original HVPSU (PSU-5, Figure 32 or 
Figure 60) with as few changes as possible. Figure 62 shows the simulated efficiency 
and total voltage output of the two HVPSU designs for different battery voltages, and 
the range of output currents required by the HVCP. The maximum battery voltage of 
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9 V is used, as opposed to a more accurate 9.5 V since PSU-5 cannot operate above 9 V 
as this would exceed the voltage limits of the TC962. 
 
Figure 62. Graphs of the power conversion efficiency (left) and the total output voltage (right) of PSU-1 and 
PSU-5 for different input voltages and output currents required by the HVCP. The gradient of the voltage 
drop with current draw indicates the output impedance of the power supply and is indicated on the plot. 
The voltage output graph strongly reflects the design flaw of HVPSU-5, showing a 
large reduction in compliance with falling battery voltage (~54 V output from ~68 V). 
This loss of compliance is not acceptable. The graphs indicate that the additional 
regulation in PSU-1 causes reduced efficiency. However, when the current draw is 
highest, and efficiency is most important, the efficiency is still substantially higher than 
commercially available solutions (~50% vs ~75%). Further, the additional two parts do 
not add significant physical bulk. Despite the efficiency loss, this is a feasible option to 
replace HVPSU-5. 
B.5.2 PSU-2 and PSU-3 
The purpose of simulating PSU-2 (Figure 57) and PSU-3 (Figure 58) was to investigate 
a particular principal of the design of this form of HVPSU rather than to find a specific 
replacement for HVPSU-5. Each uses the same 14 parts and produces the same relative 
output voltages in theory. The substantial bulk of using this many parts removes either 
as an option to replace PSU-5, but provides valuable insights into the trade-offs of such 




Figure 63. Graphs of the power conversion efficiency (left) and the total output voltage (right) of PSU-2 and 
PSU-3 for different input voltages and output currents required by the HVCP. The gradient of the voltage 
drop with current draw indicates the output impedance of the power supply (Rout). 
Firstly, the detrimental effect of the additional quiescent current of cascading multiple 
devices is not as large as might be anticipated. Even though PSU-2 has 14 parts, it still 
attains a superior efficiency and output impedance to PSU-1. The results also indicate 
that the depth of the cascade has a large effect on the output impedance of the HVPSU. 
PSU-2 has a depth of only 7 parts, whereas PSU-3 has a depth of 13 parts, which is the 
cause of the more than three-fold increase in the output impedance of the supply and 
the subsequent substantial reduction in power conversion efficiency. This effect may 
be anticipated by the model presented in [159] and Figure 55. 
If PSU-2 were not so physically large, its unexpected good performance justifies its use 
as a replacement for PSU-5. Also worth considering, is the financial cost of including 
so many inverter parts as a downside of this design. Parts capable of doubling larger 
voltages, thus reducing the part count in such an architecture, do not double voltages 
with similar efficiency to the MAX660, which can only operate up to 5.5 V. The 
principles demonstrated in this simulation, however, do indicate that using at least some 
voltage doubling is ultimately beneficial in such designs.  
B.5.3 PSU-4 
PSU-4 (Figure 59) attempts to use what we have learnt about regulated switching 
converters, (in that parts are more efficient for higher output currents that would occur 
in the HVPSU at lower voltages), and what we have learnt about the benefit of including 
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some voltage doubling in the architecture (see B.5.2). We compare in simulation 
PSU-4, which bucks the battery voltage to create a higher output current from the 
regulated stage, to PSU-6 (Figure 40) which has the same architecture but boosts the 
battery voltage (Figure 64). 
 
Figure 64. Graphs of the power conversion efficiency (left) and the total output voltage (right) of PSU-4 and 
PSU-6 for different input voltages and output currents required by the HVCP. The gradient of the voltage 
drop with current draw indicates the output impedance of the power supply (Rout). 
Both PSU-4 and PSU-6 perform better than PSU-1 with improved efficiency and 
similar voltage compliance. The increased output impedance of PSU-4 over PSU-1 and 
PSU-6 is likely caused by adding the additional boost stage increasing the cascade 
depth. It is clear that the benefit of increased output current from stepping down the 
battery voltage is exceeded by the detriment of the additional voltage multiplication 
subsequently required over using the architecture of PSU-6. 
PSU-6 appears to provide the best balance of output compliance, efficiency and 
physical size and is the best candidate of those examined to replace PSU-5 with an 
updated HVPSU that is still efficient but insensitive to battery voltage changes. 
B.5.4 PSU-5 and PSU-6 
Finally, PSU-6 (Figure 40 or Figure 61), the architecture that was selected for 
implementation in Chapter 6 is compared with the originally implemented HVPSU 
from Chapter 5 (Figure 32 or Figure 60). The simulated results are compared to actual 




Figure 65. Graphs of the power conversion efficiency (left) and the total output voltage (right) of PSU-5 and 
PSU-6 for different input voltages and output currents required by the HVCP. The gradient of the voltage 
drop with current draw indicates the output impedance of the power supply and is indicated on the plot. The 
measured data of the physically constructed circuits is shown as individual data points. 
The collected data follows very similar form and amplitude to the simulations thus 
validating the use of the tool for this design purpose. The deviations from the expected 
values can be ascribed to the ranges in possible values for the various parts’ output 
impedance, efficiency and quiescent current. For the simulation only the “typical 
values” from the datasheet were used unless it provided an indication to adjust this 
value based on current draw or supply voltage. 
PSU-6 has very similar efficiency and compliance to PSU-5. It maintains compliance 
with changes in the battery voltage whereas PSU-5 tracks the battery voltage 
proportionally without any regulation stage. 
PSU-6 has the added benefit of being powered from a single cell Li-Po battery which 
has high energy density, is available in many different battery capacities which often 
include charge and discharge protection circuitry built in. Using a low voltage battery 
that is near the mid-supply voltage of the HVPSU also allows for a single battery to be 
used for the HVPSU and the control and instrumentation circuitry (which can be 




This appendix outlines the design process of a battery powered High Voltage Power 
Supply (HVPSU) for a wearable current stimulator. Developed simulation software 
allows various types of power converter chips to be easily connected together in any 
configuration to examine the interaction of currents and energy losses regardless of the 
complexity of the design. All simulation software is available in the digital appendix 
folder “HVPSU simulation code”. The software showed good agreement with empirical 
data from constructed circuits and is thus a useful tool for steady state simulations of 
this kind. 
The simulations led to an improved understanding of these architectures which resulted 
in the design of an HVPSU that appropriately balances the design constraints. The 
updated HVPSU is more optimised than the previous version and ultimately sacrifices 
little in performance and physical size, but has multiple added benefits. 
The updated HVPSU is physically small, makes use of high-density battery technology 
and produces an efficient and regulated output voltage sufficient in amplitude for all 
current draws required and battery voltages. 
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APPENDIX C COMMON MODE GAIN CALIBRATION OF 
HIGH VOLTAGE INSTRUMENTATION CIRCUITRY 
The drawback of the self-instrumentation circuitry (see Chapter 6.2.2) is that to achieve 
the required CMRR the Wheatstone Bridges need to be balanced beyond the accuracy 
of commercially available resistors. What is required is that the ratio of the equivalents 
to R1:R2 is the same as R3:R4 regardless of the overall resistance or exact ratio 
(Figure 66). This must also be the case under AC conditions for reactive impedance. 
The “output voltage” measuring instrumentation amplifier (INA2 in Figure 43), creates 
imbalance in addition to the resistor tolerances, since it is connected to only one arm of 
each bridge. This adds an effective parallel resistance and capacitance that is hard to 
predict. 
 
Figure 66. Diagram depicting a general Wheatstone Bridge connected to a difference amplifier with a gain of 
‘G’. The labels of R1, R2, R3 and R4 here do not correspond to values in other schematics and are used for 
generic calculations for circuits of this form. VA and VB are the two high voltage input voltages. 
The process of balancing the Wheatstone Bridge has two steps: 1) Apply a common 
signal to both differential inputs, 2) Use the relative amplitudes of the input signal and 
the erroneous output signal to calculate the magnitude and location of the impedance 
mismatch. This process should first be conducted for DC mismatch (resistance only) 
and then for AC mismatch (capacitance only). 
The circuit presented in Chapter 6 has jumpers that disconnect one side of each bridge 
and allows it to be connected to the complimentary bridge terminal, the equivalent of 
disconnecting VB from its source voltage and connecting it to the VA terminal. 
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The input signal is now completely common-mode and the desired output is zero. This 
common mode input voltage is referred to as Vin. 
The imbalance is always either to the positive (R1/R2) or the negative arm (R3/R4), 
consequently the bridge can be balanced by adding resistance to R2 or R4 as required, 
or to R1 or R3. Thinking of it this way means that resistance never needs to be removed 
to attain balance. Adding to R1 or R3, being large 1 MΩ resistors, is the better choice, 
as the relative error will be less sensitive to small absolute resistance errors. 
The equation for the DC offset resistance to add is derived as follows: 
We assume that the imbalance seen is created by an added resistance ΔR to R1. 
Depending on the sign of Vout relative to Vin, R may be positive or negative. A 
negative R is the same as ΔR being added to R3. In either case, once the imbalance’s 
location and magnitude are calculated, it must be added to the complimentary branch 
of the bridge to attain balance, i.e. positive R, you must add to R3, negative R you 
must add to R1. 
Note that by design in our circuit R1 = R3 = 1 M, and will hereinafter be referred to 
as capital R. Also, that R2 = R4 = 20 k and will hereinafter be referred to as 
lower-case r. The voltage at the two output terminals is calculated as a standard resistor 
divider: 
 𝑽+ = 𝑽𝒊𝒏 (
𝒓
𝑹 + ∆𝑹 + 𝒓
) 
11 





The output of the difference amplifier is then the difference multiplied by a known gain: 
 𝑽𝒐𝒖𝒕 = 𝑮(𝑽+ − 𝑽−) 13 
Substituting V+ and V-: 
 
𝑽𝒐𝒖𝒕 = 𝑮 ( 𝑽𝒊𝒏 (
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𝐑 + ∆𝐑 + 𝐫 =
𝐆. 𝐕𝐢𝐧. 𝐫(𝐑 + 𝐫)






𝐆. 𝐕𝐢𝐧. 𝐫. (𝐑 + 𝐫)
𝐕𝐨𝐮𝐭(𝐑 + 𝐫) + 𝐆. 𝐕𝐢𝐧. 𝐫
− (𝑹 + 𝒓) 
17 
From this the required resistance to be added to the circuit, given a particular 
combination input values and output values, can be calculated. The know values are: 
R = 1 MΩ, r = 20 kΩ and G = 24.256 or 77.923 for the high side and low side currents 
sensing respectively (See Chapter 6). If a known calibration load is used on the current 
pump output then Vin is also known, and Vout can be measured with an oscilloscope or 
the microcontroller. 
The most optimal way to balance the bridge is to set the output of the current pump to 
drive a slow sine wave signal (<10 Hz) at ±1 mA into a large load (≥ 60 kΩ). This 
creates a large common mode signal (60 V), without the capacitive imbalance playing 
a significant role. Using an alternating signal allows us to use the peak to peak 
amplitude ignoring any zero offset errors. 
After inserting the appropriate balancing resistor, which is typically an addition of a 
few hundred ohms to one of the 1 MΩ resistors, repeat the process and make a second 
adjustment combining the second calculated value with the first. Two correctly 
calculated adjustments are usually enough to bring the DC common mode error near to 
the measured noise amplitude of about 10 mV. This is equivalent of approximately 
±0.35% DC common mode error. 
Next a capacitor must be added to balance the AC common mode gain. The capacitive 
mismatch is dominated by the load of INA2’s inputs (see Figure 43) on the bridge and 
is always placed at the same point in the bridge. For the high side current this is over 
the equivalent of R4 and for the low side current over R2. This is why there is only one 
option for location of the balancing capacitors, which are placed over the 
complimentary arms of the bridge (R2 for the high side and R4 for the low side). 
To measure Vout for the AC mismatch drive a ±1 mA sine wave with a frequency 
>= 500 Hz into a large load (≥ 60 kΩ). 
A similar derivation as above can be performed for Δc placed in parallel to R2 or R4. 
Here we will derive only for R2, the negative of the result will apply for placement 
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at R4. Note here that Δc will now be a complex impedance creating a phase offset at 
the output: 
 















where f is the driving frequency and j is the complex unit vector. 
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𝟐𝝅𝒇𝒋∆𝒄𝒓𝑹 + 𝑹 + 𝒓
) 
21 
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In practice the adjustment with the above result produces a good first approximation, 
usually in the order of 15 pF, but subsequent trial and error will reduce the imbalance 
close to the noise amplitude. In general, a helpful rule is that too much capacitance over 
R2 causes the output to phase lag the input and too little capacitance over R2 causes it 
to phase lead the output. The converse is true for capacitance over R4.  
The discrepancy between the ideal R or c and best values in practice, is likely due 
to the imbalance being caused in part due to resistance mismatch and stray capacitance 
as modelled, and in part due to leakage current into the difference amplifier, which is 
not modelled by the above equations. 
In summary to perform the calibration for the specific circumstances of the designed 
stimulator: 
Set the output amplitude to ±1 mA. 
Attach an artificial output load of 60 k. 
To perform the resistive balancing: 
Set the output frequency to 10 Hz. 




𝟓. 𝟗𝟑𝟕𝟖𝟐 × 𝟏𝟎𝟕
𝟏. 𝟎𝟐𝐕𝐨𝐮𝐭 + 𝟓𝟖. 𝟐𝟏𝟒
− 𝟏. 𝟎𝟐 × 𝟏𝟎𝟔 
28 
for high side current, or 
 
∆𝐑 =
𝟏. 𝟗𝟎𝟕𝟓𝟔 × 𝟏𝟎𝟖
𝟏. 𝟎𝟐𝐕𝐨𝐮𝐭 + 𝟏𝟖𝟕. 𝟎𝟏𝟓
− 𝟏. 𝟎𝟐 × 𝟏𝟎𝟔 
29 
for low side current. 
If R is positive then place R in series to the equivalent of R3 in the circuit. If R is 
negative then place R in series to the equivalent of R1 in the circuit. 
Calculate R again. Add the result to the previous result and make the necessary 
adjustment in the circuit. 
To perform the capacitive balancing: 
Set the output frequency to 500 Hz. 
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Calculate c or use a lookup table: 
 
∆𝒄 =
𝟓. 𝟗𝟑𝟕𝟖𝟐 × 𝟏𝟎𝟕
𝟏. 𝟎𝟐𝐕𝐨𝐮𝐭 + 𝟓𝟖. 𝟐𝟏𝟒
− 𝟏. 𝟎𝟐 × 𝟏𝟎𝟔
𝟔. 𝟐𝟖𝟑𝟐 × 𝟏𝟎𝟏𝟑
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for high side current, or 
 
∆𝒄 =
𝟏. 𝟗𝟎𝟕𝟓𝟔 × 𝟏𝟎𝟖
𝟏. 𝟎𝟐𝐕𝐨𝐮𝐭 + 𝟏𝟖𝟕. 𝟎𝟏𝟓
− 𝟏. 𝟎𝟐 × 𝟏𝟎𝟔
𝟔. 𝟐𝟖𝟑𝟐 × 𝟏𝟎𝟏𝟑
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for low side current. 
Place c at C29 for high side current and C30 for low side current. Then adjust by trial 
and error. 
If Vout is leading Vin: increase capacitance and vice versa. 
While at first glance this process may seem overly complicated, in reality it takes just 
a few minutes to perform, and the benefits of instrumenting the circuit in this way 
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